UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
|
| |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2014
or
|
| |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-32293
|
| | |
| | |
HARTFORD LIFE INSURANCE COMPANY |
| (Exact name of registrant as specified in its charter) | |
|
| | |
Connecticut | | 06-0974148 |
(State or other jurisdiction of | | (I.R.S. Employer |
incorporation or organization) | | Identification No.) |
200 Hopmeadow Street, Simsbury, Connecticut 06089
(Address of principal executive offices)
(860) 547-5000
(Registrant’s telephone number, including area code)
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
|
| | | | | | |
Indicate by check mark: | | Yes | | No |
• whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | | x | | | ¨ | |
| | | | | | |
• whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). | | x | | | ¨ | |
|
• whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. |
|
| | | |
Large accelerated filer o | Accelerated filer o | Non Accelerated filer x | Smaller reporting company o |
|
| | | |
• whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) | ¨ | | x |
As of May 2, 2014, there were outstanding 1,000 shares of Common Stock, $5,690 par value per share, of the registrant.
The registrant meets the conditions set forth in General Instruction (H) (1) of Form 10-Q and is therefore filing this Form with the reduced disclosure format.
HARTFORD LIFE INSURANCE COMPANY
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014
TABLE OF CONTENTS
|
| | |
Item | Description | Page |
| | |
| | |
| | |
1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
2. | | |
3. | | |
4. | | |
| | |
| | |
| | |
1. | | |
1A. | | |
6. | | |
| | |
| | |
| | |
Forward-Looking Statements
Certain of the statements contained herein are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,” “projects,” and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding economic, competitive, legislative and other developments. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. They have been made based upon management’s expectations and beliefs concerning future developments and their potential effect upon Hartford Life Insurance Company and its subsidiaries (collectively, the “Company”). Future developments may not be in line with management’s expectations or may have unanticipated effects. Actual results could differ materially from expectations, depending on the evolution of various factors, including those set forth in Part I, Item 1A, Risk Factors in the Company’s 2013 Form 10-K Annual Report. These important risks and uncertainties include:
| |
• | challenges related to the Company's current operating environment, including global political, economic and market conditions, and the effect of financial market disruptions, economic downturns or other potentially adverse macroeconomic developments on the attractiveness of our products, the returns in our investment portfolios and the hedging costs associated with the our variable annuities business; |
| |
• | the risks, challenges and uncertainties associated with the strategic realignment of The Hartford Financial Services Group, Inc. ("The Hartford") to focus on its property and casualty, group benefits and mutual fund businesses; |
| |
• | the risks, challenges and uncertainties associated with The Hartford's capital management plan, expense reduction initiatives and other actions, which may include acquisitions, divestitures or restructurings; |
| |
• | execution risk related to the continued reinvestment of our investment portfolios and refinement of our hedge program for our run-off annuity block; |
| |
• | market risks associated with our business, including changes in interest rates, credit spreads, equity prices, market volatility and foreign exchange rates, and implied volatility levels, as well as continuing uncertainty in key sectors such as the global real estate market; |
| |
• | the impact on our investment portfolio if our investment portfolio is concentrated in any particular segment of the economy; |
| |
• | volatility in our statutory and U.S. GAAP earnings and potential material changes to our results resulting from our adjustment of our risk management program to emphasize protection of economic value; |
| |
• | the impact on our statutory capital of various factors, including many that are outside the Company’s control, which can in turn affect our credit and financial strength ratings, cost of capital, regulatory compliance and other aspects of our business and results; |
| |
• | risk associated with the use of analytical models in making decisions in key areas such as underwriting, capital, hedging, and reserving; |
| |
• | risks to our business, financial position, prospects and results associated with negative rating actions or downgrades in the Company's financial strength and credit ratings or negative rating actions or downgrades relating to our investments; |
| |
• | the potential for differing interpretations of the methodologies, estimations and assumptions that underlie the valuation of the Company’s financial instruments that could result in changes to investment valuations; |
| |
• | the subjective determinations that underlie the Company’s evaluation of other-than-temporary impairments on available-for-sale securities; |
| |
• | losses due to nonperformance or defaults by others; |
| |
• | the potential for further acceleration of deferred policy acquisition cost amortization; |
| |
• | the potential for further impairments of our goodwill or the potential for changes in valuation allowances against deferred tax assets; |
| |
• | the possible occurrence of terrorist attacks and the Company’s ability to contain its exposure, including the effect of the absence or insufficiency of applicable terrorism legislation on coverage; |
| |
• | the possibility of a pandemic, or other natural or man-made disaster that may adversely affect our businesses; |
| |
• | the response of reinsurance companies under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; |
| |
• | the cost and other effects of increased regulation as a result of the implementation of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and the potential effect of other domestic and foreign regulatory developments, including those that could adversely impact the Company’s operating costs and required capital levels; |
| |
• | unfavorable judicial or legislative developments; |
| |
• | the Company’s ability to maintain the availability of its systems and safeguard the security of its data in the event of a disaster, cyber or other information security incident or other unanticipated event; |
| |
• | the risk that our framework for managing operational risks may not be effective in mitigating material risk and loss to the Company; |
| |
• | the potential for difficulties arising from outsourcing and similar third-party relationships; |
| |
• | the impact of changes in federal or state tax laws; |
| |
• | the impact of potential changes in accounting principles and related financial reporting requirements; |
| |
• | the Company’s ability to protect its intellectual property and defend against claims of infringement; and |
| |
• | other factors described in such forward-looking statements. |
Any forward-looking statement made by the Company in this document speaks only as of the date of the filing of this Form 10-Q. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise.
Part I. FINANCIAL INFORMATION
| |
Item 1. | Financial Statements |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholder of
Hartford Life Insurance Company
Hartford, Connecticut
We have reviewed the accompanying condensed consolidated balance sheet of Hartford Life Insurance Company and subsidiaries (the "Company") as of March 31, 2014, and the related condensed consolidated statements of operations, comprehensive income, changes in stockholder’s equity, and cash flows for the three-month periods ended March 31, 2014 and 2013. These interim financial statements are the responsibility of the Company's management.
We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to such condensed consolidated interim financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2013, and the related consolidated statements of operations, comprehensive income, changes in stockholder’s equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2014 (except for Note 20, as to which the date is April 25, 2014), we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2013 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
DELOITTE & TOUCHE LLP
Hartford, Connecticut
May 2, 2014
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
|
| | | | | | |
| Three Months Ended March 31, |
|
(In millions) | 2014 | 2013 |
| (Unaudited) |
Revenues | | |
Fee income and other | $ | 317 |
| $ | 353 |
|
Earned premiums | (123 | ) | 39 |
|
Net investment income: | | |
Securities available-for-sale and other | 407 |
| 432 |
|
Net realized capital gains (losses): | | |
Total other-than-temporary impairment (“OTTI”) losses | (8 | ) | (17 | ) |
OTTI losses recognized in other comprehensive income | 1 |
| 4 |
|
Net OTTI losses recognized in earnings | (7 | ) | (13 | ) |
Net realized capital gains on business dispositions | — |
| 1,560 |
|
Other net realized capital losses | (99 | ) | (104 | ) |
Total net realized capital gains (losses) | (106 | ) | 1,443 |
|
Total revenues | 495 |
| 2,267 |
|
Benefits, losses and expenses | | |
Benefits, loss and loss adjustment expenses | 254 |
| 456 |
|
Amortization of deferred policy acquisition costs and present value of future profits | 32 |
| 44 |
|
Insurance operating costs and other expenses | 166 |
| (243 | ) |
Reinsurance loss on dispositions, including reduction in goodwill of $250 in 2013 | — |
| 1,492 |
|
Dividends to policyholders | (1 | ) | 5 |
|
Total benefits, losses and expenses | 451 |
| 1,754 |
|
Income from continuing operations before income taxes | 44 |
| 513 |
|
Income tax expense (benefit) | (13 | ) | 146 |
|
Income from continuing operations, net of tax | 57 |
| 367 |
|
Income from discontinued operations, net of tax | — |
| 19 |
|
Net income | 57 |
| 386 |
|
Net income attributable to noncontrolling interest | 1 |
| 6 |
|
Net income attributable to Hartford Life Insurance Company | $ | 56 |
| $ | 380 |
|
See Notes to Condensed Consolidated Financial Statements
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
|
| | | | | | |
| Three Months Ended March 31, |
|
(In millions) | 2014 | 2013 |
| (Unaudited) |
Comprehensive Income | | |
Net income | $ | 57 |
| $ | 386 |
|
Other comprehensive income (loss): | | |
Change in net unrealized gain/loss on securities | 315 |
| (792 | ) |
Change in net gain/loss on cash-flow hedging instruments | (2 | ) | (76 | ) |
Change in foreign currency translation adjustments | (1 | ) | (41 | ) |
Total other comprehensive income/(loss) | 312 |
| (909 | ) |
Total comprehensive income/(loss) | 369 |
| (523 | ) |
Less: comprehensive income attributable to noncontrolling interest | $ | 1 |
| 6 |
|
Total comprehensive income/(loss) attributable to Hartford Life Insurance Company | $ | 368 |
| (529 | ) |
See Notes to Condensed Consolidated Financial Statements
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
|
| | | | | | |
(In millions, except for share data) | March 31, 2014 | December 31, 2013 |
| (Unaudited) |
Assets | | |
Investments: | | |
Fixed maturities, available-for-sale, at fair value (amortized cost of $25,971 and $27,188) (includes variable interest entity assets, at fair value, of $8 and $12) | $ | 27,529 |
| $ | 28,163 |
|
Fixed maturities, at fair value using the fair value option (includes variable interest entity assets, at fair value, of $125 and $131) | 917 |
| 791 |
|
Equity securities, trading, at fair value (cost of $11 and $10) | 12 |
| 12 |
|
Equity securities, available-for-sale, at fair value (cost of $306 and $362) | 315 |
| 372 |
|
Mortgage loans (net of allowance for loan losses of $12 and $12) | 3,315 |
| 3,470 |
|
Policy loans, at outstanding balance | 1,425 |
| 1,416 |
|
Limited partnerships, and other alternative investments (includes variable interest entity assets of $3 and $4) | 1,343 |
| 1,329 |
|
Other investments | 176 |
| 270 |
|
Short-term investments (includes variable interest entity assets, of $12 as of March 31, 2014) | 2,086 |
| 1,952 |
|
Total investments | 37,118 |
| 37,775 |
|
Cash | 599 |
| 446 |
|
Premiums receivable and agents’ balances | 32 |
| 33 |
|
Reinsurance recoverables | 19,671 |
| 19,794 |
|
Deferred policy acquisition costs and present value of future profits | 648 |
| 689 |
|
Deferred income taxes, net | 1,909 |
| 2,110 |
|
Other Assets | 892 |
| 994 |
|
Separate account assets | 138,480 |
| 140,874 |
|
Total assets | $ | 199,349 |
| $ | 202,715 |
|
Liabilities | | |
Reserve for future policy benefits and unpaid losses and loss adjustment expenses | $ | 13,028 |
| $ | 12,874 |
|
Other policyholder funds and benefits payable | 36,063 |
| 36,856 |
|
Other liabilities (including variable interest entity liabilities of $30 and $35) | 3,966 |
| 3,872 |
|
Separate account liabilities | 138,480 |
| 140,874 |
|
Total liabilities | 191,537 |
| 194,476 |
|
Commitments and Contingencies (Note 9) |
|
|
|
|
Stockholder’s Equity | | |
Common stock—1,000 shares authorized, issued and outstanding, par value $5,690 | 6 |
| 6 |
|
Additional paid-in capital | 6,164 |
| 6,959 |
|
Accumulated other comprehensive income, net of tax | 886 |
| 574 |
|
Retained earnings | 756 |
| 700 |
|
Total stockholder’s equity | 7,812 |
| 8,239 |
|
Total liabilities and stockholder’s equity | $ | 199,349 |
| $ | 202,715 |
|
See Notes to Condensed Consolidated Financial Statements
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Stockholder’s Equity
|
| | | | | | | | | | | | | | | | | | |
(In millions) | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings (Accumulated Deficit) | Non- Controlling Interest | Total Stockholder’s Equity |
| (Unaudited) |
Three Months Ended March 31, 2014 | | | | | | |
Balance, beginning of period | $ | 6 |
| $ | 6,959 |
| $ | 574 |
| $ | 700 |
| $ | — |
| $ | 8,239 |
|
Capital contributions to parent |
| (795 | ) | — |
|
|
|
|
| (795 | ) |
Net income |
|
|
|
|
|
| 56 |
| 1 |
| 57 |
|
Change in non-controlling interest ownership |
|
|
|
|
|
|
|
| (1 | ) | (1 | ) |
Total other comprehensive income |
|
|
|
| 312 |
|
|
|
|
| 312 |
|
Balance, end of period | $ | 6 |
| $ | 6,164 |
| $ | 886 |
| $ | 756 |
| $ | — |
| $ | 7,812 |
|
| | | | | | |
Three Months Ended March 31, 2013 | | | | | | |
Balance, beginning of period | $ | 6 |
| $ | 8,155 |
| $ | 1,987 |
| $ | 235 |
| $ | — |
| $ | 10,383 |
|
Capital contributions to parent |
|
| (1,196 | ) |
|
|
|
|
|
| (1,196 | ) |
Dividends declared |
|
|
|
|
|
| (1 | ) |
|
| (1 | ) |
Net income |
|
|
|
|
|
| 380 |
| 6 |
| 386 |
|
Change in non-controlling interest ownership |
|
|
|
|
|
|
|
| (6 | ) | (6 | ) |
Total other comprehensive loss |
|
|
|
| (909 | ) |
|
|
|
| (909 | ) |
Balance, end of period | $ | 6 |
| $ | 6,959 |
| $ | 1,078 |
| $ | 614 |
| $ | — |
| $ | 8,657 |
|
See Notes to Condensed Consolidated Financial Statements
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
|
| | | | | | |
| Three Months Ended March 31, |
(In millions) | 2014 | 2013 |
| (Unaudited) |
Operating Activities | | |
Net income | $ | 57 |
| $ | 386 |
|
Adjustments to reconcile net income to net cash provided by operating activities | | |
Amortization of deferred policy acquisition costs and present value of future profits | 32 |
| 44 |
|
Additions to deferred policy acquisition costs and present value of future profits | (5 | ) | (2 | ) |
Change in: | | |
Reserve for future policy benefits and unpaid losses and loss adjustment expenses | 62 |
| (54 | ) |
Reinsurance recoverables | (114 | ) | (5 | ) |
Receivables and other assets | 78 |
| (66 | ) |
Payables and accruals | 592 |
| (480 | ) |
Accrued and deferred income taxes | 21 |
| 660 |
|
Net realized capital (gains) losses | 106 |
| (1,434 | ) |
Net disbursements from investment contracts related to policyholder funds — international unit-linked bonds and pension products | — |
| (75 | ) |
Net decrease in equity securities, trading | — |
| 74 |
|
Reinsurance loss on dispositions | — |
| 1,492 |
|
Depreciation and amortization | 3 |
| 18 |
|
Other, net | 49 |
| (249 | ) |
Net cash provided by operating activities | 881 |
| 309 |
|
Investing Activities | | |
Proceeds from the sale/maturity/prepayment of: | | |
Fixed maturities, available-for-sale | 3,115 |
| 3,827 |
|
Fixed maturities, fair value option | 55 |
| 49 |
|
Equity securities, available-for-sale | 43 |
| 48 |
|
Mortgage loans | 62 |
| 106 |
|
Partnerships | 25 |
| 22 |
|
Payments for the purchase of: | | |
Fixed maturities, available-for-sale | (2,425 | ) | (3,357 | ) |
Fixed maturities, fair value option | (167 | ) | (31 | ) |
Equity securities, available-for-sale | (8 | ) | (45 | ) |
Mortgage loans | (34 | ) | (30 | ) |
Partnerships | (16 | ) | (29 | ) |
Proceeds from business sold | — |
| 460 |
|
Change in derivatives, net | 74 |
| (742 | ) |
Change in policy loans, net | 9 |
| (6 | ) |
Change in short-term investments, net | (159 | ) | 1,187 |
|
Change in all other, net | (2 | ) | (35 | ) |
Net cash provided by investing activities | 572 |
| 1,424 |
|
Financing Activities | | |
Deposits and other additions to investment and universal life-type contracts | 933 |
| 2,215 |
|
Withdrawals and other deductions from investment and universal life-type contracts | (5,008 | ) | (6,590 | ) |
Net transfers from separate accounts related to investment and universal life-type contracts | 3,569 |
| 4,082 |
|
Net (decrease) increase in securities loaned or sold under agreements to repurchase | — |
| (274 | ) |
Capital contributions | (795 | ) | (1,211 | ) |
Fee to recapture affiliate reinsurance | — |
| (347 | ) |
Net repayments at maturity or settlement of consumer notes | (6 | ) | (29 | ) |
Net cash used for financing activities | (1,307 | ) | (2,154 | ) |
Foreign exchange rate effect on cash | 7 |
| (1 | ) |
Net increase (decrease) in cash | 153 |
| (422 | ) |
Cash — beginning of period | 446 |
| 1,342 |
|
Cash — end of period | $ | 599 |
| $ | 920 |
|
Supplemental Disclosure of Cash Flow Information: | | |
Net cash received during the period for income taxes | $ | (38 | ) | $ | (4 | ) |
Noncash capital contributions received | (2 | ) | — |
|
See Notes to Condensed Consolidated Financial Statements
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in millions, unless otherwise stated)
(Unaudited)
1. Basis of Presentation and Significant Accounting Policies
Hartford Life Insurance Company (together with its subsidiaries, “HLIC”, “Company”, “we” or “our”) is a provider of insurance and investment products in the United States (“U.S.”) and is a wholly-owned subsidiary of Hartford Life, Inc., a Delaware corporation ("HLI"). The Hartford Financial Services Group, Inc. (“The Hartford”) is the ultimate parent of the Company.
Effective March 3, 2014, The Hartford made Hartford Life and Accident Insurance Company ("HLA") the single nationwide underwriting company for its Group Benefits business by capitalizing HLA to support the Group Benefits business and separating it from the legal entities that support The Hartford's Talcott Resolution operating segment. On January 30, 2014, The Hartford received approval from the CTDOI for Hartford Life and Annuity Insurance Company ("HLAI"), a wholly owned subsidiary of the Company, and the Company to dividend approximately $800 of cash and invested assets to HLA and this dividend was paid on February 27, 2014. All of the issued and outstanding equity of the Company was then distributed from HLA to Hartford Life, Inc.
On January 1, 2013, HLI completed the sale of its Retirement Plans business to Massachusetts Mutual Life Insurance Company ("MassMutual") and on January 2, 2013 HLI completed the sale of its Individual Life insurance business to The Prudential Insurance Company of America, a subsidiary of Prudential Financial, Inc. ("Prudential"). On December 12, 2013, the Company completed the sale of the U.K variable annuity business of Hartford Life International Limited ("HLIL"), an indirect wholly-owned subsidiary. As a result of this transaction, the operations of the Company's U.K. variable annuity business meet the criteria for reporting as discontinued operations as further discussed in Note 13 - Discontinued Operations of Notes to Condensed Consolidated Financial Statements. For further discussion of these and other such transactions, see Note 2 - Business Dispositions of Notes to Condensed Consolidated Financial Statements.
The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, which differ materially from the accounting practices prescribed by various insurance regulatory authorities. These Condensed Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company's 2013 Form 10-K Annual Report. The results of operations for interim periods are not necessarily indicative of the results that may be expected for the full year. The accompanying Condensed Consolidated Financial Statements and Notes as of March 31, 2014, and for the three months ended March 31, 2014 and 2013 are unaudited. These financial statements reflect all adjustments (generally consisting only of normal accruals) which are, in the opinion of management, necessary for the fair presentation of the financial position, results of operations and cash flows for the interim periods. The Company's significant accounting policies are summarized in Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Consolidated Financial Statements included in the Company's 2013 Form 10-K Annual Report.
Consolidation
The Condensed Consolidated Financial Statements include the accounts of HLIC, companies in which the Company directly or indirectly has a controlling financial interest and those variable interest entities (“VIEs”) in which the Company is required to consolidate. Entities in which HLIC has significant influence over the operating and financing decisions but are not required to consolidate are reported using the equity method. For further discussions on VIEs, see Note 4 - Investments and Derivative Instruments of Notes to Condensed Consolidated Financial Statements. All intercompany transactions and balances between HLIC and its subsidiaries have been eliminated.
Discontinued Operations
The results of operations of a component of the Company that either has been disposed of or is classified as held-for-sale are reported in discontinued operations if the operations and cash flows of the component have been or will be eliminated from the ongoing operations of the Company as a result of the disposal transaction and the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction. The Company presents the operations of businesses that meet these criteria as discontinued operations in the Condensed Consolidated Financial Statements. Accordingly, operating results for prior periods are retrospectively reclassified. For information on the specific businesses and related impacts, see Note 13 - Discontinued Operations of Notes to Condensed Consolidated Financial Statements.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
1. Basis of Presentation and Significant Accounting Policies (continued)
Use of Estimates
The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The most significant estimates include those used in determining estimated gross profits used in the valuation and amortization of assets and liabilities associated with variable annuity and other universal life-type contracts; evaluation of other-than-temporary impairments on available-for-sale securities and valuation allowances on investments; living benefits required to be fair valued; valuation of investments and derivative instruments; valuation allowance on deferred tax assets; and contingencies relating to corporate litigation and regulatory matters. Certain of these estimates are particularly sensitive to market conditions, and deterioration and/or volatility in the worldwide debt or equity markets could have a material impact on the Condensed Consolidated Financial Statements.
Reclassifications
Certain reclassifications have been made to prior period financial information to conform to the current year presentation.
Future Adoption of New Accounting Standard
Reporting Discontinued Operations
In April 2014, the FASB issued updated guidance on reporting discontinued operations. Under this updated guidance, a discontinued operation will include a disposal of a major part of an entity’s operations and financial results such as a separate major line of business or a separate major geographical area of operations. The guidance raises the threshold to be a major operation but no longer precludes discontinued operations presentation where there is significant continuing involvement or cash flows with a disposed component of an entity. The guidance expands disclosures to include cash flows where there is significant continuing involvement with a discontinued operation and the pre-tax profit or loss of disposal transactions not reported as discontinued operations. The updated guidance is effective prospectively for years beginning on or after December 15, 2014, with early application permitted. The Company will apply the guidance to new disposals and operations newly classified as held for sale beginning first quarter of 2015, with no effect on existing reported discontinued operations. The effect on the Company’s future results of operations or financial condition will depend on the nature of future disposal transactions.
Income Taxes
A reconciliation of the tax provision at the U.S. Federal statutory rate to the provision for income taxes is as follows: |
| | | | | | | |
| | Three Months Ended March 31, |
| | 2014 | 2013 |
Tax expense at the U.S. federal statutory rate | | $ | 15 |
| $ | 180 |
|
Dividends received deduction | | (26 | ) | (32 | ) |
Foreign related investments | | — |
| (5 | ) |
Other | | (2 | ) | 3 |
|
Income tax expense (benefit) | | $ | (13 | ) | $ | 146 |
|
The separate account dividends-received deduction (“DRD”) is estimated for the current year using information from the most recent return, adjusted for current year equity market performance and other appropriate factors, including estimated levels of corporate dividend payments and level of policy owner equity account balances. The actual current year DRD can vary from estimates based on, but not limited to, changes in eligible dividends received in the mutual funds, amounts of distribution from these mutual funds, amounts of short-term capital gains at the mutual fund level and the Company’s taxable income before the DRD. The Company evaluates its DRD computations on a quarterly basis.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
1. Basis of Presentation and Significant Accounting Policies (continued)
The Company or one or more of subsidiaries file income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions. The Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations for years prior to 2007. The audit of the years 2007-2009 commenced during 2010 and is expected to conclude in the second half of 2015. The 2010-2011 audit commenced in the fourth quarter of 2012 and is expected to conclude by the end of 2015. Management believes that adequate provision has been made in the financial statements for any potential assessments that may result from tax examinations and other tax-related matters for all open tax years. The Company records a deferred tax asset valuation allowance that is adequate to reduce the total deferred tax asset to an amount that will be more likely than not realized. There was no deferred tax asset valuation allowance as of March 31, 2014 and December 31, 2013. In assessing the need for a valuation allowance, management considered future taxable temporary difference reversals, future taxable income exclusive of reversing temporary differences and carryforwards, taxable income in open carry back years, as well as other tax planning strategies. These tax planning strategies include holding a portion of debt securities with market value losses until recovery, altering the level of tax exempt securities, selling appreciated securities to offset capital losses, business considerations such as asset-liability matching, and the sales of certain corporate assets. Management views such tax planning strategies as prudent and feasible, and will implement them, if necessary, to realize the deferred tax asset. Future economic conditions and debt market volatility, including increases in interest rates, can adversely impact the Company's tax planning strategies and in particular the Company's ability to utilize tax benefits on previously recognized realized capital losses.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
2. Business Dispositions
Sale of Hartford Life International Limited ("HLIL")
On December 12, 2013, The Company completed the sale of HLIL, an indirect wholly-owned subsidiary of the Company, in a cash transaction to Columbia Insurance Company, a Berkshire Hathaway company, for approximately $285. At closing, HLIL’s sole asset was its subsidiary, Hartford Life Limited ("HLL"), a Dublin-based company that sold variable annuities in the U.K. from 2005 to 2009. The sale transaction resulted in an after-tax loss of $51 upon disposition in the year ended December 31, 2013. The operations of the Company's U.K. variable annuity business meet the criteria for reporting as discontinued operations. For further information regarding discontinued operations, see note Note 13 - Discontinued Operations of Notes to Condensed Consolidated Financial Statements.
Sale of Retirement Plans
On January 1, 2013, HLI completed the sale of its Retirement Plans business to MassMutual for a ceding commission of $355. The business sold included products and services to corporations pursuant to Section 401(k) of the Internal Revenue Code of 1986, as amended (the “Code”), and products and services to municipalities and not-for-profit organizations under Sections 457 and 403(b) of the Code, collectively referred to as government plans. The sale was structured as a reinsurance transaction and resulted in an after-tax gain of $45 for the year ended December 31, 2013. The Company recognized $565 in reinsurance loss on disposition including a reduction in goodwill of $87, offset by $634 in realized capital gains for a $69 impact to income, pre-tax.
Upon closing, the Company reinsured $9.2 billion of policyholder liabilities and $26.3 billion of separate account liabilities under an indemnity reinsurance arrangement with MassMutual. The reinsurance transaction does not extinguish the Company's primary liability on the insurance policies issued under the Retirement Plans business. The Company also transferred invested assets with a carrying value of $9.3 billion, net of the ceding commission, to MassMutual and recognized other non-cash decreases in assets totaling $100 relating to deferred acquisition costs, deferred income taxes, goodwill, and other assets associated with the disposition. The Company will continue to sell retirement plans during a transition period and MassMutual will assume all expenses and risk for these sales through the reinsurance agreement.
Sale of Individual Life
On January 2, 2013 HLI completed the sale of its Individual Life insurance business to Prudential for consideration of $615, consisting primarily of a ceding commission, of which $590 is attributable to the Company. The business sold included variable universal life, universal life, and term life insurance.The sale was structured as a reinsurance transaction and resulted in a loss on business disposition consisting of a reinsurance loss partially offset by realized capital gains. In 2012, the Company recognized a reinsurance loss on business disposition of $61, pre-tax, which included a goodwill impairment of the same amount. Upon closing the Company recognized an additional reinsurance loss on disposition of $927, including a reduction in goodwill of $163 offset by realized capital gains of $927 for a $0 impact on income, pre-tax.
Upon closing the Company reinsured $8.3 billion of policyholder liabilities and $5.3 billion of separate account liabilities under indemnity reinsurance arrangements. The reinsurance transaction does not extinguish the Company's primary liability under the Individual Life business. The Company also transferred invested assets with a carrying value of $7.6 billion, exclusive of $1.4 billion assets supporting the modified coinsurance agreement, net of cash transferred in place of short-term investments, to Prudential and recognized other non-cash decreases in assets totaling $1.8 billion relating to deferred acquisition costs, deferred income taxes, goodwill and other assets, and other non-cash decreases in liabilities totaling $1.9 billion relating to other liabilities associated with the disposition. The Company will continue to sell life insurance products and riders during a transition period and Prudential will assume all expenses and risk for these sales through the reinsurance agreement.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
2. Business Dispositions (continued)
Composition of Invested Assets Transferred
The following table summarizes invested assets transferred by the Company in January 2013 in connection with the sale of the Retirement Plans and Individual Life businesses. |
| | | |
| As of |
| December 31, 2012 |
| Carrying Value |
Fixed maturities, at fair value (amortized cost of $13,596) [1] | $ | 15,015 |
|
Equity securities, AFS, at fair value (cost of $27) [2] | 28 |
|
Fixed maturities, at fair value using the FVO [3] | 16 |
|
Mortgage loans (net of allowances for loan losses of $1) | 1,288 |
|
Policy loans, at outstanding balance | 542 |
|
Total invested assets transferred | $ | 16,889 |
|
[1] Includes $14.4 billion and $657 of securities in level 2 and 3 of the fair value hierarchy, respectively.
[2] All equity securities transferred are included in level 2 of the fair value hierarchy.
[3] All FVO securities transferred are included in level 3 of the fair value hierarchy.
Purchase Agreement with Forethought Financial Group, Inc.
On December 31, 2012, The Hartford completed the sale of its U.S. individual annuity new business capabilities to Forethought Financial Group. Effective May 1, 2012, all new U.S. annuity policies sold by the Company are reinsured to Forethought Life Insurance Company. The Company ceased the sale of such annuity policies and the reinsurance agreement terminated as to new business in the second quarter of 2013. The reinsurance agreement has no impact on in-force policies issued on or before April 27, 2012 and the impact of this transaction was not material to the Company's results of operations, financial position or liquidity.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements
The following section applies the fair value hierarchy and disclosure requirements for the Company’s financial instruments that are carried at fair value. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad Levels (Level 1, 2 or 3).
| |
Level 1 | Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. Level 1 securities include highly liquid U.S. Treasuries, money market funds and exchange traded equity securities, open-ended mutual funds reported in separate account assets and exchange-traded derivative instruments. |
| |
Level 2 | Observable inputs, other than quoted prices included in Level 1, for the asset or liability or prices for similar assets and liabilities. Most fixed maturities and preferred stocks, including those reported in separate account assets, are model priced by vendors using observable inputs and are classified within Level 2. Also included are limited partnerships and other alternative assets measured at fair value where an investment can be redeemed, or substantially redeemed, at the NAV at the measurement date or in the near-term, not to exceed 90 days. |
| |
Level 3 | Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Level 3 securities include less liquid securities, guaranteed product embedded and reinsurance derivatives and other complex derivative instruments, as well as limited partnerships and other alternative investments carried at fair value that cannot be redeemed in the near-term at the NAV. Because Level 3 fair values, by their nature, contain one or more significant unobservable inputs as there is little or no observable market for these assets and liabilities, considerable judgment is used to determine the Level 3 fair values. Level 3 fair values represent the Company’s best estimate of an amount that could be realized in a current market exchange absent actual market exchanges. |
In many situations, inputs used to measure the fair value of an asset or liability position may fall into different levels of the fair value hierarchy. In these situations, the Company will determine the level in which the fair value falls based upon the lowest level input that is significant to the determination of the fair value. Transfers of securities among the levels occur at the beginning of the reporting period. For the three months ended March 31, 2014 and 2013 transfers from Level 1 to Level 2 were $1.1 billion and $78, respectively, which represented previously on-the-run U.S. Treasury securities that are now off-the-run, and there were no transfers from Level 2 to Level 1. In most cases, both observable (e.g., changes in interest rates) and unobservable (e.g., changes in risk assumptions) inputs are used in the determination of fair values that the Company has classified within Level 3. Consequently, these values and the related gains and losses are based upon both observable and unobservable inputs. The Company’s fixed maturities included in Level 3 are classified as such because these securities are primarily priced by independent brokers and/or within illiquid markets.
The following tables present assets and (liabilities) carried at fair value by hierarchy level. These disclosures provide information as to the extent to which the Company uses fair value to measure financial instruments and information about the inputs used to value those financial instruments to allow users to assess the relative reliability of the measurements.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
|
| | | | | | | | | | | | |
| March 31, 2014 |
| Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) |
Assets accounted for at fair value on a recurring basis | | | | |
Fixed maturities, AFS | | | | |
ABS | $ | 1,032 |
| $ | — |
| $ | 997 |
| $ | 35 |
|
CDOs | 1,275 |
| — |
| 826 |
| 449 |
|
CMBS | 2,168 |
| — |
| 1,859 |
| 309 |
|
Corporate | 17,042 |
| — |
| 16,274 |
| 768 |
|
Foreign government/government agencies | 941 |
| — |
| 911 |
| 30 |
|
Municipal | 990 |
| — |
| 939 |
| 51 |
|
RMBS | 2,359 |
| — |
| 1,552 |
| 807 |
|
U.S. Treasuries | 1,722 |
| 105 |
| 1,617 |
| — |
|
Total fixed maturities | 27,529 |
| 105 |
| 24,975 |
| 2,449 |
|
Fixed maturities, FVO | 917 |
| — |
| 727 |
| 190 |
|
Equity securities, trading | 12 |
| 12 |
| — |
| — |
|
Equity securities, AFS | 315 |
| 171 |
| 92 |
| 52 |
|
Derivative assets | | | | |
Credit derivatives | 25 |
| — |
| 15 |
| 10 |
|
Foreign exchange derivatives | (44 | ) | — |
| (44 | ) | — |
|
Interest rate derivatives | (22 | ) | — |
| (22 | ) | — |
|
U.S. guaranteed minimum withdrawal benefit ("GMWB") hedging instruments | 55 |
| — |
| (10 | ) | 65 |
|
U.S. macro hedge program | 83 |
| — |
| — |
| 83 |
|
International program hedging instruments | 72 |
| — |
| 56 |
| 16 |
|
Total derivative assets [1] | 169 |
| — |
| (5 | ) | 174 |
|
Short-term investments | 2,086 |
| 197 |
| 1,889 |
| — |
|
Limited partnerships and other alternatives [2] | 459 |
| — |
| 402 |
| 57 |
|
Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB | (529 | ) | — |
| (20 | ) | (509 | ) |
Separate account assets [3] | 137,026 |
| 97,801 |
| 38,463 |
| 762 |
|
Total assets accounted for at fair value on a recurring basis | $ | 167,984 |
| $ | 98,286 |
| $ | 66,523 |
| $ | 3,175 |
|
Liabilities accounted for at fair value on a recurring basis | | | | |
Other policyholder funds and benefits payable | | | | |
Guaranteed living benefits | $ | (536 | ) | $ | — |
| $ | — |
| $ | (536 | ) |
Equity linked notes | (19 | ) | — |
| — |
| (19 | ) |
Total other policyholder funds and benefits payable | (555 | ) | — |
| — |
| (555 | ) |
Derivative liabilities | | | | |
Credit derivatives | (14 | ) | — |
| (5 | ) | (9 | ) |
Equity derivatives | 19 |
| — |
| 17 |
| 2 |
|
Foreign exchange derivatives | (307 | ) | — |
| (307 | ) | — |
|
Interest rate derivatives | (333 | ) | — |
| (333 | ) | — |
|
U.S. GMWB hedging instruments | 46 |
| — |
| (12 | ) | 58 |
|
U.S. macro hedge program | 50 |
| — |
| — |
| 50 |
|
International program hedging instruments | (24 | ) | — |
| 32 |
| (56 | ) |
Total derivative liabilities [4] | (563 | ) | — |
| (608 | ) | 45 |
|
Consumer notes [5] | (2 | ) | — |
| — |
| (2 | ) |
Total liabilities accounted for at fair value on a recurring basis | $ | (1,120 | ) | $ | — |
| $ | (608 | ) | $ | (512 | ) |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
|
| | | | | | | | | | | | |
| December 31, 2013 |
| Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) |
Assets accounted for at fair value on a recurring basis | | | | |
Fixed maturities, AFS | | | | |
ABS | $ | 1,129 |
| $ | — |
| $ | 1,021 |
| $ | 108 |
|
CDOs | 1,448 |
| — |
| 1,020 |
| 428 |
|
CMBS | 2,347 |
| — |
| 1,987 |
| 360 |
|
Corporate | 16,917 |
| — |
| 16,127 |
| 790 |
|
Foreign government/government agencies | 1,177 |
| — |
| 1,139 |
| 38 |
|
Municipal | 965 |
| — |
| 916 |
| 49 |
|
RMBS | 2,431 |
| — |
| 1,633 |
| 798 |
|
U.S. Treasuries | 1,749 |
| 1,077 |
| 672 |
| — |
|
Total fixed maturities | 28,163 |
| 1,077 |
| 24,515 |
| 2,571 |
|
Fixed maturities, FVO | 791 |
| — |
| 613 |
| 178 |
|
Equity securities, trading | 12 |
| 12 |
| — |
| — |
|
Equity securities, AFS | 372 |
| 207 |
| 114 |
| 51 |
|
Derivative assets | | | | |
Credit derivatives | 9 |
| — |
| 11 |
| (2 | ) |
Foreign exchange derivatives | 14 |
| — |
| 14 |
| — |
|
Interest rate derivatives | (57 | ) | — |
| (57 | ) | — |
|
U.S. GMWB hedging instruments | 26 |
| — |
| (42 | ) | 68 |
|
U.S. macro hedge program | 109 |
| — |
| — |
| 109 |
|
International program hedging instruments | 171 |
| — |
| 173 |
| (2 | ) |
Total derivative assets [1] | 272 |
| — |
| 99 |
| 173 |
|
Short-term investments | 1,952 |
| 228 |
| 1,724 |
| — |
|
Limited partnerships and other alternative investments [2] | 468 |
| — |
| 414 |
| 54 |
|
Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB | (398 | ) | — |
| 67 |
| (465 | ) |
Separate account assets [3] | 138,482 |
| 99,917 |
| 37,828 |
| 737 |
|
Total assets accounted for at fair value on a recurring basis | $ | 170,114 |
| $ | 101,441 |
| $ | 65,374 |
| $ | 3,299 |
|
Liabilities accounted for at fair value on a recurring basis | | | | |
Other policyholder funds and benefits payable | | | | |
Guaranteed living benefits | $ | (576 | ) | $ | — |
| $ | — |
| $ | (576 | ) |
Equity linked notes | (18 | ) | — |
| — |
| (18 | ) |
Total other policyholder funds and benefits payable | (594 | ) | — |
| — |
| (594 | ) |
Derivative liabilities | | | | |
Credit derivatives | 11 |
| — |
| 7 |
| 4 |
|
Equity derivatives | 18 |
| — |
| 16 |
| 2 |
|
Foreign exchange derivatives | (382 | ) | — |
| (382 | ) | — |
|
Interest rate derivatives | (319 | ) | — |
| (295 | ) | (24 | ) |
U.S. GMWB hedging instruments | 15 |
| — |
| (63 | ) | 78 |
|
U.S. macro hedge program | 30 |
| — |
| — |
| 30 |
|
International program hedging instruments | (198 | ) | — |
| (139 | ) | (59 | ) |
Total derivative liabilities [4] | (825 | ) | — |
| (856 | ) | 31 |
|
Consumer notes [5] | (2 | ) | — |
| — |
| (2 | ) |
Total liabilities accounted for at fair value on a recurring basis | $ | (1,421 | ) | $ | — |
| $ | (856 | ) | $ | (565 | ) |
| |
[1] | Includes over-the-counter("OTC") and OTC-cleared derivative instruments in a net asset value position after consideration of the impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. As of March 31, 2014 and December 31, 2013, $109 and $120, respectively, of cash collateral liability was netted against the derivative asset value in the Condensed Consolidated Balance Sheet and is excluded from the table above. See footnote 4 below for derivative liabilities. |
| |
[2] | Represents hedge funds where investment company accounting has been applied to a wholly-owned fund of funds measured at fair value. |
| |
[3] | As of March 31, 2014 and December 31, 2013, excludes approximately $1.5 billion and $2.4 billion, respectively, of investment sales receivable that are not subject to fair value accounting. |
| |
[4] | Includes OTC and OTC-cleared derivative instruments in a net negative market value position (derivative liability) after consideration of the impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. In the Level 3 roll forward table included below in this Note, the derivative asset and liability are referred to as “freestanding derivatives” and are presented on a net basis. |
| |
[5] | Represents embedded derivatives associated with non-funding agreement-backed consumer equity-linked notes. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Determination of Fair Values
The valuation methodologies used to determine the fair values of assets and liabilities under the “exit price” notion, reflect market-participant objectives and are based on the application of the fair value hierarchy that prioritizes relevant observable market inputs over unobservable inputs. The Company determines the fair values of certain financial assets and financial liabilities based on quoted market prices where available and where prices represent a reasonable estimate of fair value. The Company also determines fair value based on future cash flows discounted at the appropriate current market rate. Fair values reflect adjustments for counterparty credit quality, the Company’s default spreads, liquidity and, where appropriate, risk margins on unobservable parameters. The following is a discussion of the methodologies used to determine fair values for the financial instruments listed in the above tables.
The fair value process is monitored by the Valuation Committee, which is a cross-functional group of senior management within the Company that meets at least quarterly. The Valuation Committee is co-chaired by the Heads of Investment Operations and Accounting, and has representation from various investment sector professionals, accounting, operations, legal, compliance and risk management. The purpose of the committee is to oversee the pricing policy and procedures by ensuring objective and reliable valuation practices and pricing of financial instruments, as well as addressing fair valuation issues and approving changes to valuation methodologies and pricing sources. There are also two working groups under the valuation committee, a Securities Fair Value Working Group (“Securities Working Group”) and a Derivatives Fair Value Working Group ("Derivatives Working Group"), which include the Heads of Investment Operations and Accounting, as well as other investment, operations, accounting and risk management professionals that meet monthly to review market data trends, pricing and trading statistics and results, and any proposed pricing methodology changes described in more detail in the following paragraphs.
The Company also has an enterprise-wide Operational Risk Management function, led by the Chief Operational Risk Officer, which is responsible for establishing, maintaining and communicating the framework, principles and guidelines of the Company's operational risk management program. This includes model risk management which provides an independent review of the suitability, characteristics and reliability of model inputs; as well as, an analysis of significant changes to current models.
AFS Securities, Fixed Maturities, FVO, Equity Securities, Trading, and Short-term Investments
The fair value of AFS securities, fixed maturities, FVO, equity securities, trading, and short-term investments in an active and orderly market (e.g. not distressed or forced liquidation) are determined by management after considering one of three primary sources of information: third-party pricing services, independent broker quotations or pricing matrices. Security pricing is applied using a “waterfall” approach whereby publicly available prices are first sought from third-party pricing services, the remaining unpriced securities are submitted to independent brokers for prices, or lastly, securities are priced using a pricing matrix. Typical inputs used by these pricing methods include, but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, and/or estimated cash flows, prepayment speeds and default rates. Based on the typical trading volumes and the lack of quoted market prices for fixed maturities, third-party pricing services will normally derive the security prices from recent reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information as outlined above. If there are no recently reported trades, the third-party pricing services and independent brokers may use matrix or model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Included in the pricing of ABS and RMBS are estimates of the rate of future prepayments of principal over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and prepayment speeds previously experienced at the interest rate levels projected for the underlying collateral. Actual prepayment experience may vary from these estimates.
Prices from third-party pricing services are often unavailable for securities that are rarely traded or are traded only in privately negotiated transactions. As a result, certain securities are priced via independent broker quotations which utilize inputs that may be difficult to corroborate with observable market based data. Additionally, the majority of these independent broker quotations are non-binding.
A pricing matrix is used to price private placement securities for which the Company is unable to obtain a price from a third-party pricing service by discounting the expected future cash flows from the security by a developed market discount rate utilizing current credit spreads. Credit spreads are developed each month using market based data for public securities adjusted for credit spread differentials between public and private securities which are obtained from a survey of multiple private placement brokers. The appropriate credit spreads determined through this survey approach are based upon the issuer’s financial strength and term to maturity, utilizing an independent public security index and trade information and adjusting for the non-public nature of the securities.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
The Securities Working Group performs an ongoing analysis of the prices and credit spreads received from third parties to ensure that the prices represent a reasonable estimate of the fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. As a part of this analysis, the Company considers trading volume, new issuance activity and other factors to determine whether the market activity is significantly different than normal activity in an active market, and if so, whether transactions may not be orderly considering the weight of available evidence. If the available evidence indicates that pricing is based upon transactions that are stale or not orderly, the Company places little, if any, weight on the transaction price and will estimate fair value utilizing an internal pricing model. In addition, the Company ensures that prices received from independent brokers represent a reasonable estimate of fair value through the use of internal and external cash flow models developed based on spreads, and when available, market indices. As a result of this analysis, if the Company determines that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly and approved by the Valuation Committee. The Company’s internal pricing model utilizes the Company’s best estimate of expected future cash flows discounted at a rate of return that a market participant would require. The significant inputs to the model include, but are not limited to, current market inputs, such as credit loss assumptions, estimated prepayment speeds and market risk premiums.
The Company conducts other specific monitoring controls around pricing. Daily analyses identify price changes over 3-5%, sale trade prices that differ over 3% from the prior day’s price and purchase trade prices that differ more than 3% from the current day’s price. Weekly analyses identify prices that differ more than 5% from published bond prices of a corporate bond index. Monthly analyses identify price changes over 3%, prices that haven’t changed, and missing prices. Also on a monthly basis, a second source validation is performed on most sectors. Analyses are conducted by a dedicated pricing unit that follows up with trading and investment sector professionals and challenges prices with vendors when the estimated assumptions used differ from what the Company feels a market participant would use. Any changes from the identified pricing source are verified by further confirmation of assumptions used. Examples of other procedures performed include, but are not limited to, initial and on-going review of third-party pricing services’ methodologies, review of pricing statistics and trends and back testing recent trades.
The Company has analyzed the third-party pricing services’ valuation methodologies and related inputs, and has also evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Most prices provided by third-party pricing services are classified into Level 2 because the inputs used in pricing the securities are market observable. Due to a general lack of transparency in the process that brokers use to develop prices, most valuations that are based on brokers’ prices are classified as Level 3. Some valuations may be classified as Level 2 if the price can be corroborated with observable market data.
Derivative Instruments, including embedded derivatives within investments
Derivative instruments are fair valued using pricing valuation models for OTC derivatives that utilize independent market data inputs, quoted market prices for exchange-traded and OTC-cleared derivatives, or independent broker quotations. Excluding embedded and reinsurance related derivatives, as of March 31, 2014 and December 31, 2013, 98% and 97%, respectively, of derivatives, based upon notional values, were priced by valuation models or quoted market prices. The remaining derivatives were priced by broker quotations.
The Derivatives Working Group performs ongoing analysis of the valuations, assumptions and methodologies used to ensure that the prices represent a reasonable estimate of the fair value. The Company performs various controls on derivative valuations which include both quantitative and qualitative analysis. Analyses are conducted by a dedicated derivative pricing team that works directly with investment sector professionals to analyze impacts of changes in the market environment and investigate variances. There is a monthly analysis to identify market value changes greater than pre-defined thresholds, stale prices, missing prices and zero prices. Also on a monthly basis, a second source validation, typically to broker quotations, is performed for certain of the more complex derivatives as well as for any existing deals with a market value greater than $10 and all new deals during the month. A model validation review is performed on any new models, which typically includes detailed documentation and validation to a second source. The model validation documentation and results of validation are presented to the Valuation Committee for approval. There is a monthly control to review changes in pricing sources to ensure that new models are not moved to production until formally approved.
The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instrument may not be classified with the same fair value hierarchy level as the associated assets and liabilities. Therefore the realized and unrealized gains and losses on derivatives reported in Level 3 may not reflect the offsetting impact of the realized and unrealized gains and losses of the associated assets and liabilities.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Limited partnerships and other alternative investments
Limited partnerships and other alternative investments include hedge funds where investment company accounting has been applied to a wholly-owned fund of funds measured at fair value. These funds are fair valued using the net asset value per share or equivalent (“NAV”), as a practical expedient, calculated on a monthly basis and is the amount at which a unit or shareholder may redeem their investment, if redemption is allowed. Certain impediments to redemption include, but are not limited to the following: 1) redemption notice periods vary and may be as long as 90 days, 2) redemption may be restricted (e.g. only be allowed on a quarter-end), 3) a holding period referred to as a lock-up may be imposed whereby an investor must hold their investment for a specified period of time before they can make a notice for redemption, 4) gating provisions may limit all redemptions in a given period to a percentage of the entities' equity interests, or may only allow an investor to redeem a portion of their investment at one time and 5) early redemption penalties may be imposed that are expressed as a percentage of the amount redeemed. The Company will assess impediments to redemption and current market conditions that will restrict the redemption at the end of the notice period. Any funds that are subject to significant liquidity restrictions are reported in Level 3; all others are classified as Level 2.
Valuation Techniques and Inputs for Investments
Generally, the Company determines the estimated fair value of its AFS securities, fixed maturities, FVO, equity securities, trading, and short-term investments using the market approach. The income approach is used for securities priced using a pricing matrix, as well as for derivative instruments. Certain limited partnerships and other alternative investments are measured at fair value using a NAV as a practical expedient. For Level 1 investments, which are comprised of on-the-run U.S. Treasuries, exchange-traded equity securities, short-term investments, and exchange traded futures and option contracts, valuations are based on observable inputs that reflect quoted prices for identical assets in active markets that the Company has the ability to access at the measurement date.
For most of the Company’s debt securities, the following inputs are typically used in the Company’s pricing methods: reported trades, benchmark yields, bids and/or estimated cash flows. For securities except U.S. Treasuries, inputs also include issuer spreads, which may consider credit default swaps. Derivative instruments are valued using mid-market inputs that are predominantly observable in the market.
A description of additional inputs used in the Company’s Level 2 and Level 3 measurements is listed below:
| |
Level 2 | The fair values of most of the Company’s Level 2 investments are determined by management after considering prices received from third party pricing services. These investments include most fixed maturities and preferred stocks, including those reported in separate account assets, as well as certain limited partnerships and other alternative investments and derivative instruments. |
| |
• | ABS, CDOs, CMBS and RMBS – Primary inputs also include monthly payment information, collateral performance, which varies by vintage year and includes delinquency rates, collateral valuation loss severity rates, collateral refinancing assumptions, credit default swap indices and, for ABS and RMBS, estimated prepayment rates. |
| |
• | Corporates, including investment grade private placements – Primary inputs also include observations of credit default swap curves related to the issuer. |
| |
• | Foreign government/government agencies—Primary inputs also include observations of credit default swap curves related to the issuer and political events in emerging market economies. |
| |
• | Municipals – Primary inputs also include Municipal Securities Rulemaking Board reported trades and material event notices, and issuer financial statements. |
| |
• | Short-term investments – Primary inputs also include material event notices and new issue money market rates. |
| |
• | Equity securities, trading – Consist of investments in mutual funds. Primary inputs include net asset values obtained from third party pricing services. |
| |
• | Credit derivatives – Primary inputs include the swap yield curve and credit default swap curves. |
| |
• | Foreign exchange derivatives – Primary inputs include the swap yield curve, currency spot and forward rates, and cross currency basis curves. |
| |
• | Interest rate derivatives – Primary input is the swap yield curve. |
| |
• | Limited partnerships and other alternative investments — Primary inputs include a NAV for investment companies with no redemption restrictions as reported on their U.S. GAAP financial statements. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
| |
Level 3 | Most of the Company’s securities classified as Level 3 include less liquid securities such as lower quality ABS, CMBS, commercial real estate (“CRE”) CDOs and RMBS primarily backed by sub-prime loans. Securities included in level 3 are primarily valued based on broker prices or broker spreads, without adjustments. Primary inputs for non-broker priced investments, including structured securities, are consistent with the typical inputs used in Level 2 measurements noted above, but are Level 3 due to their less liquid markets. Additionally, certain long-dated securities are priced based on third party pricing services, including municipal securities, foreign government/government agencies, bank loans and below investment grade private placement securities. Primary inputs for these long-dated securities are consistent with the typical inputs used in Level 1 and Level 2 measurements noted above, but include benchmark interest rate or credit spread assumptions that are not observable in the marketplace. Level 3 investments also include certain limited partnerships and other alternative investments measured at fair value where the Company does not have the ability to redeem the investment in the near-term at the NAV. Also included in Level 3 are certain derivative instruments that either have significant unobservable inputs or are valued based on broker quotations. Significant inputs for these derivative contracts primarily include the typical inputs used in the Level 1 and Level 2 measurements noted above; but also include equity and interest rate volatility and swap yield curves beyond observable limits. |
Significant Unobservable Inputs for Level 3 Assets Measured at Fair Values
The following tables present information about significant unobservable inputs used in Level 3 assets measured at fair value.
|
| | | | | | | | | | | | |
| As of March 31, 2014 |
Securities | | | | Unobservable Inputs | |
Assets accounted for at fair value on a recurring basis | Fair Value | Predominant Valuation Method | Significant Unobservable Input | Minimum | Maximum | Weighted Average [1] | Impact of Increase in Input on Fair Value [2] |
CMBS | $ | 309 |
| Discounted cash flows | Spread (encompasses prepayment, default risk and loss severity) | 98bps | 2,439bps | 317bps | Decrease |
Corporate [3] | 447 |
| Discounted cash flows | Spread | 118bps | 697bps | 267bps | Decrease |
Municipal [3] | 30 |
| Discounted cash flows | Spread | 189bps | 189bps | 189bps | Decrease |
RMBS | 807 |
| Discounted cash flows | Spread | 58bps | 1,763bps | 213bps | Decrease |
| | | Constant prepayment rate | 0.0 | % | 10.0 | % | 3.0 | % | Decrease [4] |
| | | Constant default rate | 1.0 | % | 22.0 | % | 7.0 | % | Decrease |
| | | Loss severity | — | % | 100.0 | % | 79.0 | % | Decrease |
| As of December 31, 2013 |
CMBS | $ | 360 |
| Discounted cash flows | Spread (encompasses prepayment, default risk and loss severity) | 99bps | 2,511bps | 446bps | Decrease |
Corporate [3] | 398 |
| Discounted cash flows | Spread | 119bps | 5,594bps | 332bps | Decrease |
Municipal [3] | 29 |
| Discounted cash flows | Spread | 184bps | 184bps | 184bps | Decrease |
RMBS | 798 |
| Discounted cash flows | Spread | 62bps | 1,748bps | 245bps | Decrease |
| | | Constant prepayment rate | 0.0 | % | 10.0 | % | 3.0 | % | Decrease [4] |
| | | Constant default rate | 1.0 | % | 22.0 | % | 8.0 | % | Decrease |
| | | Loss severity | — | % | 100.0 | % | 80.0 | % | Decrease |
| |
[1] | The weighted average is determined based on the fair value of the securities. |
| |
[2] | Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table above. |
| |
[3] | Level 3 corporate and municipal securities excludes those for which the Company bases fair value on broker quotations as discussed below. |
| |
[4] | Decrease for above market rate coupons and increase for below market rate coupons. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Significant Unobservable Inputs for Level 3 Assets Measured at Fair Values (continued)
|
| | | | | | | |
| As of March 31, 2014 |
Freestanding Derivatives | | | | Unobservable Inputs | |
| Fair Value | Predominant Valuation Method | Significant Unobservable Input | Minimum | Maximum | Impact of Increase in Input on Fair Value [1] |
U.S. GMWB hedging instruments | | | | | | |
Equity options | 52 |
| Option model | Equity volatility | 20% | 30% | Increase |
Customized swaps | 71 |
| Discounted cash flows | Equity volatility | 10% | 50% | Increase |
U.S. macro hedge program | | | | | | |
Equity options | 133 |
| Option model | Equity volatility | 23% | 34% | Increase |
International hedging program [2] | | | | | | |
Equity options | (68 | ) | Option model | Equity volatility | 28% | 36% | Increase |
Long interest rate swaptions | 61 |
| Option model | Interest rate volatility | —% | 3% | Increase |
| As of December 31, 2013 |
Interest rate derivative | | | | | | |
Interest rate swaps | (24 | ) | Discounted cash flows | Swap curve beyond 30 years | 4% | 4% | Increase |
U.S. GMWB hedging instruments | | | | | | |
Equity options | 72 |
| Option model | Equity volatility | 21% | 29% | Increase |
Customized swaps | 74 |
| Discounted cash flows | Equity volatility | 10% | 50% | Increase |
U.S. macro hedge program | | | | | | |
Equity options | 139 |
| Option model | Equity volatility | 24% | 31% | Increase |
International hedging program [2] | | | | | | |
Equity options | (66 | ) | Option model | Equity volatility | 29% | 37% | Increase |
Short interest rate swaptions | (12 | ) | Option model | Interest rate volatility | —% | 1% | Decrease |
Long interest rate swaptions | 48 |
| Option model | Interest rate volatility | 1% | 1% | Increase |
| |
[1] | Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. Changes are based on long positions, unless otherwise noted. Changes in fair value will be inversely impacted for short positions. |
| |
[2] | Level 3 international program hedging instruments excludes those for which the Company bases fair value on broker quotations. |
Securities and derivatives for which the Company bases fair value on broker quotations predominately include ABS, CDOs, corporate, fixed maturities, FVO. Due to the lack of transparency in the process brokers use to develop prices for these investments, the Company does not have access to the significant unobservable inputs brokers use to price these securities and derivatives. The Company believes however, the types of inputs brokers may use would likely be similar to those used to price securities and derivatives for which inputs are available to the Company, and therefore may include, but not be limited to, loss severity rates, constant prepayment rates, constant default rates and counterparty credit spreads. Therefore, similar to non broker priced securities and derivatives, generally, increases in these inputs would cause fair values to decrease. For the three months ended, March 31, 2014, no significant adjustments were made by the Company to broker prices received.
As of March 31, 2014 and December 31, 2013, excluded from the tables above are limited partnerships and other alternative investments which total $57 and $54, respectively, of level 3 assets measured at fair value. The predominant valuation method uses a NAV calculated on a monthly basis and represents funds where the Company does not have the ability to redeem the investment in the near-term at that NAV, including an assessment of the investee's liquidity.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Product Derivatives
The Company formerly offered and subsequently reinsured certain variable annuity products with GMWB riders in the U.S. The Company has also assumed, through reinsurance from Hartford Life Insurance KK (“HLIKK”). GMIB, GMWB and GMAB riders. The Company has subsequently ceded certain GMWB rider liabilities and the assumed reinsurance from HLIKK to an affiliated captive reinsurer. The GMWB provides the policyholder with a guaranteed remaining balance (“GRB”) which is generally equal to premiums less withdrawals. If the policyholder’s account value is reduced a specified level through a combination of market declines and withdrawals but the GRB still has value, the Company is obligated to continue to make annuity payments to the policyholder until the GRB is exhausted. Certain contract provisions can increase the GRB at contract holder election or after the passage of time. The GMWB represents an embedded derivative in the variable annuity contract. When it is determined that (1) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host for measurement purposes. The embedded derivative, which is reported with the host instrument in the Consolidated Balance Sheets, is carried at fair value with changes in fair value reported in net realized capital gains and losses. The Company’s GMWB liability is carried at fair value and reported in other policyholder funds. The notional value of the embedded derivative is the GRB.
In valuing the embedded derivative, the Company attributes to the derivative a portion of the fees collected from the contract holder equal to the present value of future GMWB claims (the “Attributed Fees”). All changes in the fair value of the embedded derivative are recorded in net realized capital gains and losses. The excess of fees collected from the contract holder over the Attributed Fees are associated with the host variable annuity contract reported in fee income.
The reinsurance assumed on the HLIKK GMIB, GMWB, and GMAB and ceded to an affiliated captive reinsurer meets the characteristics of a free-standing derivative instrument. As a result, the derivative asset or liability is recorded at fair value with changes in the fair value reported in net realized capital gains and losses.
Effective April 1, 2014, HLAI, terminated its reinsurance agreement with an affiliated captive reinsurer and recaptured all reinsurance risks. For further information regarding this reinsurance agreement, see Note 11 -Transactions with Affiliates and Note - 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements .
Living Benefits Required to be Fair Valued (in Other Policyholder Funds and Benefits Payable)
Living benefits required to be fair valued include U.S guaranteed withdrawal benefits, international guaranteed withdrawal benefits and international other guaranteed living benefits. Fair values for GMWB and GMAB contracts are calculated using the income approach based upon internally developed models because active, observable markets do not exist for those items. The fair value of the Company’s guaranteed benefit liabilities, classified as embedded derivatives, and the related reinsurance and customized freestanding derivatives are calculated as an aggregation of the following components: Best Estimate Claims Costs calculated based on actuarial and capital market assumptions related to projected cash flows over the lives of the contracts; Credit Standing Adjustment; and Margins representing an amount that market participants would require for the risk that the Company’s assumptions about policyholder behavior could differ from actual experience. The resulting aggregation is reconciled or calibrated, if necessary, to market information that is, or may be, available to the Company, but may not be observable by other market participants, including reinsurance discussions and transactions. The Company believes the aggregation of these components, as necessary and as reconciled or calibrated to the market information available to the Company, results in an amount that the Company would be required to transfer or receive, for an asset, to or from market participants in an active liquid market, if one existed, for those market participants to assume the risks associated with the guaranteed minimum benefits and the related reinsurance and customized derivatives. The fair value is likely to materially diverge from the ultimate settlement of the liability as the Company believes settlement will be based on our best estimate assumptions rather than those best estimate assumptions plus risk margins. In the absence of any transfer of the guaranteed benefit liability to a third party, the release of risk margins is likely to be reflected as realized gains in future periods’ net income. Each component described below is unobservable in the marketplace and requires subjectivity by the Company in determining their value.
Oversight of the Company’s valuation policies and processes for product and U.S. GMWB reinsurance derivatives is performed by a multidisciplinary group comprised of finance, actuarial and risk management professionals. This multidisciplinary group reviews and approves changes and enhancements to the Company’s valuation model as well as associated controls.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Best Estimate
Claim Payments
The Best Estimate Claim Payments are calculated based on actuarial and capital market assumptions related to projected cash flows, including the present value of benefits and related contract charges, over the lives of the contracts, incorporating expectations concerning policyholder behavior such as lapses, fund selection, resets and withdrawal utilization. For the customized derivatives, policyholder behavior is prescribed in the derivative contract. Because of the dynamic and complex nature of these cash flows, best estimate assumptions and a Monte Carlo stochastic process is used in valuation. The Monte Carlo stochastic process involves the generation of thousands of scenarios that assume risk neutral returns consistent with swap rates and a blend of observable implied index volatility levels. Estimating these cash flows involves numerous estimates and subjective judgments regarding a number of variables –including expected market rates of return, market volatility, correlations of market index returns to funds, fund performance, discount rates and assumptions about policyholder behavior which emerge over time.
At each valuation date, the Company assumes expected returns based on:
| |
• | risk-free rates as represented by the Eurodollar futures, LIBOR deposits and swap rates to derive forward curve rates; |
| |
• | market implied volatility assumptions for each underlying index based primarily on a blend of observed market “implied volatility” data; |
| |
• | correlations of historical returns across underlying well known market indices based on actual observed returns over the ten years preceding the valuation date; and |
| |
• | three years of history for fund indexes compared to separate account fund regression. |
On a daily basis, the Company updates capital market assumptions used in the GMWB liability model such as interest rates, equity indices and the blend of implied equity index volatilities. The Company monitors various aspects of policyholder behavior and may modify certain of its assumptions, including living benefit lapses and withdrawal rates, if credible emerging data indicates that changes are warranted. The Company continually monitors policyholder behavior assumptions in response to initiatives intended to reduce the size of the variable annuity business. At a minimum, all policyholder behavior assumptions are reviewed and updated, as appropriate, in conjunction with the completion of the Company’s comprehensive study to refine its estimate of future gross profits during the third quarter of each year.
Credit Standing Adjustment
This assumption makes an adjustment that market participants would make, in determining fair value, to reflect the risk that guaranteed benefit obligations or the GMWB reinsurance recoverables will not be fulfilled as nonperformance risk. The Company incorporates a blend of observable Company and reinsurer credit default spreads from capital markets, adjusted for market recoverability. For the three months ended March 31, 2014 and 2013, the credit standing adjustment assumption, net of reinsurance and exclusive of the impact of the credit standing adjustment on other market sensitivities, resulted in pre-tax realized gains/(losses) of $38 and $248, respectively.
Margins
The behavior risk margin adds a margin that market participants would require, in determining fair value, for the risk that the Company’s assumptions about policyholder behavior could differ from actual experience. The behavior risk margin is calculated by taking the difference between adverse policyholder behavior assumptions and best estimate assumptions.
Assumption updates, including policyholder behavior assumptions, affected best estimates and margins for total pre-tax realized gains of$0 and $1 for the three months ended March 31, 2014 and 2013. As of March 31, 2014 and December 31, 2013 the behavior risk margin was $30 and $32, respectively.
In addition to the non-market-based updates described above, the Company recognized non-market-based updates driven by the relative outperformance (underperformance) of the underlying actively managed funds as compared to their respective indices resulting in pre-tax realized gains/(losses) of approximately $4 and $2 for the three months ended March 31, 2014 and 2013, respectively.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Significant unobservable inputs used in the fair value measurement of living benefits required to be fair valued and the U.S. GMWB reinsurance derivative are withdrawal utilization and withdrawal rates, lapse rates, reset elections and equity volatility. The following table provides quantitative information about the significant unobservable inputs and is applicable to all of the Living Benefits Required to be Fair Valued and the reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB and GMAB. Significant increases in any of the significant unobservable inputs, in isolation, will generally have an increase or decrease correlation with the fair value measurement, as shown in the following table.
|
| | | |
Significant Unobservable Input | Unobservable Inputs (Minimum) | Unobservable Inputs (Maximum) | Impact of Increase in Input on Fair Value Measurement [1] |
Withdrawal Utilization[2] | 20% | 100% | Increase |
Withdrawal Rates [2] | —% | 8% | Increase |
Annuitization utilization [3] | —% | 100% | Increase |
Lapse Rates [4] | —% | 75% | Decrease |
Reset Elections [5] | 20% | 75% | Increase |
Equity Volatility [6] | 10% | 50% | Increase |
| |
[1] | Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. |
| |
[2] | Ranges represent assumed cumulative percentages of policyholders taking withdrawals and the annual amounts withdrawn. |
| |
[3] | For reinsurance associated with Japan GMIB, range represents assumed cumulative percentages of policyholders annuitizing variable annuity contracts. |
| |
[4] | Range represents assumed annual percentages of full surrender of the underlying variable annuity contracts across all policy durations for in force business. |
| |
[5] | Range represents assumed cumulative percentages of policyholders that would elect to reset their guaranteed benefit base. |
| |
[6] | Range represents implied market volatilities for equity indices based on multiple pricing sources. |
Generally a change in withdrawal utilization assumptions would be accompanied by a directionally opposite change in lapse rate assumptions, as the behavior of policyholders that utilize GMWB or GMAB riders is typically different from policyholders that do not utilize these riders.
Separate Account Assets
Separate account assets are primarily invested in mutual funds. Other separate account assets include fixed maturities, limited partnerships, equity securities, short-term investments and derivatives that are valued in the same manner, and using the same pricing sources and inputs, as those investments held by the Company. Separate account assets classified as Level 3 primarily include limited partnerships in which fair value represents the separate account’s share of the fair value of the equity in the investment (“net asset value”) and are classified in level 3 based on the Company’s ability to redeem its investment.
Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
The tables below provide a fair value roll forward for the three months ended March 31, 2014, for Level 3 financial instruments.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fixed Maturities, AFS | Fixed Maturities, FVO |
Assets | ABS | CDOs | CMBS | Corporate | Foreign govt./govt. agencies | Municipal | RMBS | Total Fixed Maturities, AFS |
Fair value as of January 1, 2014 | $ | 108 |
| $ | 428 |
| $ | 360 |
| $ | 790 |
| $ | 38 |
| $ | 49 |
| $ | 798 |
| $ | 2,571 |
| $ | 178 |
|
Total realized/unrealized gains (losses) | | | | | | | | | |
Included in net income [1], [2] | — |
| — |
| 8 |
| (4 | ) | (1 | ) | — |
| (1 | ) | 2 |
| 9 |
|
Included in OCI [3] | 2 |
| — |
| (6 | ) | 18 |
| 3 |
| 2 |
| 9 |
| 28 |
| — |
|
Purchases | — |
| — |
| 1 |
| 24 |
| — |
| — |
| 87 |
| 112 |
| 5 |
|
Settlements | — |
| (11 | ) | (25 | ) | 2 |
| (2 | ) | — |
| (31 | ) | (67 | ) | (1 | ) |
Sales | (3 | ) | (9 | ) | (22 | ) | (34 | ) | (8 | ) | — |
| (47 | ) | (123 | ) | (1 | ) |
Transfers into Level 3 [4] | — |
| 48 |
| — |
| 30 |
| — |
| — |
| — |
| 78 |
| — |
|
Transfers out of Level 3 [4] | (72 | ) | (7 | ) | (7 | ) | (58 | ) | — |
| — |
| (8 | ) | (152 | ) | — |
|
Fair value as of March 31, 2014 | $ | 35 |
| $ | 449 |
| $ | 309 |
| $ | 768 |
| $ | 30 |
| $ | 51 |
| $ | 807 |
| $ | 2,449 |
| $ | 190 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2014 [2] [7] | $ | — |
| $ | — |
| $ | 1 |
| $ | (6 | ) | $ | (1 | ) | $ | — |
| $ | — |
| $ | (6 | ) | $ | 9 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Freestanding Derivatives [5] |
Assets (Liabilities) | Equity Securities, AFS | Credit | Equity | Interest Rate | U.S. GMWB Hedging | U.S. Macro Hedge Program | Intl. Program Hedging | Other derivative contracts | Total Free- Standing Derivatives [5] |
Fair value as of January 1, 2014 | $ | 51 |
| $ | 2 |
| $ | 2 |
| $ | (24 | ) | $ | 146 |
| $ | 139 |
| $ | (61 | ) | $ | — |
| $ | 204 |
|
Total realized/unrealized gains (losses) | | | | | | | |
| |
Included in net income [1], [2] | (1 | ) | (1 | ) | — |
| — |
| (34 | ) | (10 | ) | 12 |
| — |
| (33 | ) |
Included in OCI [3] | 2 |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Purchases | — |
| — |
| — |
| — |
| 5 |
| 4 |
| 9 |
| — |
| 18 |
|
Settlements | — |
| — |
| — |
| — |
| 6 |
| — |
| — |
| — |
| 6 |
|
Sales | — |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Transfers into Level 3 [4] | — |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Transfers out of Level 3 [4] | — |
| — |
| — |
| 24 |
| — |
| — |
| — |
| — |
| 24 |
|
Fair value as of March 31, 2014 | $ | 52 |
| $ | 1 |
| $ | 2 |
| $ | — |
| $ | 123 |
| $ | 133 |
| $ | (40 | ) | $ | — |
| $ | 219 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2014 [2] [7] | $ | (1 | ) | $ | (1 | ) | $ | — |
| $ | (1 | ) | $ | (50 | ) | $ | (10 | ) | $ | 17 |
| $ | — |
| $ | (45 | ) |
|
| | | | | | | | | |
Assets | Limited Partnerships and Other Alternative Investments | Reinsurance Recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB [6] | Separate Accounts |
Fair value as of January 1, 2014 | $ | 54 |
| $ | (465 | ) | $ | 737 |
|
Transfers to assets held for sale | — |
| — |
| — |
|
Total realized/unrealized gains (losses) | | | |
Included in net income [1], [2] | 4 |
| (107 | ) | 5 |
|
Included in OCI [3] | — |
| — |
| — |
|
Purchases | 16 |
| — |
| 130 |
|
Settlements | (12 | ) | 63 |
| (1 | ) |
Sales | — |
| — |
| (86 | ) |
Transfers into Level 3 [4] | — |
| — |
| 3 |
|
Transfers out of Level 3 [4] | (5 | ) | — |
| (26 | ) |
Fair value as of March 31, 2014 | $ | 57 |
| $ | (509 | ) | $ | 762 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2014 [2] [7] | $ | 4 |
| $ | (107 | ) | $ | 5 |
|
|
| | | | | | | | | | | | |
| Other Policyholder Funds and Benefits Payable | |
Liabilities | Guaranteed Living Benefits [7] | Equity Linked Notes | Total Other Policyholder Funds and Benefits Payable | Consumer Notes |
Fair value as of January 1, 2014 | $ | (576 | ) | $ | (18 | ) | $ | (594 | ) | $ | (2 | ) |
Transfers to liabilities held for sale | — |
| — |
| — |
| — |
|
Total realized/unrealized gains (losses) | | | | |
Included in net income [1], [2] | 74 |
| (1 | ) | 73 |
| — |
|
Included in OCI [3] | — |
| — |
| — |
| — |
|
Settlements | (34 | ) | — |
| (34 | ) | — |
|
Fair value as of March 31, 2014 | $ | (536 | ) | $ | (19 | ) | $ | (555 | ) | $ | (2 | ) |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2014 [2] [7] | $ | 74 |
| $ | (1 | ) | $ | 73 |
| $ | — |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
The tables below provide a fair value roll forward for the three months ended March 31, 2013, for Level 3 financial instruments.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fixed Maturities, AFS | |
Assets | ABS | CDOs | CMBS | Corporate | Foreign govt./govt. agencies | Municipal | RMBS | Total Fixed Maturities, AFS | Fixed Maturities, FVO |
Fair value as of January 1, 2013 | $ | 238 |
| $ | 723 |
| $ | 532 |
| $ | 1,340 |
| $ | 34 |
| $ | 169 |
| $ | 1,133 |
| $ | 4,169 |
| $ | 199 |
|
Total realized/unrealized gains (losses) | | | | | | | | | |
Included in net income [1], [2] | (3 | ) | (11 | ) | (2 | ) | 16 |
| 1 |
| — |
| 29 |
| 30 |
| 14 |
|
Included in OCI [3] | 22 |
| 36 |
| 13 |
| (8 | ) | (1 | ) | 1 |
| 15 |
| 78 |
| — |
|
Purchases | 14 |
| 1 |
| — |
| 18 |
| 10 |
| — |
| 13 |
| 56 |
| 6 |
|
Settlements | (3 | ) | (21 | ) | (14 | ) | (58 | ) | (1 | ) | — |
| (32 | ) | (129 | ) | (1 | ) |
Sales | (34 | ) | (186 | ) | (60 | ) | (255 | ) | (6 | ) | (38 | ) | (192 | ) | (771 | ) | (18 | ) |
Transfers into Level 3 [4] | — |
| 23 |
| 21 |
| 56 |
| — |
| — |
| — |
| 100 |
| 2 |
|
Transfers out of Level 3 [4] | (9 | ) | — |
| — |
| (13 | ) | (2 | ) | — |
| — |
| (24 | ) | (1 | ) |
Fair value as of March 31, 2013 | $ | 225 |
| $ | 565 |
| $ | 490 |
| $ | 1,096 |
| $ | 35 |
| $ | 132 |
| $ | 966 |
| $ | 3,509 |
| $ | 201 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2013 [2] [7] | $ | (4 | ) | $ | — |
| $ | (2 | ) | $ | (2 | ) | $ | — |
| $ | — |
| $ | — |
| $ | (8 | ) | $ | 35 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Freestanding Derivatives [5] |
Assets (Liabilities) | Equity Securities, AFS | Credit | Equity | Interest Rate | U.S. GMWB Hedging | U.S. Macro Hedge Program | Intl. Program Hedging | Total Free- Standing Derivatives [5] |
Fair value as of January 1, 2013 | $ | 55 |
| $ | (388 | ) | $ | 43 |
| $ | (91 | ) | $ | 756 |
| $ | 180 |
| $ | (55 | ) | $ | 445 |
|
Total realized/unrealized gains (losses) | | | | | | | | |
Included in net income [1], [2] | (4 | ) | 49 |
| (12 | ) | 1 |
| (159 | ) | (98 | ) | (79 | ) | (298 | ) |
Included in OCI [3] | 6 |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Purchases | — |
| — |
| 24 |
| 1 |
| 19 |
| — |
| 15 |
| 59 |
|
Settlements | — |
| 59 |
| — |
| — |
| — |
| — |
| 17 |
| 76 |
|
Sales | (2 | ) | — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Transfers out of Level 3 [4] | — |
| — |
| — |
| 31 |
| — |
| — |
| — |
| 31 |
|
Fair value as of March 31, 2013 | $ | 55 |
| $ | (280 | ) | $ | 55 |
| $ | (58 | ) | $ | 616 |
| $ | 82 |
| $ | (102 | ) | $ | 313 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2013 [2] [7] | $ | (3 | ) | $ | 25 |
| $ | (10 | ) | $ | 1 |
| $ | (159 | ) | $ | (98 | ) | $ | (51 | ) | $ | (292 | ) |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
|
| | | | | | |
Assets | Reinsurance Recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB [6][8] | Separate Accounts |
Fair value as of January 1, 2013 | $ | 1,081 |
| $ | 583 |
|
Total realized/unrealized gains (losses) | | |
Included in net income [1], [2] | (573 | ) | 15 |
|
Purchases | — |
| 255 |
|
Settlements | 84 |
| — |
|
Sales | — |
| (26 | ) |
Transfers into Level 3 [4] | — |
| — |
|
Transfers out of Level 3 [4] | — |
| (4 | ) |
Fair value as of March 31, 2013 | $ | 592 |
| $ | 823 |
|
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2013 [2] [7] | $ | (573 | ) | $ | 8 |
|
|
| | | | | | | | | | | | | | | |
| Other Policyholder Funds and Benefits Payable [1] | | |
Liabilities | Guaranteed Living Benefits [7][8] | Equity Linked Notes | Total Other Policyholder Funds and Benefits Payable | Other Liabilities | Consumer Notes |
Fair value as of January 1, 2013 | $ | (3,119 | ) | $ | (8 | ) | $ | (3,127 | ) | $ | (29 | ) | $ | (2 | ) |
Total realized/unrealized gains (losses) | | | | | |
Included in net income [1], [2] | 937 |
| (2 | ) | 935 |
| (14 | ) | — |
|
Settlements | (22 | ) | — |
| (22 | ) | — |
| — |
|
Fair value as of March 31, 2013 | $ | (2,204 | ) | $ | (10 | ) | $ | (2,214 | ) | $ | (43 | ) | $ | (2 | ) |
Changes in unrealized gains (losses) included in net income related to financial instruments still held at March 31, 2013 [2] [7] | $ | 937 |
| $ | (2 | ) | $ | 935 |
| $ | (14 | ) | $ | — |
|
| |
[1] | The Company classifies gains and losses on GMWB reinsurance derivatives and Guaranteed Living Benefit embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives. |
| |
[2] | All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC. |
| |
[3] | All amounts are before income taxes and amortization of DAC. |
| |
[4] | Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs. |
| |
[5] | Derivative instruments are reported in this table on a net basis for asset/(liability) positions and reported in the Condensed Consolidated Balance Sheet in other investments and other liabilities. |
| |
[6] | Includes fair value of reinsurance recoverables of approximately $539 and $435 as of March 31, 2014 and 2013, respectively, related to a transaction entered into with an affiliated captive reinsurer. See Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial Statements for more information. |
| |
[7] | Includes both market and non-market impacts in deriving realized and unrealized gains (losses). |
| |
[8] | As of March 31, 2013, ($111) and $135 were inappropriately presented as Included in OCI within the Reinsurance Recoverable for U.S. GMWB and Japan GMWB, GMIB and GMAB and Guaranteed Living Benefits, respectively. Amounts have been rescheduled to Included in Net Income. This change in presentation of this disclosure had no impact on the Company's net income or OCI. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Fair Value Option
The Company holds fair value option investments . Also included are foreign government securities that align with the accounting for yen-based fixed annuity liabilities, which are adjusted for changes in spot rates through realized gains and losses. Also included are securities that contain an embedded credit derivative with underlying credit risk primarily related to corporate bonds and commercial real estate. Income earned from FVO securities is recorded in net investment income and changes in fair value are recorded in net realized capital gains and losses.
The Company also elected the fair value option for certain investments held within consolidated VIE investment funds. The Company elected the fair value option in order to report investments of consolidated investment companies at fair value with changes in the fair value of these securities recognized in net realized capital gains and losses, which is consistent with accounting requirements for investment companies. The investment funds hold fixed income securities and the Company has management and control of the funds as well as a significant ownership interest.
The following table presents the changes in fair value of those assets and liabilities accounted for using the fair value option reported in net realized capital gains and losses in the Company's Condensed Consolidated Statements of Operations.
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Assets | | |
Fixed maturities, FVO | | |
Corporate | $ | 1 |
| $ | (9 | ) |
CRE CDOs | 9 |
| 9 |
|
Foreign government | 9 |
| (48 | ) |
RMBS | 1 |
| — |
|
Total realized capital gains (losses) | $ | 20 |
| $ | (48 | ) |
The following table presents the fair value of assets and liabilities accounted for using the fair value option included in the Company's Condensed Consolidated Balance Sheets.
|
| | | | | | |
| As of |
| March 31, 2014 | December 31, 2013 |
Assets | | |
Fixed maturities, FVO | | |
ABS | $ | 12 |
| $ | 3 |
|
Corporate | 90 |
| 84 |
|
CDO | 176 |
| 167 |
|
CMBS | 11 |
| 8 |
|
Foreign government | 563 |
| 494 |
|
Municipals | 2 |
| 1 |
|
RMBS | 61 |
| 9 |
|
U.S. Government | 2 |
| 25 |
|
Total fixed maturities, FVO | $ | 917 |
| $ | 791 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
3. Fair Value Measurements (continued)
Financial Instruments Not Carried at Fair Value
The following presents carrying amounts and fair values of the Company's financial instruments not carried at fair value, and not included in the above fair value discussion as of March 31, 2014 and December 31, 2013 were as follows:
|
| | | | | | | | | |
| March 31, 2014 | December 31, 2013 |
| Fair Value Hierarchy Level | Carrying Amount | Fair Value | Carrying Amount | Fair Value |
Assets | | | | | |
Policy loans | Level 3 | 1,425 |
| 1,474 |
| 1,416 |
| 1,476 |
|
Mortgage loans | Level 3 | 3,315 |
| 3,383 |
| 3,470 |
| 3,519 |
|
Liabilities | | | | | |
Other policyholder funds and benefits payable [1] | Level 3 | 8,703 |
| 8,949 |
| 8,955 |
| 9,153 |
|
Consumer notes [2] | Level 3 | 76 |
| 76 |
| 82 |
| 82 |
|
| |
[1] | Excludes group accident and health and universal life insurance contracts, including corporate owned life insurance. |
| |
[2] | Excludes amounts carried at fair value and included in disclosures above. |
The Company has not made any changes in its valuation methodologies for the following assets and liabilities since December 31, 2013.
| |
• | Fair value for policy loans and consumer notes were estimated using discounted cash flow calculations using current interest rates adjusted for estimated loan duration. |
| |
• | Fair values for mortgage loans were estimated using discounted cash flow calculations based on current lending rates for similar type loans. Current lending rates reflect changes in credit spreads and the remaining terms of the loans. |
| |
• | Other policyholder funds and benefits payable, not carried at fair value, is determined by estimating future cash flows, discounted at the current market rate. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments
Net Realized Capital Gains (Losses) |
| | | | | | |
| Three Months Ended March 31, |
(Before-tax) | 2014 | 2013 |
Gross gains on sales [1] | $ | 108 |
| $ | 1,613 |
|
Gross losses on sales | (104 | ) | (54 | ) |
Net OTTI losses recognized in earnings | (7 | ) | (13 | ) |
Valuation allowances on mortgage loans | — |
| 1 |
|
Japanese fixed annuity contract hedges, net [2] | (9 | ) | 3 |
|
Periodic net coupon settlements on credit derivatives/Japan | 5 |
| (3 | ) |
Results of variable annuity hedge program | | |
U.S. GMWB derivatives, net | 15 |
| 47 |
|
U.S. macro hedge program | (10 | ) | (85 | ) |
Total U.S. program | 5 |
| (38 | ) |
International Program [3] | (23 | ) | (83 | ) |
Total results of variable annuity hedge program | (18 | ) | (121 | ) |
GMIB/GMAB/GMWB reinsurance | 51 |
| 337 |
|
Coinsurance and modified coinsurance reinsurance contracts | (130 | ) | (399 | ) |
Other, net [4] | (2 | ) | 79 |
|
Net realized capital gains (losses), before-tax | $ | (106 | ) | $ | 1,443 |
|
| |
[1] | Includes $1.5 billion of gross gains relating to the sales of the Retirement Plans and Individual Life businesses for the three months ended March 31, 2013. |
| |
[2] | Includes for the three months ended March 31, 2014 and 2013, transactional foreign currency re-valuation related to the Japan fixed annuity product of $(30) and $151, respectively, as well as the change in value related to the derivative hedging instruments and the Japan government FVO securities of $21 and $(148), respectively. |
| |
[3] | Includes $3 and $(33) of transactional foreign currency re-valuation for the three months ended March 31, 2014 and 2013, respectively. |
| |
[4] | For the three months ended March 31, 2014 and 2013, other, net gains and losses includes $(3) and $22, respectively, of transactional foreign currency re-valuation associated with the internal reinsurance of the Japan GMIB variable annuity business, which is offset in AOCI. Also includes for the three months ended March 31, 2014 and 2013, $(28) and $116, respectively, of other transactional foreign currency revaluation, primarily associated with the internal reinsurance of the Japan 3 wins variable annuity business, of which a portion is offset within realized gains and losses by the change in value of the associated hedging derivatives. Includes $71 of gains relating to the sales of the Retirement Plans and Individual Life businesses for the three months ended March 31, 2013. |
Net realized capital gains and losses from investment sales, are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains and losses on sales and impairments previously reported as unrealized gains in AOCI were $3 and $1.5 for the three months ended March 31, 2014 and 2013, respectively. Proceeds from sales of AFS securities totaled $3.5 billion and $4.8 billion, for the three months ended March 31, 2014 and 2013, respectively.
Other-Than-Temporary Impairment Losses
The following table presents a roll-forward of the Company’s cumulative credit impairments on debt securities held.
|
| | | | | | |
| Three Months Ended March 31, |
(Before-tax) | 2014 | 2013 |
Balance, beginning of period | $ | (410 | ) | $ | (813 | ) |
Additions for credit impairments recognized on [1]: | | |
Securities not previously impaired | (3 | ) | (5 | ) |
Securities previously impaired | (3 | ) | — |
|
Reductions for credit impairments previously recognized on: | | |
Securities that matured or were sold during the period | 30 |
| 111 |
|
Securities due to an increase in expected cash flows | 4 |
| 1 |
|
Balance, end of period | $ | (382 | ) | $ | (706 | ) |
| |
[1] | These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Available-for-Sale Securities
The following table presents the Company’s AFS securities by type.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | December 31, 2013 |
| Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1] | | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1] |
ABS | $ | 1,060 |
| $ | 15 |
| $ | (43 | ) | $ | 1,032 |
| $ | (2 | ) | | $ | 1,172 |
| $ | 13 |
| $ | (56 | ) | $ | 1,129 |
| $ | (2 | ) |
CDOs [2] | 1,216 |
| 93 |
| (33 | ) | 1,275 |
| — |
| | 1,392 |
| 98 |
| (41 | ) | 1,448 |
| — |
|
CMBS | 2,090 |
| 101 |
| (23 | ) | 2,168 |
| (4 | ) | | 2,275 |
| 106 |
| (34 | ) | 2,347 |
| (3 | ) |
Corporate | 15,670 |
| 1,485 |
| (113 | ) | 17,042 |
| (4 | ) | | 15,913 |
| 1,196 |
| (192 | ) | 16,917 |
| (6 | ) |
Foreign govt./govt. agencies | 996 |
| 31 |
| (86 | ) | 941 |
| — |
| | 1,267 |
| 27 |
| (117 | ) | 1,177 |
| — |
|
Municipal | 955 |
| 54 |
| (19 | ) | 990 |
| — |
| | 988 |
| 26 |
| (49 | ) | 965 |
| — |
|
RMBS | 2,329 |
| 61 |
| (31 | ) | 2,359 |
| (2 | ) | | 2,419 |
| 60 |
| (48 | ) | 2,431 |
| (3 | ) |
U.S. Treasuries | 1,655 |
| 69 |
| (2 | ) | 1,722 |
| — |
| | 1,762 |
| 1 |
| (14 | ) | 1,749 |
| — |
|
Total fixed maturities, AFS | 25,971 |
| 1,909 |
| (350 | ) | 27,529 |
| (12 | ) | | 27,188 |
| 1,527 |
| (551 | ) | 28,163 |
| (14 | ) |
Equity securities, AFS | 306 |
| 31 |
| (22 | ) | 315 |
| — |
| | 362 |
| 35 |
| (25 | ) | 372 |
| — |
|
Total AFS securities | $ | 26,277 |
| $ | 1,940 |
| $ | (372 | ) | $ | 27,844 |
| $ | (12 | ) | | $ | 27,550 |
| $ | 1,562 |
| $ | (576 | ) | $ | 28,535 |
| $ | (14 | ) |
| |
[1] | Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of March 31, 2014 and December 31, 2013. |
| |
[2] | Gross unrealized gains (losses) exclude the change in fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in fair value will be recorded in net realized capital gains (losses). |
The following table presents the Company’s fixed maturities, AFS, by contractual maturity year.
|
| | | | | | |
| March 31, 2014 |
Contractual Maturity | Amortized Cost | Fair Value |
One year or less | $ | 1,738 |
| $ | 1,762 |
|
Over one year through five years | 5,368 |
| 5,610 |
|
Over five years through ten years | 3,776 |
| 3,960 |
|
Over ten years | 8,394 |
| 9,363 |
|
Subtotal | 19,276 |
| 20,695 |
|
Mortgage-backed and asset-backed securities | 6,695 |
| 6,834 |
|
Total fixed maturities, AFS | $ | 25,971 |
| $ | 27,529 |
|
Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.
Concentration of Credit Risk
The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk.
As of March 31, 2014, the Company's only exposure to any credit concentration risk of a single issuer equal to or greater than 10% of the Company’s stockholder’s equity, other than U.S. government and certain U.S. government securities, was the Government of Japan, which represented $785, or 10% of stockholders' equity and 2% of total invested assets. As of March 31, 2013, the Company's only exposure to any concentration of credit risk of a single issuer equal to or greater than 10% of the Company’s stockholder’s equity other than the U.S. government and certain U.S. government agencies, was the Government of Japan,which represented $868, or 10% of stockholders' equity and 1.9% of total invested assets. For further discussion of concentration of credit risk, see the Concentration of Credit Risk section in Note 4 of Notes to Consolidated Financial Statements in the Company’s 2013 Form 10-K Annual Report.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Securities Unrealized Loss Aging
The following tables present the Company’s unrealized loss aging for AFS securities by type and length of time the security was in a continuous unrealized loss position.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 |
| Less Than 12 Months | 12 Months or More | Total |
| Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses |
ABS | $ | 145 |
| $ | 144 |
| $ | (1 | ) | $ | 372 |
| $ | 330 |
| $ | (42 | ) | $ | 517 |
| $ | 474 |
| $ | (43 | ) |
CDOs [1] | 82 |
| 81 |
| (1 | ) | 1,002 |
| 969 |
| (32 | ) | 1,084 |
| 1,050 |
| (33 | ) |
CMBS | 255 |
| 246 |
| (9 | ) | 317 |
| 303 |
| (14 | ) | 572 |
| 549 |
| (23 | ) |
Corporate | 1,532 |
| 1,494 |
| (38 | ) | 711 |
| 636 |
| (75 | ) | 2,243 |
| 2,130 |
| (113 | ) |
Foreign govt./govt. agencies | 226 |
| 212 |
| (14 | ) | 315 |
| 243 |
| (72 | ) | 541 |
| 455 |
| (86 | ) |
Municipal | 285 |
| 275 |
| (10 | ) | 85 |
| 76 |
| (9 | ) | 370 |
| 351 |
| (19 | ) |
RMBS | 514 |
| 509 |
| (5 | ) | 401 |
| 375 |
| (26 | ) | 915 |
| 884 |
| (31 | ) |
U.S. Treasuries | 349 |
| 347 |
| (2 | ) | — |
| — |
| — |
| 349 |
| 347 |
| (2 | ) |
Total fixed maturities, AFS | 3,388 |
| 3,308 |
| (80 | ) | 3,203 |
| 2,932 |
| (270 | ) | 6,591 |
| 6,240 |
| (350 | ) |
Equity securities, AFS | 48 |
| 46 |
| (2 | ) | 130 |
| 110 |
| (20 | ) | 178 |
| 156 |
| (22 | ) |
Total securities in an unrealized loss position | $ | 3,436 |
| $ | 3,354 |
| $ | (82 | ) | $ | 3,333 |
| $ | 3,042 |
| $ | (290 | ) | $ | 6,769 |
| $ | 6,396 |
| $ | (372 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2013 |
| Less Than 12 Months | 12 Months or More | Total |
| Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses |
ABS | $ | 288 |
| $ | 286 |
| $ | (2 | ) | $ | 418 |
| $ | 364 |
| $ | (54 | ) | $ | 706 |
| $ | 650 |
| $ | (56 | ) |
CDOs [1] | 64 |
| 63 |
| (1 | ) | 1,185 |
| 1,144 |
| (40 | ) | 1,249 |
| 1,207 |
| (41 | ) |
CMBS | 437 |
| 423 |
| (14 | ) | 392 |
| 372 |
| (20 | ) | 829 |
| 795 |
| (34 | ) |
Corporate | 2,449 |
| 2,360 |
| (89 | ) | 799 |
| 696 |
| (103 | ) | 3,248 |
| 3,056 |
| (192 | ) |
Foreign govt./govt. agencies | 542 |
| 501 |
| (41 | ) | 303 |
| 227 |
| (76 | ) | 845 |
| 728 |
| (117 | ) |
Municipal | 508 |
| 475 |
| (33 | ) | 99 |
| 83 |
| (16 | ) | 607 |
| 558 |
| (49 | ) |
RMBS | 922 |
| 909 |
| (13 | ) | 475 |
| 440 |
| (35 | ) | 1,397 |
| 1,349 |
| (48 | ) |
U.S. Treasuries | 1,456 |
| 1,442 |
| (14 | ) | — |
| — |
| — |
| 1,456 |
| 1,442 |
| (14 | ) |
Total fixed maturities, AFS | 6,666 |
| 6,459 |
| (207 | ) | 3,671 |
| 3,326 |
| (344 | ) | 10,337 |
| 9,785 |
| (551 | ) |
Equity securities, AFS | 77 |
| 73 |
| (4 | ) | 135 |
| 114 |
| (21 | ) | 212 |
| 187 |
| (25 | ) |
Total securities in an unrealized loss position | $ | 6,743 |
| $ | 6,532 |
| $ | (211 | ) | $ | 3,806 |
| $ | 3,440 |
| $ | (365 | ) | $ | 10,549 |
| $ | 9,972 |
| $ | (576 | ) |
| |
[1] | Unrealized losses exclude the change in fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in fair value are recorded in net realized capital gains (losses). |
As of March 31, 2014, AFS securities in an unrealized loss position, consisted of 1,631 securities, primarily related to floating rate corporate and foreign government and government agencies, which are depressed due to an increase in interest rates since the securities were purchased and/or declines in the value of the currency in which the assets are denominated. As of March 31, 2014, 94% of these securities were depressed less than 20% of cost or amortized cost. The decrease in unrealized losses during 2014 was primarily attributable to a decrease in interest rates and tighter credit spreads.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Most of the securities depressed for twelve months or more relate to certain floating rate corporate securities with greater than 10 years to maturity concentrated in the financial services sector, foreign government and government agencies, and structured securities with exposure to commercial and residential real estate. Corporate financial services securities are primarily depressed because the securities have floating-rate coupons and/or long-dated maturities. Unrealized losses on foreign government securities are primarily due to depreciation of the Japanese yen in relation to the U.S. dollar. Although credit spreads have continued to tighten over the past five years, current market spreads continue to be wider than spreads at the securities' respective purchase dates for structured securities with exposure to commercial and residential real estate largely due to reduced liquidity as a result of economic and market uncertainties regarding future performance of certain commercial and residential real estate backed securities. The majority of these securities have a floating-rate coupon referenced to a market index that has declined substantially. In addition, equity securities include investment grade perpetual preferred securities that contain “debt-like” characteristics where the decline in fair value is not attributable to issuer-specific credit deterioration, none of which have, nor are expected to, miss a periodic dividend payment. These securities have been depressed due to the securities’ floating-rate coupon in the current low interest rate environment, general market credit spread widening since the date of purchase and the long-dated nature of the securities. The Company neither has an intention to sell nor does it expect to be required to sell the securities outlined above.
Mortgage Loans
|
| | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 |
| Amortized Cost [1] | Valuation Allowance | Carrying Value | Amortized Cost [1] | Valuation Allowance | Carrying Value |
Total commercial mortgage loans | $ | 3,327 |
| $ | (12 | ) | $ | 3,315 |
| $ | 3,482 |
| $ | (12 | ) | $ | 3,470 |
|
| |
[1] | Amortized cost represents carrying value prior to valuation allowances, if any. |
As of March 31, 2014, and December 31, 2013, the carrying value of mortgage loans associated with the valuation allowance was $93 and $86, respectively . Included in the table above are mortgage loans held-for-sale with a carrying value and valuation allowance of $40 and $1, respectively, as of March 31, 2014 and $53 and $3, respectively, as of December 31, 2013. The carrying value of these loans is included in mortgage loans in the Company’s Condensed Consolidated Balance Sheets. As of March 31, 2014, loans within the Company’s mortgage loan portfolio that have had extensions or restructurings other than what is allowable under the original terms of the contract are immaterial.
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Balance, beginning of period | $ | (12 | ) | $ | (14 | ) |
(Additions)/Reversals | — |
| (1 | ) |
Deductions | — |
| 2 |
|
Balance, end of period | $ | (12 | ) | $ | (13 | ) |
The weighted-average LTV ratio of the Company’s commercial mortgage loan portfolio was 58% as of March 31, 2014, while the weighted-average LTV ratio at origination of these loans was 63%. LTV ratios compare the loan amount to the value of the underlying property collateralizing the loan. The loan values are updated no less than annually through property level reviews of the portfolio. Factors considered in the property valuation include, but are not limited to, actual and expected property cash flows, geographic market data and capitalization rates. DSCR compare a property’s net operating income to the borrower’s principal and interest payments. The weighted average DSCR of the Company’s commercial mortgage loan portfolio was 2.28x as of March 31, 2014. The Company held no delinquent commercial mortgage loans as of March 31, 2014.
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR.
|
| | | | | | | | |
Commercial Mortgage Loans Credit Quality |
| March 31, 2014 | December 31, 2013 |
Loan-to-value | Carrying Value | Avg. Debt-Service Coverage Ratio | Carrying Value | Avg. Debt-Service Coverage Ratio |
Greater than 80% | $ | 29 |
| 1.08x | $ | 35 |
| 1.15x |
65% - 80% | 675 |
| 2.01x | 777 |
| 1.94x |
Less than 65% | 2,611 |
| 2.37x | 2,658 |
| 2.34x |
Total commercial mortgage loans | $ | 3,315 |
| 2.28x | $ | 3,470 |
| 2.23x |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
The following tables present the carrying value of the Company’s mortgage loans by region and property type.
|
| | | | | | | | |
Mortgage Loans by Region |
| March 31, 2014 | December 31, 2013 |
| Carrying Value | Percent of Total | Carrying Value | Percent of Total |
East North Central | $ | 73 |
| 2.2% | $ | 79 |
| 2.3% |
Middle Atlantic | 247 |
| 7.5% | 255 |
| 7.3% |
Mountain | 40 |
| 1.2% | 40 |
| 1.2% |
New England | 146 |
| 4.4% | 163 |
| 4.7% |
Pacific | 934 |
| 28.2% | 1,019 |
| 29.4% |
South Atlantic | 560 |
| 16.9% | 548 |
| 15.8% |
West North Central | 17 |
| 0.5% | 17 |
| 0.5% |
West South Central | 124 |
| 3.7% | 144 |
| 4.1% |
Other [1] | 1,174 |
| 35.4% | 1,205 |
| 34.7% |
Total mortgage loans | $ | 3,315 |
| 100.0% | $ | 3,470 |
| 100.0% |
| |
[1] | Primarily represents loans collateralized by multiple properties in various regions. |
|
| | | | | | | | | | |
Mortgage Loans by Property Type |
| March 31, 2014 | December 31, 2013 |
| Carrying Value | Percent of Total | Carrying Value | Percent of Total |
Commercial | | | | |
Agricultural | $ | 56 |
| 1.7 | % | $ | 93 |
| 2.7 | % |
Industrial | 1,151 |
| 34.7 | % | 1,182 |
| 34.1 | % |
Lodging | 27 |
| 0.8 | % | 27 |
| 0.8 | % |
Multifamily | 559 |
| 16.9 | % | 576 |
| 16.6 | % |
Office | 683 |
| 20.6 | % | 723 |
| 20.8 | % |
Retail | 725 |
| 21.9 | % | 745 |
| 21.5 | % |
Other | 114 |
| 3.4 | % | 124 |
| 3.5 | % |
Total mortgage loans | $ | 3,315 |
| 100.0 | % | $ | 3,470 |
| 100.0 | % |
Variable Interest Entities
The Company is involved with various special purpose entities and other entities that are deemed to be VIEs primarily as a collateral or investment manager and as an investor through normal investment activities.
A VIE is an entity that either has investors that lack certain essential characteristics of a controlling financial interest or lacks sufficient funds to finance its own activities without financial support provided by other entities.
The Company performs ongoing qualitative assessments of its VIEs to determine whether the Company has a controlling financial interest in the VIE and therefore is the primary beneficiary. The Company is deemed to have a controlling financial interest when it has both the ability to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s assessment, if it determines it is the primary beneficiary, the Company consolidates the VIE in the Company’s Condensed Consolidated Financial Statements.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Consolidated VIEs
The following table presents the carrying value of assets and liabilities, and the maximum exposure to loss relating to the VIEs for which the Company is the primary beneficiary. Creditors have no recourse against the Company in the event of default by these VIEs nor does the Company have any implied or unfunded commitments to these VIEs. The Company’s financial or other support provided to these VIEs is limited to its collateral or investment management services and original investment.
|
| | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 |
| Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2] | Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2] |
CDOs [3] | $ | 8 |
| $ | 9 |
| $ | — |
| $ | 12 |
| $ | 13 |
| $ | — |
|
Investment funds [4] | 137 |
| 20 |
| 121 |
| 134 |
| 20 |
| 119 |
|
Limited partnerships | 3 |
| 1 |
| 2 |
| 4 |
| 2 |
| 2 |
|
Total | $ | 148 |
| $ | 30 |
| $ | 123 |
| $ | 150 |
| $ | 35 |
| $ | 121 |
|
| |
[1] | Included in other liabilities in the Company’s Condensed Consolidated Balance Sheets. |
| |
[2] | The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment. |
| |
[3] | Total assets included in fixed maturities, AFS in the Company’s Condensed Consolidated Balance |
Sheets.
| |
[4] | Total assets included in fixed maturities, FVO, short-term investments, and equity, AFS in the Company’s Condensed Consolidated Balance Sheets. |
CDOs represent structured investment vehicles for which the Company has a controlling financial interest as it provides collateral management services, earns a fee for those services and also holds investments in the securities issued by these vehicles. Investment funds represents wholly-owned fixed income funds for which the Company has exclusive management and control including management of investment securities which is the activity that most significantly impacts its economic performance. Limited partnerships represent one hedge fund of funds for which the Company holds a majority interest in the fund as an investment.
Non-Consolidated VIEs
The Company, through normal investment activities, makes passive investments in structured securities issued by VIEs for which the Company is not the manager which are included in ABS, CDOs, CMBS and RMBS in the Available-for-Sale Securities table and fixed maturities, FVO, in the Company’s Condensed Consolidated Balance Sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the relative size of the Company’s investment in comparison to the principal amount of the structured securities issued by the VIEs, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits and the Company’s inability to direct the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of the Company’s investment.
Repurchase and Dollar Roll Agreements and Other Collateral Transactions
The Company enters into repurchase agreements and dollar roll transactions to manage liquidity or to earn incremental spread income. A repurchase agreement is a transaction in which one party (transferor) agrees to sell securities to another party (transferee) in return for cash (or securities), with a simultaneous agreement to repurchase the same securities at a specified price at a later date. A dollar roll is a type of repurchase agreement where a mortgage backed security is sold with an agreement to repurchase substantially the same security at a specified time in the future. These transactions are generally short-term in nature, and therefore, the carrying amounts of these instruments approximate fair value.
As part of repurchase agreements and dollar roll transactions, the Company transfers collateral of U.S. government and government agency securities and receives cash. For the repurchase agreements, the Company obtains cash in an amount equal to at least 95% of the fair value of the securities transferred. The agreements contain contractual provisions that require additional collateral to be transferred when necessary and provide the counterparty the right to sell or re-pledge the securities transferred. The cash received from the repurchase program is typically invested in short-term investments or fixed maturities. Repurchase agreements include master netting provisions that provide the counterparties the right to offset claims and apply securities held by them in respect of their obligations in the event of a default. Although the Company has the contractual right to offset claims, fixed maturities do not meet the specific conditions for net presentation under U.S. GAAP. The Company accounts for the repurchase agreements and dollar roll transactions as collateralized borrowings. The securities transferred under repurchase agreements and dollar roll transactions are included in fixed maturities, AFS with the obligation to repurchase those securities recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of March 31, 2014, the Company reported financial collateral pledged, related to dollar roll transactions, with a fair value of $41 in fixed maturities, AFS with a corresponding obligation to repurchase $41 reported in other liabilities. The Company had no outstanding dollar roll transactions as of December 31, 2013. The Company had no outstanding repurchase agreements as of March 31, 2014 and December 31, 2013.
The Company is required by law to deposit securities with government agencies in states where it conducts business. As of March 31, 2014 and December 31, 2013 the fair value of securities on deposit was approximately $13 and $13, respectively.
Refer to Derivative Collateral Arrangements section of this note for disclosure of collateral in support of derivative transactions.
Derivative Instruments
The Company utilizes a variety of OTC, OTC-cleared and exchange traded derivative instruments as a part of its overall risk management strategy as well as to enter into replication transactions. Derivative instruments are used to manage risk associated with interest rate, equity market, credit spread, issuer default, price, and currency exchange rate risk or volatility. Replication transactions are used as an economical means to synthetically replicate the characteristics and performance of assets that would be permissible investments under the Company’s investment policies. The Company also may enter into and has previously issued financial instruments and products that either are accounted for as free-standing derivatives, such as certain reinsurance contracts, or may contain features that are deemed to be embedded derivative instruments, such as the GMWB rider included with certain variable annuity products.
Strategies that qualify for hedge accounting
Certain derivatives that the Company enters into satisfy the hedge accounting requirements as outlined in Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements, included in The Hartford’s 2013 Form 10-K Annual Report. Typically, these hedge relationships include interest rate and foreign currency swaps where the terms or expected cash flows of the hedged item closely match the terms of the swap. The swaps are typically used to manage interest rate duration of certain fixed maturity securities or liability contracts. The Company also formerly entered into swaps to convert securities or liabilities denominated in a foreign currency to U.S. dollars. The hedge strategies by hedge accounting designation include:
Cash flow hedges
Interest rate swaps are predominantly used to manage portfolio duration and better match cash receipts from assets with cash disbursements required to fund liabilities. These derivatives primarily convert interest receipts on floating-rate fixed maturity securities to fixed rates. The Company also enters into forward starting swap agreements primarily to hedge interest rate risk inherent in the assumptions used to price certain liabilities.
Foreign currency swaps are used to convert foreign currency-denominated cash flows related to certain investment receipts and liability payments to U.S. dollars in order to reduce cash flow fluctuations due to changes in currency rates.
Fair value hedges
Interest rate swaps are used to hedge the changes in fair value of fixed maturity securities due to fluctuations in interest rates. Foreign currency swaps were formally used to hedge the changes in fair value of certain foreign currency-denominated fixed rate liabilities due to changes in foreign currency rates by swapping the fixed foreign payments to floating rate U.S. dollar denominated payments.
Non-qualifying strategies
Derivative relationships that do not qualify for hedge accounting (“non-qualifying strategies”) primarily include the hedge programs for the Company's U.S. and international variable annuity products as well as the hedging and replication strategies that utilize credit default swaps. In addition, hedges of interest rate and foreign currency risk of certain fixed maturities and liabilities do not qualify for hedge accounting. The non-qualifying strategies include:
Interest rate swaps, swaptions and futures
The Company uses interest rate swaps, swaptions and futures to manage duration between assets and liabilities in certain investment portfolios. In addition, the Company enters into interest rate swaps to terminate existing swaps, thereby offsetting the changes in value of the original swap. As of March 31, 2014 and December 31, 2013 the notional amount of interest rate swaps in offsetting relationships was $4.5 billion.
Foreign currency swaps and forwards
The Company enters into foreign currency swaps and forwards to convert the foreign currency exposures of certain foreign currency-denominated fixed maturity investments to U.S. dollars.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Japan 3Win foreign currency swaps
The Company formerly offered certain variable annuity products with a guaranteed minimum income benefit ("GMIB") rider through a wholly-owned Japanese subsidiary. The GMIB rider is reinsured to a wholly-owned U.S. subsidiary which invests in U.S. dollar denominated assets to support the liability. The U.S. subsidiary entered into pay U.S. dollar, receive yen swap contracts to hedge the currency and yen interest rate exposure between the U.S. dollar denominated assets and the yen denominated fixed liability reinsurance payments.
Japanese fixed annuity hedging instruments
The Company formerly offered a yen denominated fixed annuity product through a wholly-owned Japanese subsidiary and reinsured to a wholly-owned U.S. subsidiary. The U.S. subsidiary invests in U.S. dollar denominated securities to support the yen denominated fixed liability payments and entered into currency rate swaps to hedge the foreign currency exchange rate and yen interest rate exposures that exist as a result of U.S. dollar assets backing the yen denominated liability.
Credit contracts
Credit default swaps are used to purchase credit protection on an individual entity or referenced index to economically hedge against default risk and credit-related changes in value on fixed maturity securities. Credit default swaps are also used to assume credit risk related to an individual entity or referenced index as a part of replication transactions. These contracts require the Company to pay or receive a periodic fee in exchange for compensation from the counterparty should the referenced security issuers experience a credit event, as defined in the contract. The Company is also exposed to credit risk related to credit derivatives embedded within certain fixed maturity securities. These securities are primarily comprised of structured securities that contain credit derivatives that reference a standard index of corporate securities. In addition, the Company enters into credit default swaps to terminate existing credit default swaps, thereby offsetting the changes in value of the original swap going forward.
Equity index swaps and options
The Company formerly offered certain equity indexed products which may contain an embedded derivative that requires bifurcation. The Company has entered into equity index swaps and options to economically hedge the equity volatility risk associated with these embedded derivatives. The Company also enters into equity index options and futures with the purpose of hedging the impact of an adverse equity market environment on the investment portfolio.
U.S. GMWB derivatives, net
The Company formerly offered certain variable annuity products with GMWB riders in the U.S. The GMWB product is a bifurcated embedded derivative (“U.S. GMWB product derivatives”) that has a notional value equal to the GRB. The Company uses reinsurance contracts to transfer a portion of its risk of loss due to U.S GMWB. The reinsurance contracts covering U.S. GMWB (“U.S. GMWB reinsurance contracts”) are accounted for as free-standing derivatives with a notional amount equal to the GRB amount.
The Company utilizes derivatives (“U.S. GMWB hedging instruments”) as part of an actively managed program designed to hedge a portion of the capital market risk exposures of the non-reinsured GMWB riders due to changes in interest rates, equity market levels, and equity volatility. These derivatives include customized swaps, interest rate swaps and futures, and equity swaps, options and futures, on certain indices including the S&P 500 index, EAFE index and NASDAQ index. The following table presents notional and fair value for U.S. GMWB hedging instruments.
|
| | | | | | | | | | | | |
| Notional Amount | Fair Value |
| March 31, 2014 | December 31, 2013 | March 31, 2014 | December 31, 2013 |
Customized swaps | $ | 7,561 |
| $ | 7,839 |
| $ | 71 |
| $ | 74 |
|
Equity swaps, options, and futures | 3,888 |
| 4,237 |
| 32 |
| 44 |
|
Interest rate swaps and futures | 3,975 |
| 6,615 |
| (2 | ) | (77 | ) |
Total | $ | 15,424 |
| $ | 18,691 |
| $ | 101 |
| $ | 41 |
|
U.S. macro hedge program
The Company utilizes equity options and swaps to partially hedge against a decline in the equity markets and the resulting statutory surplus and capital impact primarily arising from GMDB and GMWB obligations. The following table represents notional and fair value for the U.S. macro hedge program.
|
| | | | | | | | | | | | |
| Notional Amount | Fair Value |
| March 31, 2014 | December 31, 2013 | March 31, 2014 | December 31, 2013 |
Equity options and swaps | 7,596 |
| 9,934 |
| 133 |
| 139 |
|
Total | $ | 7,596 |
| $ | 9,934 |
| $ | 133 |
| $ | 139 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
International program
The Company formerly offered certain variable annuity products in Japan with GMWB or GMAB riders, which are bifurcated embedded derivatives (“International program product derivatives”). The GMWB provides the policyholder with a GRB which is generally equal to premiums less withdrawals. If the policyholder’s account value is reduced to the specified level through a combination of market declines and withdrawals but the GRB still has value, the Company is obligated to continue to make annuity payments to the policyholder until the GRB is exhausted. The GMAB provides the policyholder with their initial deposit in a lump sum after a specified waiting period. The notional amount of the International program product derivatives are the foreign currency denominated GRBs converted to U.S. dollars at the current foreign spot exchange rate as of the reporting period date.
The Company enters into derivative contracts (“International program hedging instruments”) to hedge a portion of the capital market risk exposures associated with the guaranteed benefits associated with the international variable annuity contracts. The hedging derivatives are comprised of equity futures, options, swaps and currency forwards and options to hedge against a decline in the debt and equity markets or changes in foreign currency exchange rates and the resulting statutory surplus and capital impact primarily arising from guaranteed minimum death benefits ("GMDB"), GMIB and GMWB obligations issued in Japan. The Company also enters into foreign currency denominated interest rate swaps and swaptions to hedge the interest rate exposure related to the potential annuitization of certain benefit obligations. The following table represents notional and fair value for the international program hedging instruments.
|
| | | | | | | | | | | | |
| Notional Amount | Fair Value |
| March 31, 2014 | December 31, 2013 | March 31, 2014 | December 31, 2013 |
Credit derivatives | $ | 350 |
| $ | 350 |
| $ | — |
| $ | 5 |
|
Currency forwards [1] | 12,254 |
| 8,778 |
| 32 |
| 24 |
|
Currency options | 4,774 |
| 8,408 |
| (15 | ) | (58 | ) |
Equity futures | 473 |
| 999 |
| — |
| — |
|
Equity options | 949 |
| 1,022 |
| (65 | ) | (63 | ) |
Equity swaps | 2,121 |
| 3,830 |
| (50 | ) | (95 | ) |
Customized swaps | — |
| — |
| — |
| — |
|
Interest rate futures | 551 |
| 566 |
| — |
| — |
|
Interest rate swaps and swaptions | 34,216 |
| 33,072 |
| 146 |
| 160 |
|
Total | $ | 55,688 |
| $ | 57,025 |
| $ | 48 |
| $ | (27 | ) |
| |
[1] | As of March 31, 2014 and December 31, 2013 net notional amounts are $(0.8) billion and $(1.6) billion, respectively, which include $5.7 billion and $3.6 billion, respectively, related to long positions and $6.5 billion and $5.2 billion, respectively, related to short positions. |
GMAB, GMWB and GMIB assumed reinsurance contracts
The Company reinsures the GMAB, GMWB, and GMIB embedded derivatives for host variable annuity contracts written by HLIKK. The reinsurance contracts are accounted for as free-standing derivative contracts. The notional amount of the reinsurance contracts is the yen denominated GRB balance value converted at the period-end yen to U.S. dollar foreign spot exchange rate. For further information on this transaction, refer to Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial Statements.
Coinsurance and modified coinsurance reinsurance contracts
During 2010, a subsidiary entered into a coinsurance with funds withheld and modified coinsurance reinsurance agreement with an affiliated captive reinsurer, which creates an embedded derivative. In addition, provisions of this agreement include reinsurance to cede a portion of direct written U.S. GMWB riders, which is accounted for as an embedded derivative. Additional provisions of this agreement cede variable annuity contract GMAB, GMWB and GMIB riders reinsured by the Company that have been assumed from HLIKK and is accounted for as a free-standing derivative. For further information on this transaction, refer to Note 11 - Transactions with Affiliates and Note 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of March 31, 2014 and December 31, 2013 the Company had approximately $1.3 billion of invested assets supporting other policyholder funds and benefits payable reinsured under a modified coinsurance arrangement in connection with the sale of the Individual Life business structured as a reinsurance transaction. The assets are primarily held in a trust established by the Company. The Company pays or receives cash quarterly to settle the results of the reinsured business, including the investment results. As a result of this modified coinsurance arrangement, the Company has an embedded derivative that transfers to the reinsurer certain unrealized changes in fair value due to interest rate and credit risks of these assets. The notional amounts of the reinsurance contracts are the invested assets that are carried at fair value supporting the reinsured reserves.
Derivative Balance Sheet Classification
The following table summarizes the balance sheet classification of the Company’s derivative related fair value amounts as well as the gross asset and liability fair value amounts. For reporting purposes, the Company has elected to offset the fair value amounts, income accruals, and related cash collateral receivables and payables of OTC derivative instruments executed in a legal entity and with the same counterparty under a master netting agreement, which provides the Company with the legal right of offset. The Company has also elected to offset the fair value amounts, income accruals and related cash collateral receivables and payables of OTC-cleared derivative instruments based on clearing house agreements. The fair value amounts presented below do not include income accruals or related cash collateral receivables and payables, which are netted with derivative fair value amounts to determine balance sheet presentation. Derivatives in the Company’s separate accounts, where the associated gains and losses accrue directly to policyholders, are not included. The Company’s derivative instruments are held for risk management purposes, unless otherwise noted in the following table. The notional amount of derivative contracts represents the basis upon which pay or receive amounts are calculated and is presented in the table to quantify the volume of the Company’s derivative activity. Notional amounts are not necessarily reflective of credit risk. The tables below exclude investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| Net Derivatives | Asset Derivatives | Liability Derivatives |
| Notional Amount | Fair Value | Fair Value | Fair Value |
Hedge Designation/ Derivative Type | Mar 31, 2014 | Dec 31, 2013 | Mar 31, 2014 | Dec 31, 2013 | Mar 31, 2014 | Dec 31, 2013 | Mar 31, 2014 | Dec 31, 2013 |
Cash flow hedges | | | | | | | | |
Interest rate swaps | $ | 2,966 |
| $ | 3,215 |
| $ | 25 |
| $ | 16 |
| $ | 43 |
| $ | 49 |
| $ | (18 | ) | $ | (33 | ) |
Foreign currency swaps | 143 |
| 143 |
| (6 | ) | (5 | ) | 2 |
| 2 |
| (8 | ) | (7 | ) |
Total cash flow hedges | 3,109 |
| 3,358 |
| 19 |
| 11 |
| 45 |
| 51 |
| (26 | ) | (40 | ) |
Fair value hedges | | | | | | | | |
Interest rate swaps | 699 |
| 1,261 |
| (25 | ) | (24 | ) | 1 |
| 2 |
| (26 | ) | (26 | ) |
Total fair value hedges | 699 |
| 1,261 |
| (25 | ) | (24 | ) | 1 |
| 2 |
| (26 | ) | (26 | ) |
Non-qualifying strategies | | | | | | | | |
Interest rate contracts | | | | | | | | |
Interest rate swaps, swaptions, caps, floors, and futures | 4,679 |
| 4,633 |
| (355 | ) | (368 | ) | 193 |
| 123 |
| (548 | ) | (491 | ) |
Foreign exchange contracts | | | | | | | | |
Foreign currency swaps and forwards | 107 |
| 118 |
| (5 | ) | (4 | ) | 6 |
| 6 |
| (11 | ) | (10 | ) |
Japan 3Win foreign currency swaps | 1,571 |
| 1,571 |
| (338 | ) | (354 | ) | — |
| — |
| (338 | ) | (354 | ) |
Japanese fixed annuity hedging instruments | 1,381 |
| 1,436 |
| (2 | ) | (6 | ) | 88 |
| 88 |
| (90 | ) | (94 | ) |
Credit contracts | | | | | | | | |
Credit derivatives that purchase credit protection | 220 |
| 243 |
| (4 | ) | (4 | ) | — |
| — |
| (4 | ) | (4 | ) |
Credit derivatives that assume credit risk [1] | 1,356 |
| 1,507 |
| 17 |
| 27 |
| 19 |
| 28 |
| (2 | ) | (1 | ) |
Credit derivatives in offsetting positions | 2,785 |
| 3,501 |
| (2 | ) | (3 | ) | 32 |
| 35 |
| (34 | ) | (38 | ) |
Equity contracts | | | | | | | | |
Equity index swaps and options | 129 |
| 131 |
| (3 | ) | (2 | ) | 18 |
| 18 |
| (21 | ) | (20 | ) |
Variable annuity hedge program | | | | | | | | |
U.S. GMWB product derivatives [2] | 21,195 |
| 21,512 |
| (24 | ) | (36 | ) | — |
| — |
| (24 | ) | (36 | ) |
U.S. GMWB reinsurance contracts | 4,280 |
| 4,508 |
| 30 |
| 29 |
| 30 |
| 29 |
| — |
| — |
|
U.S. GMWB hedging instruments | 15,424 |
| 18,691 |
| 101 |
| 41 |
| 278 |
| 333 |
| (177 | ) | (292 | ) |
U.S. macro hedge program | 7,596 |
| 9,934 |
| 133 |
| 139 |
| 166 |
| 178 |
| (33 | ) | (39 | ) |
International program hedging instruments | 55,688 |
| 57,025 |
| 48 |
| (27 | ) | 441 |
| 649 |
| (393 | ) | (676 | ) |
Other | | | | | | | | |
GMAB, GMWB, and GMIB reinsurance contracts | 11,080 |
| 11,999 |
| (512 | ) | (540 | ) | — |
| — |
| (512 | ) | (540 | ) |
Coinsurance and modified coinsurance reinsurance contracts | 28,387 |
| 29,423 |
| (559 | ) | (427 | ) | 283 |
| 383 |
| (842 | ) | (810 | ) |
Total non-qualifying strategies | 155,878 |
| 166,232 |
| (1,475 | ) | (1,535 | ) | 1,554 |
| 1,870 |
| (3,029 | ) | (3,405 | ) |
Total cash flow hedges, fair value hedges, and non-qualifying strategies | $ | 159,686 |
| $ | 170,851 |
| $ | (1,481 | ) | $ | (1,548 | ) | $ | 1,600 |
| $ | 1,923 |
| $ | (3,081 | ) | $ | (3,471 | ) |
Balance Sheet Location | | | | | | | | |
Fixed maturities, available-for-sale | $ | 199 |
| $ | 196 |
| $ | (1 | ) | $ | (1 | ) | $ | — |
| $ | — |
| $ | (1 | ) | $ | (1 | ) |
Other investments | 42,463 |
| 40,564 |
| 169 |
| 272 |
| 550 |
| 721 |
| (381 | ) | (449 | ) |
Other liabilities | 52,023 |
| 62,590 |
| (563 | ) | (825 | ) | 738 |
| 789 |
| (1,301 | ) | (1,614 | ) |
Consumer notes | 9 |
| 9 |
| (2 | ) | (2 | ) | — |
| — |
| (2 | ) | (2 | ) |
Reinsurance recoverable | 32,667 |
| 33,931 |
| (529 | ) | (398 | ) | 312 |
| 413 |
| (841 | ) | (811 | ) |
Other policyholder funds and benefits payable | 32,325 |
| 33,561 |
| (555 | ) | (594 | ) | — |
| — |
| (555 | ) | (594 | ) |
Total derivatives | $ | 159,686 |
| $ | 170,851 |
| $ | (1,481 | ) | $ | (1,548 | ) | $ | 1,600 |
| $ | 1,923 |
| $ | (3,081 | ) | $ | (3,471 | ) |
| |
[1] | The derivative instruments related to this strategy are held for other investment purposes. |
| |
[2] | These derivatives are embedded within liabilities and are not held for risk management purposes. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Change in Notional Amount
The net decrease in notional amount of derivatives since December 31, 2013 was primarily due to the following:
| |
• | The decrease in notional amount related to the U.S. GMWB hedging instruments and the U.S. macro hedge program was primarily driven by the expiration of certain out-of-the-money options. |
| |
• | The decrease in notional amount related to the international program hedging instruments resulted from a reduction in the liability position due to continued elevated surrender and withdrawal rates as well as portfolio re-balancing including the termination of offsetting positions and the expiration of certain out-of-the-money options. |
| |
• | The decrease in notional amount related to credit derivatives in offsetting positions and interest rate swaps was primarily related to maturities. |
Change in Fair Value
The net increase in the total fair value of derivative instruments since December 31, 2013 was primarily related to the following:
| |
• | The fair value associated with the international program hedging instruments increased primarily from re-balancing of the portfolio, partially offset by a decrease in volatility and interest rates. |
| |
• | The fair value related to the combined U.S. GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily driven by outperformance of underlying actively managed funds compared to their respective indices. |
| |
• | The coinsurance and modified coinsurance reinsurance contracts represent U.S. and International product guarantees that are ceded to an affiliate. The primary driver of the decline in the fair value of these derivatives is a result of changes in the unrealized gains/losses of the underlying portfolios associated with these contracts. For a discussion related to the reinsurance agreement refer to Note 11 - Transactions with Affiliates and Note 2 - Business Dispositions of Notes to Condensed Consolidated Financial Statements for more information on this transaction. |
Offsetting of Derivative Assets/Liabilities
The following tables present the gross fair value amounts, the amounts offset, and net position of derivative instruments eligible for offset in the Company's Condensed Consolidated Balance Sheets. Amounts offset include fair value amounts, income accruals and related cash collateral receivables and payables associated with derivative instruments that are traded under a common master netting agreement, as described above. Also included in the tables are financial collateral receivables and payables, which are contractually permitted to be offset upon an event of default, although are disallowed for offsetting under U.S. GAAP.
As of March 31, 2014 |
| | | | | | | | | | | | | | | | | | | | | | | |
| (i) | | (ii) | | (iii) = (i) - (ii) | (iv) | | (v) = (iii) - (iv) |
| | | | | Net Amounts Presented in the Statement of Financial Position | | Collateral Disallowed for Offset in the Statement of Financial Position | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Assets [1] | | Accrued Interest and Cash Collateral Received [2] | | Financial Collateral Received [4] | | Net Amount |
Description | | | | | | | | | | | |
Other investments | $ | 1,288 |
| | $ | 1,112 |
| | $ | 169 |
| | $ | 7 |
| | $ | 124 |
| | $ | 52 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Liabilities [3] | | Accrued Interest and Cash Collateral Pledged [3] | | Financial Collateral Pledged [4] | | Net Amount |
Description | | | | | | | | | | | |
Other liabilities | $ | (1,682 | ) | | $ | (973 | ) | | $ | (563 | ) | | $ | (146 | ) | | $ | (739 | ) | | $ | 30 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of December 31, 2013
|
| | | | | | | | | | | | | | | | | | | | | | | |
| (i) | | (ii) | | (iii) = (i) - (ii) | (iv) | | (v) = (iii) - (iv) |
| | | | | Net Amounts Presented in the Statement of Financial Position | | Gross Amounts Not Offset in the Statement of Financial Position | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Assets [1] | | Accrued Interest and Cash Collateral Received [2] | | Financial Collateral Received [4] | | Net Amount |
Description | | | | | | | | | | | |
Other investments | $ | 1,510 |
| | $ | 1,290 |
| | $ | 272 |
| | $ | (52 | ) | | $ | 121 |
| | $ | 99 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Liabilities [3] | | Accrued Interest and Cash Collateral Pledged [3] | | Financial Collateral Pledged [4] | | Net Amount |
Description | | | | | | | | | | | |
Other liabilities | $ | (2,063 | ) | | $ | (1,308 | ) | | $ | (825 | ) | | $ | 70 |
| | $ | (826 | ) | | $ | 71 |
|
| |
[1] | Included in other invested assets in the Company's Condensed Consolidated Balance Sheets. |
| |
[2] | Included in other assets in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty. |
| |
[3] | Included in other liabilities in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty. |
| |
[4] | Excludes collateral associated with exchange-traded derivative instruments. |
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge ineffectiveness are recognized in current period earnings. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
The following tables present the components of the gain or loss on derivatives that qualify as cash flow hedges:
Derivatives in Cash Flow Hedging Relationships
|
| | | | | | | | | | | | | |
| Gain (Loss) Recognized in OCI on Derivative (Effective Portion) | | Net Realized Capital Gains(Losses) Recognized in Income on Derivative (Ineffective Portion) |
| Three months ended March 31, | | Three months ended March 31, |
| 2014 | 2013 | | 2014 | 2013 |
Interest rate swaps | $ | 10 |
| $ | (42 | ) | | $ | (1 | ) | $ | — |
|
Foreign currency swaps | (1 | ) | 1 |
| | — |
| — |
|
Total | $ | 9 |
| $ | (41 | ) | | $ | (1 | ) | $ | — |
|
|
| | | | | | | |
| | Gain or (Loss) Reclassified from AOCI into Income (Effective Portion) |
| | Three months ended March 31, |
| Location | 2014 | 2013 |
Interest rate swaps | Net realized capital gain/(loss) | $ | 1 |
| $ | 64 |
|
Interest rate swaps | Net investment income | 13 |
| 14 |
|
Foreign currency swaps | Net realized capital gain/(loss) | — |
| (3 | ) |
Total | | $ | 14 |
| $ | 75 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of March 31, 2014 the before-tax deferred net gains on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are $43. This expectation is based on the anticipated interest payments on hedged investments in fixed maturity securities that will occur over the next twelve months, at which time the Company will recognize the deferred net gains (losses) as an adjustment to interest income over the term of the investment cash flows.
During the three months ended March 31, 2014 and March 31, 2013 the Company had no net reclassifications from AOCI to earnings resulting from the discontinuance of cash-flow hedges due to forecasted transactions that were no longer probable of occurring.
Fair Value Hedges
For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. The Company includes the gain or loss on the derivative in the same line item as the offsetting loss or gain on the hedged item. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
The Company recognized in income gains (losses) representing the ineffective portion of fair value hedges as follows:
Derivatives in Fair-Value Hedging Relationships |
| | | | | | | | | | | | | |
| Gain or (Loss) Recognized in Income [1] |
| Three months ended March 31, |
| 2014 | | 2013 |
| Derivative | Hedge Item | | Derivative | Hedge Item |
Interest rate swaps | | | | | |
Net realized capital gain/(loss) | $ | (1 | ) | $ | 2 |
| | $ | 6 |
| $ | (8 | ) |
Foreign currency swaps | | | | | |
Net realized capital gain/(loss) |
|
|
|
| | (2 | ) | 2 |
|
Benefits, losses and loss adjustment expenses | — |
|
|
| | (1 | ) | 1 |
|
Total | $ | (1 | ) | $ | 2 |
| | $ | 3 |
| $ | (5 | ) |
| |
[1] | The amounts presented do not include the periodic net coupon settlements of the derivative or the coupon income (expense) related to the hedged item. The net of the amounts presented represents the ineffective portion of the hedge. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Non-qualifying Strategies
For non-qualifying strategies, including embedded derivatives that are required to be bifurcated from their host contracts and accounted for as derivatives, the gain or loss on the derivative is recognized currently in earnings within net realized capital gains (losses). The following table presents the gain or loss recognized in income on non-qualifying strategies:
Derivatives Used in Non-Qualifying Strategies
Gain or (Loss) Recognized within Net Realized Capital Gains and Losses |
| | | | | | |
| Three months ended March 31, |
| 2014 | 2013 |
Interest rate contracts | | |
Interest rate swaps, caps, floors, and forwards | $ | 1 |
| $ | 10 |
|
Foreign exchange contracts | | |
Foreign currency swaps and forwards | 1 |
| — |
|
Japan 3Win foreign currency swaps [1] | 15 |
| (130 | ) |
Japanese fixed annuity hedging instruments [2] | 12 |
| (101 | ) |
Credit contracts | | |
Credit derivatives that purchase credit protection | (3 | ) | (5 | ) |
Credit derivatives that assume credit risk | — |
| 9 |
|
Equity contracts | | |
Equity index swaps and options | — |
| (14 | ) |
Variable annuity hedge program | | |
U.S. GMWB product derivatives | 36 |
| 456 |
|
U.S. GMWB reinsurance contracts | (4 | ) | (60 | ) |
U.S. GMWB hedging instruments | (17 | ) | (349 | ) |
U.S. macro hedge program | (10 | ) | (85 | ) |
International program hedging instruments | (23 | ) | (83 | ) |
Other | | |
GMAB, GMWB, and GMIB reinsurance contracts | 51 |
| 337 |
|
Coinsurance and modified coinsurance reinsurance contracts | (130 | ) | (396 | ) |
Total [3] | $ | (71 | ) | $ | (411 | ) |
| |
[1] | The associated liability is adjusted for changes in spot rates through realized capital gains and was $(28) and $116 for the three months ended March 31, 2014 and 2013, respectively. |
| |
[2] | The associated liability is adjusted for changes in spot rates through realized capital gains and was $(30) and $151 for the three months ended March 31, 2014 and 2013, respectively. |
| |
[3] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements. |
For the three months ended March 31, 2014 the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following:
| |
• | The net loss on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument largely offsets the net gain on the GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement, refer to Note 13 - Transactions with Affiliates of the notes to the Condensed Consolidated Financial Statements for more information on this transaction. |
| |
• | The net losses associated with the international program hedging instruments were primarily driven by a decrease in volatility and interest rates. |
| |
• | The net gain on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to a decline in volatility and policyholder experience. |
| |
• | The net gain related to the combined U.S. GMWB hedging program, which includes the U.S. GMWB product, reinsurance, and hedging derivatives, was primarily due to outperformance of underlying actively managed funds compared to their respective indices. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
In addition, for the three months ended March 31, 2014, the Company received gains of $7 on derivative instruments as a result of prior counterparty losses related to the bankruptcy of Lehman Brothers Inc. The losses were the result of the contractual collateral threshold amounts and open collateral calls prior to the bankruptcy filing as well as interest rate and credit spread movements from the date of the last collateral call to the date of the bankruptcy filing.
For the three months ended March 31, 2013 the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following:
| |
• | The net loss associated with the international program hedging instruments was primarily driven by an improvement in global equity markets and depreciation of the Japanese yen in relation to the euro and the U.S. dollar. These losses were partially offset by gains due to a decrease in Japanese interest rates. |
| |
• | The net gain on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to an improvement in global and domestic equity markets and a decrease in currency volatility. |
| |
• | The net loss on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument, primarily offsets the net gain on GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement refer to Note 11 - Transactions with Affiliates for more information on this transaction. |
| |
• | The net loss related to the Japanese fixed annuity hedging instruments and the Japan 3Win foreign currency swaps was primarily due to depreciation of the Japanese yen in relation to the U.S. dollar. |
| |
• | The net gain related to the combined U.S. GMWB hedging program, which includes the U.S. GMWB product, reinsurance, and hedging derivatives, was primarily a result of favorable policyholder behavior. |
| |
• | The net loss on U.S. macro hedge program was primarily due to an improvement in domestic equity markets, the passage of time, and lower equity volatility. |
For additional disclosures regarding contingent credit related features in derivative agreements, see Note 7 - Separate Accounts, Death Benefits and Other Insurance Benefit Features of Notes to Condensed Consolidated Financial Statements.
Credit Risk Assumed through Credit Derivatives
The Company enters into credit default swaps that assume credit risk of a single entity or referenced index in order to synthetically replicate investment transactions. The Company will receive periodic payments based on an agreed upon rate and notional amount and will only make a payment if there is a credit event. A credit event payment will typically be equal to the notional value of the swap contract less the value of the referenced security issuer’s debt obligation after the occurrence of the credit event. A credit event is generally defined as a default on contractually obligated interest or principal payments or bankruptcy of the referenced entity. The credit default swaps in which the Company assumes credit risk primarily reference investment grade single corporate issuers and baskets, which include standard and customized diversified portfolios of corporate issuers. The diversified portfolios of corporate issuers are established within sector concentration limits and may be divided into tranches that possess different credit ratings.
The following tables present the notional amount, fair value, weighted average years to maturity, underlying referenced credit obligation type and average credit ratings, and offsetting notional amounts and fair value for credit derivatives in which the Company is assuming credit risk as of March 31, 2014 and December 31, 2013.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
As of March 31, 2014 |
| | | | | | | | | | | | | | | |
| | | | Underlying Referenced Credit Obligation(s) [1] | | |
Credit Derivative type by derivative risk exposure | Notional Amount [2] | Fair Value | Weighted Average Years to Maturity | Type | Average Credit Rating | Offsetting Notional Amount [3] | Offsetting Fair Value [3] |
Single name credit default swaps | | | | | | | |
Investment grade risk exposure | $ | 297 |
| $ | 5 |
| 4 years | Corporate Credit/ Foreign Gov. | A- | $ | 163 |
| $ | (3 | ) |
Below investment grade risk exposure | 24 |
| — |
| 4 months | Corporate Credit | CCC | 24 |
| — |
|
Basket credit default swaps [4] | | | | | | | |
Investment grade risk exposure | 1,881 |
| 22 |
| 3 years | Corporate Credit | BBB+ | 857 |
| (10 | ) |
Below investment grade risk exposure | 42 |
| 3 |
| 5 years | Corporate Credit | B | — |
| — |
|
Investment grade risk exposure | 240 |
| (4 | ) | 3 years | CMBS Credit | AA- | 234 |
| 4 |
|
Below investment grade risk exposure | 115 |
| (16 | ) | 3 years | CMBS Credit | B | 115 |
| 15 |
|
Embedded credit derivatives | | | | | | | |
Investment grade risk exposure | 150 |
| 145 |
| 3 years | Corporate Credit | A- | — |
| — |
|
Total [5] | $ | 2,749 |
| $ | 155 |
| | | | $ | 1,393 |
| $ | 6 |
|
As of December 31, 2013 |
| | | | | | | | | | | | | | | |
| | | | Underlying Referenced Credit Obligation(s) [1] | | |
Credit Derivative type by derivative risk exposure | Notional Amount [2] | Fair Value | Weighted Average Years to Maturity | Type | Average Credit Rating | Offsetting Notional Amount [3] | Offsetting Fair Value [3] |
Single name credit default swaps | | | | | | | |
Investment grade risk exposure | $ | 735 |
| $ | 6 |
| 2 years | Corporate Credit/ Foreign Gov. | A | $ | 592 |
| $ | (4 | ) |
Below investment grade risk exposure | 24 |
| — |
| 1 year | Corporate Credit | CCC | 25 |
| — |
|
Basket credit default swaps [4] | | | | | | | |
Investment grade risk exposure | 1,912 |
| 25 |
| 3 years | Corporate Credit | BBB+ | 784 |
| (10 | ) |
Below investment grade risk exposure | 87 |
| 8 |
| 5 years | Corporate Credit | BB- | — |
| — |
|
Investment grade risk exposure | 235 |
| (5 | ) | 3 years | CMBS Credit | A | 235 |
| 5 |
|
Below investment grade risk exposure | 115 |
| (18 | ) | 3 years | CMBS Credit | B- | 115 |
| 18 |
|
Embedded credit derivatives | | | | | | | |
Investment grade risk exposure | 150 |
| 145 |
| 3 years | Corporate Credit | BBB+ | — |
| — |
|
Total [5] | $ | 3,258 |
| $ | 161 |
| | | | $ | 1,751 |
| $ | 9 |
|
| |
[1] | The average credit ratings are based on availability and the midpoint of the applicable ratings among Moody’s, S&P, Fitch, and Morningstar. If no rating is available from a rating agency, then an internally developed rating is used. |
| |
[2] | Notional amount is equal to the maximum potential future loss amount. These derivatives are governed by agreements and clearing house rules and applicable law which include collateral posting requirements. There is no additional specific collateral related to these contracts or recourse provisions included in the contracts to offset losses going forward. |
| |
[3] | The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap. |
| |
[4] | Includes $2.3 billion and $2.3 billion as of March 31, 2014 and December 31, 2013, respectively, of standard market indices of diversified portfolios of corporate issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index. |
| |
[5] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
4. Investments and Derivative Instruments (continued)
Derivative Collateral Arrangements
The Company enters into various collateral arrangements in connection with its derivative instruments, which require both the pledging and accepting of collateral. As of March 31, 2014 and December 31, 2013 the Company pledged securities collateral associated with derivative instruments with a fair value of $763 and $865, respectively, which have been included in fixed maturities on the Condensed Consolidated Balance Sheets. The counterparties have the right to sell or re-pledge these securities. The Company also pledged cash collateral associated with derivative instruments with a fair value of $58 and $290, respectively, as of March 31, 2014 and December 31, 2013 which have been primarily included within other assets on the Company's Condensed Consolidated Balance Sheets.
As of March 31, 2014 and December 31, 2013 the Company accepted cash collateral associated with derivative instruments with a fair value of $225 and $171, respectively, which was invested and recorded in the Company's Condensed Consolidated Balance Sheets in fixed maturities and short-term investments with corresponding amounts recorded in other liabilities. The Company also accepted securities collateral as of March 31, 2014 and December 31, 2013 of $124 and $121, respectively, of which the Company has the ability to sell or repledge $124 and $117, respectively. As of March 31, 2014 and December 31, 2013 the fair value of repledged securities totaled $0 and $39, respectively, and the Company did not sell any securities. In addition, as of March 31, 2014 and December 31, 2013 non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Condensed Consolidated Balance Sheets.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
5. Reinsurance
The Company cedes insurance to affiliated and unaffiliated insurers to enable the Company to manage capital and risk exposure. Such arrangements do not relieve the Company of its primary liability to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company. The Company's procedures include careful initial selection of its reinsurers, structuring agreements to provide collateral funds where necessary, and regularly monitoring the financial condition and ratings of its reinsurers. The Company entered into two reinsurance transactions in connection with the sales of its Retirement Plans and Individual Life businesses in January 2013. For further discussion of these transactions, see Note 2 - Business Dispositions of Notes to Condensed Consolidated Financial Statements.
The cost of reinsurance related to long-duration contracts is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies. Insurance recoveries on ceded reinsurance agreements, which reduce death and other benefits, were $207 and $231 for three months ended March 31, 2014, and 2013, respectively. In addition, the Company has reinsured a portion of the risk associated with U.S. variable annuities and the associated GMDB and GMWB riders.
The Company maintains a reinsurance agreement with HLA, whereby the Company cedes group life, accident and health risks. Under the treaty, the Company ceded group life premium of $22 and $7 for the three months ended March 31, 2014, and 2013, respectively. The Company ceded accident and health premiums to HLA of $219 and $42, respectively.
Until April 1, 2014, a subsidiary of the Company, Hartford Life and Annuity Insurance Company (“HLAI”) had a modified coinsurance ("modco") and coinsurance with funds withheld reinsurance agreement with an affiliated captive reinsurer. Under this agreement, the Company ceded $5 and $10 for the three months ended March 31, 2014, and 2013, respectively. For further information regarding the White River Life Reinsurance ("WRR") reinsurance agreement, see Note 11 -Transactions with Affiliates and Note 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements.
Reinsurance Recoverables
The Company's reinsurance recoverables are summarized as follows:
|
| | | | | | |
| As of March 31, | As of December 31, |
| 2014 | 2013 |
Future policy benefits and unpaid loss and loss adjustment expenses and other policyholder funds and benefits payable | | |
Sold businesses (MassMutual and Prudential) | $ | 18,748 |
| $ | 18,969 |
|
Other reinsurers | 923 |
| 825 |
|
Gross reinsurance recoverables | $ | 19,671 |
| $ | 19,794 |
|
As of March 31, 2014, the Company has reinsurance recoverables from MassMutual and Prudential of $9.1 billion and $9.6 billion, respectively. These reinsurance recoverables are secured by invested assets held in trust for the benefit of the Company in the event of a default by the reinsurers. As of March 31, 2014, the fair value of assets held in trust securing the reinsurance recoverables from MassMutual and Prudential were $9.7 billion and $7.7 billion, respectively. As of March 31, 2014, the net reinsurance recoverables from Prudential represents approximately 25% of the Company's consolidated stockholders' equity. As of March 31, 2014, the Company has no other reinsurance-related concentrations of credit risk greater than 10% of the Company’s consolidated stockholder's equity.
Insurance Revenues
Net fee income, earned premiums and other were comprised of the following:
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Gross fee income, earned premiums and other | $ | 822 |
| $ | 798 |
|
Reinsurance assumed | 18 |
| 3 |
|
Reinsurance ceded | (646 | ) | (409 | ) |
Fee income, earned premiums and other | $ | 194 |
| $ | 392 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
6. Deferred Policy Acquisition Costs and Present Value of Future Profits
Changes in the Deferred Policy Acquisition Costs ('DAC") and present value of future profits balances are as follows:
|
| | | | | | |
| March 31, 2014 |
| 2014 | 2013 |
Balance, beginning of period | $ | 689 |
| $ | 3,072 |
|
Deferred costs | 5 |
| 2 |
|
Amortization — DAC | (40 | ) | (43 | ) |
Amortization — Unlock benefit (charge), pre-tax | 8 |
| (1 | ) |
Amortization — DAC related to business dispositions [1] [2] | — |
| (2,229 | ) |
Adjustments to unrealized gains and losses on securities available-for-sale and other | (14 | ) | (3 | ) |
Balance, end of period | $ | 648 |
| $ | 798 |
|
| |
[1] | Includes accelerated amortization of $352 and $2,374 recognized upon the sale of the Retirement Plans and Individual Life businesses, respectively, in the first quarter of 2013. For further information, see Note 2 - Business Dispositions of Notes to Consolidated Financial Statements. |
| |
[2] | Includes previously unrealized gains on securities AFS of $148 and $349 recognized upon the sale of the Retirement Plans and Individual Life businesses, respectively, in the first quarter of 2013. |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
7. Separate Accounts, Death Benefits and Other Insurance Benefit Features
Changes in the gross GMDB and UL secondary guarantee benefits are as follows:
|
| | | | | | |
| GMDB | UL Secondary Guarantees |
Liability balance as of January 1, 2014 | $ | 849 |
| $ | 1,802 |
|
Incurred | 47 |
| 56 |
|
Paid | (31 | ) | — |
|
Unlock | (11 | ) | — |
|
Liability balance as of March 31, 2014 | $ | 854 |
| $ | 1,858 |
|
Reinsurance recoverable asset, as of January 1, 2014 | $ | 533 |
| $ | 1,802 |
|
Incurred | 26 |
| 56 |
|
Paid | (22 | ) | — |
|
Unlock | (5 | ) | — |
|
Reinsurance recoverable asset, as of March 31, 2014 | $ | 532 |
| $ | 1,858 |
|
|
| | | | | | |
| GMDB | UL Secondary Guarantees |
Liability balance as of January 1, 2013 | $ | 944 |
| $ | 363 |
|
Incurred | 45 |
| 68 |
|
Paid | (52 | ) | — |
|
Unlock | (52 | ) | — |
|
Impact of reinsurance transaction | — |
| 1,143 |
|
Currency translation adjustment | (2 | ) | — |
|
Liability balance as of March 31, 2013 | $ | 883 |
| $ | 1,574 |
|
Reinsurance recoverable asset, as of January 1, 2013 | $ | 608 |
| $ | 21 |
|
Incurred | 27 |
| 68 |
|
Paid | (28 | ) | — |
|
Unlock | (28 | ) | — |
|
Impact of reinsurance transaction | — |
| 1,485 |
|
Reinsurance recoverable asset, as of March 31, 2013 | $ | 579 |
| $ | 1,574 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
7. Separate Accounts, Death Benefits and Other Insurance Benefit Features (continued)
The following table presents details concerning GMDB and GMIB exposure as of March 31, 2014:
|
| | | | | | | | | | |
Individual Variable and Group Annuity Account Value by GMDB/GMIB Type |
Maximum anniversary value (“MAV”) [1] | Account Value (“AV”) [8] | Net amount at Risk (“NAR”) [9] | Retained Net Amount at Risk (“RNAR”) [9] | Weighted Average Attained Age of Annuitant |
MAV only | $ | 18,971 |
| $ | 2,836 |
| $ | 170 |
| 69 |
With 5% rollup [2] | 1,563 |
| 227 |
| 16 |
| 69 |
With Earnings Protection Benefit Rider (“EPB”) [3] | 4,735 |
| 615 |
| 19 |
| 68 |
With 5% rollup & EPB | 576 |
| 117 |
| 5 |
| 70 |
Total MAV | 25,845 |
| 3,795 |
| 210 |
| |
Asset Protection Benefit (APB) [4] | 17,717 |
| 256 |
| 52 |
| 68 |
Lifetime Income Benefit (LIB) – Death Benefit [5] | 733 |
| 8 |
| 2 |
| 67 |
Reset [6] (5-7 years) | 3,205 |
| 66 |
| 29 |
| 69 |
Return of Premium [7] /Other | 12,047 |
| 67 |
| 15 |
| 67 |
Subtotal U.S. GMDB | 59,547 |
| 4,192 |
| 308 |
| 68 |
Less: General Account Value with U.S. GMDB | 4,249 |
| | | |
Subtotal Separate Account Liabilities with GMDB | 55,298 |
| | | |
Separate Account Liabilities without U.S. GMDB | 83,182 |
| | | |
Total Separate Account Liabilities | $ | 138,480 |
| | | |
Japan GMDB [10], [11] | $ | 11,564 |
| $ | 202 |
| $ | — |
| 69 |
Japan GMIB [10], [11] | $ | 11,375 |
| $ | 121 |
| $ | — |
| 70 |
| |
[1] | MAV: the GMDB is the greatest of current AV, net premiums paid and the highest AV on any anniversary before age 80 (adjusted for withdrawals). |
| |
[2] | Rollup: the GMDB is the greatest of the MAV, current AV, net premium paid and premiums (adjusted for withdrawals) accumulated at generally 5% simple interest up to the earlier of age 80 or 100% of adjusted premiums. |
| |
[3] | EPB GMDB is the greatest of the MAV, current AV, or contract value plus a percentage of a contract’s growth. A contract’s growth is AV less premiums net of withdrawals, subject to a cap of 200% of premiums net of withdrawals. |
| |
[4] | APB GMDB is the greater of current AV or MAV, not to exceed current AV plus 25% times the greater of net premiums and MAV (each adjusted for premiums in the past 12 months). |
| |
[5] | LIB GMDB is the greatest of current AV, net premiums paid, or for certain contracts a benefit amount that ratchets over time, generally based on market performance. |
| |
[6] | Reset GMDB is the greatest of current AV, net premiums paid and the most recent five to seven year anniversary AV before age 80 (adjusted for withdrawals). |
| |
[7] | ROP: the GMDB is the greater of current AV and net premiums paid. |
| |
[8] | AV includes the contract holder’s investment in the separate account and the general account. |
| |
[9] | NAR is defined as the guaranteed benefit in excess of the current AV. RNAR is NAR reduced for reinsurances. NAR and RNAR are highly sensitive to equity market movements and increase when equity markets decline. |
| |
[10] | Assumed GMDB includes a ROP and MAV (before age 80) paid in a single lump sum. GMIB is a guarantee to return initial investment, adjusted for earnings liquidity, paid through a fixed annuity, after a minimum deferral period of 10, 15 or 20 years. The GRB related to the Japan GMIB was $10.8 billion as of March 31, 2014. The GRB related to the Japan GMAB and GMWB was $300 as of March 31, 2014. These liabilities are not included in the Separate Account as they are not legally insulated from the general account liabilities of the insurance enterprise. As of March 31, 2014, 100% of NAR is reinsured to an affiliate. See Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial statements. |
| |
[11] | Policies with a guaranteed living benefit (a GMWB in the US or a GMIB in Japan) also have a guaranteed death benefit. The NAR for each benefit is shown, however these benefits are not additive. When a policy terminates due to death, any NAR related to GMWB or GMIB is released. Similarly, when a policy goes into benefit status on a GMWB or GMIB, its GMDB NAR is released. |
For a description of the Company’s guaranteed living benefits that are accounted for at fair value, see Note 3 - Fair Value Measurements of Notes to Condensed Consolidated Financial Statements.
Account balances of contracts with death benefit guarantees were invested in variable separate accounts as follows:
|
| | | | | | |
Asset type | March 31, 2014 | December 31, 2013 |
Equity securities (including mutual funds) | $ | 50,866 |
| $ | 52,858 |
|
Cash and cash equivalents | 4,432 |
| 4,605 |
|
Total | $ | 55,298 |
| $ | 57,463 |
|
As of March 31, 2014 and December 31, 2013, approximately 17% of the equity securities above were invested in fixed income securities through these funds and approximately 83% were invested in equity securities through these funds.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
8. Sales Inducements
Changes in sales inducement activity are as follows:
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Balance, beginning of period | $ | 36 |
| $ | 118 |
|
Amortization — Unlock | — |
| (1 | ) |
Amortization charged to income | (1 | ) | (1 | ) |
Amortization related to business dispositions [1] | — |
| (71 | ) |
Balance, end of period | $ | 35 |
| $ | 45 |
|
| |
[1] | Includes $22 and $49, related to sale of the Company's Retirement Plans and Individual Life businesses, respectively, in the first quarter of 2013. For further information, see Note 2 -Business Dispositions of Notes to Condensed Consolidated Financial Statements. |
9. Commitments and Contingencies
Litigation
The Company is involved in claims litigation arising in the ordinary course of business, both as a liability insurer defending or providing indemnity for third-party claims brought against insureds and as an insurer defending coverage claims brought against it. The Company accounts for such activity through the establishment of unpaid loss and loss adjustment expense reserves. Management expects that the ultimate liability, if any, with respect to such ordinary-course claims litigation, after consideration of provisions made for potential losses and costs of defense, will not be material to the consolidated financial condition, results of operations or cash flows of the Company.
The Company is also involved in other kinds of legal actions, some of which assert claims for substantial amounts. These actions include, among others, individual actions in which punitive damages are sought, such as claims alleging bad faith in the handling of insurance claims or other allegedly unfair or improper business practices. Management expects that the ultimate liability, if any, with respect to such lawsuits, after consideration of provisions made for estimated losses, will not be material to the consolidated financial condition of the Company. Nonetheless, given the large or indeterminate amounts sought in certain of these actions, and the inherent unpredictability of litigation, the outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows in particular quarterly or annual periods.
Derivative Commitments
Certain of the Company’s derivative agreements contain provisions that are tied to the financial strength ratings of the individual legal entity that entered into the derivative agreement as set by nationally recognized statistical rating agencies. If the legal entity’s financial strength were to fall below certain ratings, the counterparties to the derivative agreements could demand immediate and ongoing full collateralization and in certain instances demand immediate settlement of all outstanding derivative positions traded under each impacted bilateral agreement. The settlement amount is determined by netting the derivative positions transacted under each agreement. If the termination rights were to be exercised by the counterparties, it could impact the legal entity’s ability to conduct hedging activities by increasing the associated costs and decreasing the willingness of counterparties to transact with the legal entity. The aggregate fair value of all derivative instruments with credit-risk-related contingent features that are in a net liability position as of March 31, 2014, is $721. Of this $721 the legal entities have posted collateral of $780 in the normal course of business. In addition, the Company has posted collateral of $44 associated with a customized GMWB derivative. Based on derivative market values as of March 31, 2014, a downgrade of one or two levels below the current financial strength ratings by either Moody’s or S&P would not require additional assets to be posted as collateral. These collateral amounts could change as derivative market values change, as a result of changes in our hedging activities or to the extent changes in contractual terms are negotiated. The nature of the collateral that we would post, if required, would be primarily in the form of U.S. Treasury bills, U.S. Treasury notes and government agencies.
On March 6, 2014, Moody’s lowered its counterparty credit and insurer financial strength ratings on Hartford Life Insurance Company to Baa2. Given this downgrade action, termination rating triggers of four derivative counterparty relationships were impacted. The counterparties have the right to terminate the relationships and would have to settle the outstanding derivatives prior to exercising termination rights. The Company is in the process of re-negotiating the rating triggers which it expects to successfully complete.
Accordingly, the Company's hedging programs have not been adversely impacted by the announcement of the downgrade of Hartford Life Insurance Company. As of March 31, 2014, the notional amount and fair value related to this counterparty is $10.3 billion and $(34), respectively.
10. Stock Compensation Plans
The Hartford has three primary stock-based compensation plans. The Company is included in these plans and has been allocated compensation expense, after tax of $2 and $1 for the three months ended March 31, 2014 and 2013. The Company did not capitalize the cost of stock-based compensation.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
11. Transactions with Affiliates
Parent Company Transactions
Transactions of the Company with Hartford Fire Insurance Company, Hartford Holdings and its affiliates relate principally to tax settlements, reinsurance, insurance coverage, rental and service fees, payment of dividends and capital contributions. In addition, an affiliated entity purchased group annuity contracts from the Company to fund structured settlement periodic payment obligations assumed by the affiliated entity as part of claims settlements with property casualty insurance companies and self-insured entities. As of March 31, 2014 and December 31, 2013, the Company had $54 of reserves for claim annuities purchased by affiliated entities. For the three months ended March 31, 2014 and 2013 the Company recorded earned premiums of $8 and $3, respectively, for these intercompany claim annuities. In 2008, the Company issued a payout annuity to an affiliate for $2.2 billion of consideration. The Company will pay the benefits associated with this payout annuity over 12 years.
Substantially all general insurance expenses related to the Company, including rent and employee benefit plan expenses are initially paid by The Hartford. Direct expenses are allocated to the Company using specific identification, and indirect expenses are allocated using other applicable methods. Indirect expenses include those for corporate areas which, depending on type, are allocated based on either a percentage of direct expenses or on utilization.
The Company has issued a guarantee to retirees and vested terminated employees (“Retirees”) of The Hartford Retirement Plan for U.S. Employees (“the Plan”) who retired or terminated prior to January 1, 2004. The Plan is sponsored by The Hartford. The guarantee is an irrevocable commitment to pay all accrued benefits which the Retiree or the Retiree’s designated beneficiary is entitled to receive under the Plan in the event the Plan assets are insufficient to fund those benefits and The Hartford is unable to provide sufficient assets to fund those benefits. The Company believes that the likelihood that payments will be required under this guarantee is remote.
In 1990, Hartford Fire guaranteed the obligations of the Company with respect to life, accident and health insurance and annuity contracts issued after January 1, 1990. The guarantee was issued to provide an increased level of security to potential purchasers of the Company’s products. Although the guarantee was terminated in 1997, it still covers policies that were issued from 1990 to 1997. As of March 31, 2014 and March 31, 2013, no recoverables have been recorded for this guarantee, as the Company was able to meet these policyholder obligations.
Reinsurance Assumed from Affiliates
Prior to June 1, 2009, yen and U.S. dollar based fixed market value adjusted (“MVA”) annuity products, written by HLIKK, were sold to customers in Japan. HLIKK, a wholly owned Japanese subsidiary of Hartford Life, Inc., reinsured to the Company in-force and prospective MVA annuities sold from September 1, 2004 to June 1, 2009. As of March 31, 2014 and December 31, 2013, $1.4 billion and $1.5 billion, respectively, of the account value had been assumed by the Company.
HLAI assumed from HLIKK GMDB on covered contracts that have an associated GMIB rider in force on or after July 31, 2006 and GMIB riders issued on or after April 1, 2005. HLAI assumed certain in-force and prospective GMAB, GMIB and GMDB riders issued on or after February 5, 2007 by HLIKK. HLAI assumed certain in-force and prospective GMIB and GMDB riders issued on or after February 1, 2008 by HLIKK. HLAI assumed certain in-force and prospective GMDB riders issued on or after April 1, 2005 by HLIKK.
The GMDB reinsurance is accounted for as a Death Benefit and Other Insurance Benefit Reserve which is not reported at fair value. There was no liability for the assumed GMDB reinsurance and the net amount at risk for the assumed GMDB reinsurance was $0.2 billion at March 31, 2014 and December 31, 2013.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
11. Transactions with Affiliates (continued)
While the form of the agreement between HLAI and HLIKK for the GMIB business is reinsurance, in substance and for accounting purposes the agreement is a free standing derivative. As such, the reinsurance agreement for the GMIB business is recorded at fair value on the Company’s balance sheet, with prospective changes in fair value recorded in net realized capital gains (losses) in net income (loss). The fair value of the GMIB liability was $0.5 billion at March 31, 2014 and December 31, 2013.
While the form of the agreements between HLAI and HLIKK for the GMAB/GMWB business is reinsurance, in substance and for accounting purposes these agreements are free standing derivatives. As such, the reinsurance agreements for the GMAB/GMWB business are recorded at fair value on the Company’s Condensed Consolidated Balance Sheets, with prospective changes in fair value recorded in net realized capital gains (losses) in net income (loss). The fair value of the GMAB/GMWB liability/(asset) was $4 at March 31, 2014 and December 31, 2013.
Reinsurance Ceded to Affiliates
Until April 1, 2014, HLAI had a modified coinsurance (“modco”) and coinsurance with funds withheld reinsurance agreement with WRR. HLAI ceded to WRR variable annuity contracts, associated riders, and payout annuities written by HLAI; annuity contracts and associated riders assumed by HLAI under unaffiliated reinsurance agreements; GMAB, GMIB riders and GMDB risks assumed by HLAI from HLIKK; and, up until the sale of HLL on December 12, 2013, GMDB and GMWB riders assumed by HLAI from HLL. For further information regarding the WRR reinsurance agreement, see Note 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements.
Under modco, the assets and the liabilities, and under coinsurance with funds withheld, the assets, associated with the reinsured business will remain on the consolidated balance sheet of HLIC in segregated portfolios, and WRR will receive the economic risks and rewards related to the reinsured business through modco and funds withheld adjustments. These adjustments are recorded as an adjustment to operating expenses.
The impact of this transaction on the Company’s Condensed Consolidated Statements of Operations is as follows:
|
| | | | | | |
| Three Months Ended March 31, |
|
| 2014 | 2013 |
Earned premiums | $ | (5 | ) | $ | (10 | ) |
Net realized gains (losses) [1] | (103 | ) | (517 | ) |
Total revenues | (108 | ) | (527 | ) |
Benefits, losses and loss adjustment expenses | (1 | ) | (8 | ) |
Insurance operating costs and other expenses | (4 | ) | (422 | ) |
Total expenses | (5 | ) | (430 | ) |
Income (loss) before income taxes | (103 | ) | (97 | ) |
Income tax expense (benefit) | (36 | ) | (34 | ) |
Income from continuing operations, net of tax | $ | (67 | ) | $ | (63 | ) |
Income from discontinued operations, net of tax | — |
| (1 | ) |
Net income (loss) | $ | (67 | ) | $ | (64 | ) |
[1] Amounts represent the change in valuation of the derivative associated with this transaction.
The Company's Condensed Consolidated Balance Sheets include a modco reinsurance (payable)/recoverable and a deposit liability, as well as a net reinsurance recoverable that is comprised of an embedded derivative. The balance of the modco reinsurance recoverable, deposit liability and net reinsurance recoverable were $0, $917, $539, respectively at March 31, 2014 and $129, $638, $495, respectively at December 31, 2013.
Champlain Life Reinsurance Company
Effective November 1, 2007, HLAI entered into a modco and coinsurance with funds withheld agreement with Champlain Life Reinsurance Company ("Champlain Life"), an affiliate captive insurance company, to provide statutory surplus relief for certain life insurance policies. The agreement was accounted for as a financing transaction in accordance with U.S. GAAP. Simultaneous with the sale of the Individual Life business to Prudential, HLAI recaptured the business assumed by Champlain Life. As a result, on January 2, 2013, HLAI was relieved of its funds withheld obligation to Champlain Life of $691; HLAI paid a recapture fee of $347 to Champlain Life; and, HLAI recognized a pre-tax gain of $344 ($224 after-tax). HLAI simultaneously ceded the recaptured reserves to Prudential and recognized the gain on recapture as part of the reinsurance loss on disposition.
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
12. Restructuring and Other Costs
As a result of a strategic business realignment announced in 2012, The Hartford is currently focusing on its Property & Casualty, Group Benefits and Mutual Funds businesses. In addition, the Company implemented restructuring activities in 2011 across several areas aimed at reducing overall expense levels. The Company intends to substantially complete the related restructuring activities over the next 15 months. For further discussion of the Company's strategic business realignment and related business disposition transactions, see Note 2 - Business Dispositions of Notes to Condensed Consolidated Financial Statements.
Termination benefits related to workforce reductions and lease and other contract terminations have been accrued through March 31, 2014. Additional costs, mainly severance benefits and other related costs and professional fees, expected to be incurred subsequent to March 31, 2014, and asset impairment and related charges, will be expensed as appropriate.
As of March 31, 2014, estimated restructuring and other costs, including costs incurred to date, are expected to approximate $147, pre-tax. As the Company executes on its operational and strategic initiatives, the Company's estimate of and actual costs incurred for restructuring activities may differ from these estimates.
Restructuring and other costs, pre-tax incurred in connection with these activities are as follows:
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Severance benefits and related costs | $ | 1 |
| $ | 6 |
|
Professional fees | — |
| 4 |
|
Asset impairment charges | — |
| — |
|
Total restructuring and other costs | $ | 1 |
| $ | 10 |
|
Changes in the accrued restructuring liability balance included in other liabilities in the Company's Consolidated Balance Sheets
are as follows:
|
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2014 |
| Severance Benefits and Related Costs | Professional Fees | Asset Impairment Charges | Other Contract Termination Charges | Total Restructuring and Other Costs |
Balance, beginning of period | $ | 1 |
| $ | — |
| $ | — |
| $ | — |
| $ | 1 |
|
Accruals/provisions | 1 |
| — |
| — |
| — |
| 1 |
|
Payments/write-offs | (2 | ) | — |
| — |
| — |
| (2 | ) |
Balance, end of period | $ | — |
| $ | — |
| $ | — |
| $ | — |
| $ | — |
|
|
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2013 |
| Severance Benefits and Related Costs | Professional Fees | Asset Impairment Charges | Other Contract Termination Charges | Total Restructuring and Other Costs |
Balance, beginning of period | $ | 31 |
| $ | — |
| $ | — |
| $ | — |
| $ | 31 |
|
Accruals/provisions | 6 |
| 4 |
| — |
| — |
| 10 |
|
Payments/write-offs | (10 | ) | (2 | ) | — |
| — |
| (12 | ) |
Balance, end of period | $ | 27 |
| $ | 2 |
| $ | — |
| $ | — |
| $ | 29 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
13. Discontinued Operations
On December 12, 2013, the Company completed the sale of HLIL, an indirect wholly-owned subsidiary of the Company. For further
information regarding the sale of HLIL, see Note 2 -Business Dispositions of Notes to Condensed Consolidated Financial Statements.
The results of operations reflected as discontinued operations in the Condensed Consolidated Statements of Operations, consisting of amounts related to HLIL are as follows:
|
| | | |
| Three Months Ended March 31, |
| 2013 |
Revenues | |
Earned premiums | $ | (2 | ) |
Fee income | 8 |
|
Net investment income | |
Equity securities, trading | 138 |
|
Total net investment income | 138 |
|
Net realized capital losses | (9 | ) |
Total revenues | 135 |
|
Benefits, losses and expenses | |
Benefits, losses and loss adjustment expenses | 1 |
|
Benefits, losses and loss adjustment expenses - returns credited on international variable annuity | 138 |
|
Insurance operating costs and other expenses | (22 | ) |
Total benefits, losses and expenses | 117 |
|
Income before income taxes | 18 |
|
Income tax benefit | (1 | ) |
Income from discontinued operations, net of tax | $ | 19 |
|
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
14. Changes in and Reclassifications From Accumulated Other Comprehensive Income
Changes in AOCI, net of tax and DAC, by component consist of the following:
Three months ended March 31, 2014 |
| | | | | | | | | | | | |
| Net Unrealized Gain on Securities | Net Gain (Loss) on Cash-Flow Hedging Instruments | Foreign Currency Translation Adjustments | Total AOCI |
Beginning balance | $ | 495 |
| $ | 79 |
| $ | — |
| $ | 574 |
|
OCI before reclassifications | 317 |
| 7 |
| (1 | ) | 323 |
|
Amounts reclassified from AOCI | (2 | ) | (9 | ) | — |
| (11 | ) |
Net OCI | 315 |
| (2 | ) | (1 | ) | 312 |
|
Ending balance | $ | 810 |
| $ | 77 |
| $ | (1 | ) | $ | 886 |
|
Reclassifications from AOCI consist of the following for the three months ended March 31, 2014:
|
| | | | |
| Amount Reclassified from AOCI | |
AOCI | Three months ended March 31, 2014 | Affected Line Item in the Condensed Consolidated Statement of Operations |
Net Unrealized Gain on Securities | | |
Available-for-sale securities | $ | 3 |
| Net realized capital gains (losses) |
| 3 |
| Total before tax |
| 1 |
| Income tax expense |
| $ | 2 |
| Net income |
Net Gains on Cash-Flow Hedging Instruments | | |
Interest rate swaps | $ | 1 |
| Net realized capital gains (losses) |
Interest rate swaps | 13 |
| Net investment income |
Foreign currency swaps | — |
| Net realized capital gains (losses) |
| 14 |
| Total before tax |
| 5 |
| Income tax expense |
| $ | 9 |
| Net income |
Total amounts reclassified from AOCI | $ | 11 |
| Net income |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
14. Changes in and Reclassifications From Accumulated Other Comprehensive Income (continued)
Three Months Ended March 31, 2013
|
| | | | | | | | | | | | |
| Net Unrealized Gain on Securities [1] | Net Gain (Loss) on Cash-Flow Hedging Instruments | Foreign Currency Translation Adjustments | Total AOCI [1] |
Beginning balance | $ | 1,752 |
| $ | 258 |
| $ | (23 | ) | $ | 1,987 |
|
OCI before reclassifications | 213 |
| (27 | ) | (41 | ) | 145 |
|
Amounts reclassified from AOCI | (1,005 | ) | (49 | ) | — |
| (1,054 | ) |
Net OCI | (792 | ) | (76 | ) | (41 | ) | (909 | ) |
Ending balance | $ | 960 |
| $ | 182 |
| $ | (64 | ) | $ | 1,078 |
|
Reclassifications from AOCI consist of the following for the three months ended March 31, 2013:
|
| | | | |
| Amount Reclassified from AOCI | |
AOCI | Three months ended March 31, 2013 | Affected Line Item in the Condensed Consolidated Statement of Operations |
Net Unrealized Gain on Securities | | |
Available-for-sale securities [1] | $ | 1,546 |
| Net realized capital gains (losses) |
| 1,546 |
| Total before tax |
| 541 |
| Income tax expense |
| $ | 1,005 |
| Net income |
Net Gains on Cash-Flow Hedging Instruments | | |
Interest rate swaps [2] | $ | 64 |
| Net realized capital gains (losses) |
Interest rate swaps | 14 |
| Net investment income |
Foreign currency swaps | (3 | ) | Net realized capital gains (losses) |
| 75 |
| Total before tax |
| 26 |
| Income tax expense |
| $ | 49 |
| Net income |
Total amounts reclassified from AOCI | $ | 1,054 |
| Net income |
[1] Includes $1.5 billion of net unrealized gains on securities relating to the sales of the Retirement Plans and Individual Life businesses.
[2] Includes $71 of net gains on cash flow hedging instruments relating to the sales of the Retirement Plans and Individual Life businesses.
15. Subsequent Events
Effective April 1, 2014, HLAI, terminated its reinsurance agreement with WRR, following receipt of approval from the State of Connecticut Insurance Department ("CTDOI") and Vermont Department of Financial Regulation. As a result the Company will reclassify $310 in aggregate reserves for annuity contracts from funds withheld within Other liabilities to Other policyholder funds and benefits payable. The Company expects to recognize a gain of approximately $215 resulting from the termination of derivatives associated with the reinsurance transaction. On April 30, The Hartford dissolved WRR which resulted in WRR paying off the $655 surplus note and returning $345 in capital to The Hartford, all of which was contributed as capital to HLAI to support the recaptured risks.
On April 28, 2014, HLI entered into a Stock Purchase Agreement ("Agreement") to sell to ORIX Life Insurance Corporation ("Buyer"), a subsidiary of ORIX Corporation, a Japanese company, all of the issued and outstanding equity of HLIKK.
Under the terms of the Agreement, and subject to regulatory approval, on closing HLIKK will recapture certain risks reinsured to the Company and HLAI by terminating intercompany agreements. Upon closing, Buyer will be responsible for all liabilities for the recaptured business. HLAI will, however, continue to be obligated for approximately $1.1 billion of fixed payout annuities related to the 3Win product formerly written by HLIKK. This transaction is not expected to have a material impact on the Company’s condensed consolidated results of operations, financial position or liquidity.
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollar amounts in millions, unless otherwise stated)
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) addresses the financial condition of Hartford Life Insurance Company and its subsidiaries (“Hartford Life Insurance Company” or the “Company”) as of March 31, 2014, and its results of operations for the three months ended March 31, 2014 compared to the equivalent 2013 period. This discussion should be read in conjunction with MD&A in Hartford Life Insurance Company��s 2013 Form 10-K Annual Report. Certain reclassifications have been made to prior period financial information to conform to the current period classifications.
The Company meets the conditions specified in General Instruction H(1) of Form 10-Q and is filing this Form with the reduced disclosure format permitted for wholly-owned subsidiaries of reporting entities. The Company has omitted, from this Form 10-Q, certain information in Part I Item 2 Management Discussion and Analysis of Financial Condition and Results of Operations. The Company has included, under Item 2, Consolidated Results of Operations to explain any material changes in revenue and expense items for the periods presented.
INDEX
CONSOLIDATED RESULTS OF OPERATIONS
|
| | | | | | | | |
Operating Summary | Three Months Ended March 31, |
| 2014 | 2013 | Change |
Fee income and other | $ | 317 |
| $ | 353 |
| (10 | %) |
Earned premiums | (123 | ) | 39 |
| NM |
|
Net investment income: | | |
|
|
Securities available-for-sale and other | 407 |
| 432 |
| (6 | %) |
Total net investment income | 407 |
| 432 |
| (6 | %) |
Net realized capital gains (losses) [1] | (106 | ) | 1,443 |
| (107 | %) |
Total revenues | 495 |
| 2,267 |
| (78 | %) |
Benefits, losses and loss adjustment expenses | 254 |
| 456 |
| (44 | %) |
Amortization of deferred policy acquisition costs and present value of future profits | 32 |
| 44 |
| (27 | %) |
Insurance operating costs and other expenses | 166 |
| (243 | ) | (168 | %) |
Reinsurance loss on dispositions, including reduction in goodwill of $250 in 2013 | — |
| 1,492 |
| (100 | %) |
Dividends to policyholders | (1 | ) | 5 |
| (120 | %) |
Total benefits, losses and expenses | 451 |
| 1,754 |
| (74 | %) |
Income from continuing operations before income taxes | 44 |
| 513 |
| (91 | %) |
Income tax expense (benefit) | (13 | ) | 146 |
| (109 | %) |
Income from continuing operations, net of tax | 57 |
| 367 |
| (84 | %) |
Income from discontinued operations, net of tax | — |
| 19 |
| (100 | %) |
Net income | 57 |
| 386 |
| (85 | %) |
Net income attributable to noncontrolling interest | 1 |
| 6 |
| (83 | %) |
Net income attributable to Hartford Life Insurance Company | $ | 56 |
| $ | 380 |
| (85 | %) |
| |
[1] | Includes net realized capital gains (losses) on business dispositions of $1,560 for the three months ended March 31, 2013. |
Three months ended March 31, 2014 compared to the three months ended March 31, 2013
Net income decreased for the three months ended March 31, 2014 as compared to the prior year period. The decrease in net income was primarily driven by net capital losses, excluding the impacts of the affiliate modco reinsurance agreement and gains on business dispositions and a decline in net investment income.
Net realized capital gains (losses), excluding the impacts of the affiliate modco reinsurance agreement and the net realized gains on business disposition, decreased by $403 for the three months ended March 31, 2014, as compared to the prior year period, resulting in net realized capital losses of $3 for the three months ended March 31, 2014. For further discussion of the results, see MD&A - Investment Results, Net Realized Capital Gains (Losses).
Net investment income decreased for the three months ended March 31, 2014 as compared to the prior year period due to lower income from fixed maturities as a result of a decline in asset levels and lower income from repurchase agreements. These decreases were partially offset by an increase in income from limited partnerships and other alternative investments which resulted primarily from an increase in valuations of underlying funds. For further discussion, see MD&A - Investments Results, Net Investment Income (Loss).
An increase in the loss on the affiliate modco reinsurance agreement decreased earnings by $3 for the three months ended March 31, 2014, as compared to the prior year period. The most significant fluctuations of the modco agreement were within net realized capital gains (losses) and insurance operating costs and other expenses, which are primarily due to changes in reserves and hedging costs associated with the reinsured block of business. For further discussion on the affiliate modco reinsurance agreement see Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial Statements.
The effective tax rates in 2014 and 2013 differ from the U.S. Federal statutory rate of 35% primarily due to permanent differences related to the separate account dividends received deduction (“DRD”). For further discussion of income taxes, see the Income Taxes section within Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements.
Investment Results
Net Investment Income (Loss)
|
| | | | | | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
(Before-tax) | Amount | Yield [1] | Amount | Yield [1] |
Fixed maturities [2] | $ | 292 |
| 4.3 | % | $ | 321 |
| 4.3 | % |
Equity securities, AFS | 2 |
| 2.6 | % | 1 |
| 1.1 | % |
Mortgage loans | 40 |
| 4.7 | % | 45 |
| 5.0 | % |
Policy loans | 20 |
| 5.7 | % | 19 |
| 5.0 | % |
Limited partnerships and other alternative investments | 42 |
| 13.0 | % | 26 |
| 8.1 | % |
Other [3] | 27 |
| | 37 |
| |
Investment expense | (16 | ) | | (17 | ) | |
Total securities AFS and other | 407 |
| 4.5 | % | 432 |
| 4.4 | % |
Equity securities, trading | — |
| | — |
| |
Total net investment income (loss) | $ | 407 |
| | $ | 432 |
| |
Total securities, AFS and other excluding limited partnerships and other alternative investments | $ | 365 |
| 4.2 | % | $ | 406 |
| 4.3 | % |
| |
[1] | Yields calculated using annualized net investment income (excluding income related to equity securities, trading) before investment expenses divided by the monthly average invested assets at cost, or adjusted carrying value, as applicable, excluding equity securities, trading, and repurchase agreement and dollar roll collateral. Yield calculations for the three months ended March 31, 2013 exclude assets transfered due to the sale of the Retirement Plans and Individual Life businesses. Yield calculations for the three months ended March 31, 2013 exclude income and assets associated with the disposal of the HLIL business. Yields by asset type exclude investment expenses. |
| |
[2] | Includes net investment income on short-term investments. |
| |
[3] | Primarily includes income from derivatives that qualify for hedge accounting and hedge fixed maturities. |
Three months ended March 31, 2014 compared to the three months ended March 31, 2013
Total net investment income decreased primarily due to lower income from fixed maturities as a result of a decline in asset levels and lower income from repurchase agreements. These decreases were partially offset by an increase in income from limited partnerships and other alternative investments which resulted primarily from an increase in valuations of underlying funds.
The annualized net investment income yield, excluding limited partnerships and other alternative investments, has declined to 4.2% in the first quarter of 2014 versus 4.3% in the first quarter of 2013. The decline was primarily attributable to lower income from repurchase agreements. Refer to Note 4 - Investments and Derivative Instruments of Notes to Condensed Consolidated Financial Statements for further discussion of repurchase agreements. The average reinvestment rate for the three months ended March 31, 2014 was approximately 3.7%, excluding treasury securities which approximated the average yield of sales and maturities for the same period. Based upon current reinvestment rates, we expect the annualized net investment income yield, excluding limited partnerships and other alternative investments, for 2014, to remain relatively consistent with the current net investment income yield. The estimated impact on net investment income is subject to change as the composition of the portfolio changes through normal portfolio management and trading activities and changes in market conditions.
Net Realized Capital Gains (Losses) |
| | | | | | |
| Three Months Ended March 31, |
(Before-tax) | 2014 | 2013 |
Gross gains on sales | $ | 108 |
| $ | 1,613 |
|
Gross losses on sales | (104 | ) | (54 | ) |
Net OTTI losses recognized in earnings | (7 | ) | (13 | ) |
Valuation allowances on mortgage loans | — |
| 1 |
|
Japanese fixed annuity contract hedges, net [1] | (9 | ) | 3 |
|
Periodic net coupon settlements on credit derivatives/Japan | 5 |
| (3 | ) |
Results of variable annuity hedge program |
|
|
|
|
U.S. GMWB derivatives, net | 15 |
| 47 |
|
U.S. macro hedge program | (10 | ) | (85 | ) |
Total U.S. program | 5 |
| (38 | ) |
International Program | (23 | ) | (83 | ) |
Total results of variable annuity hedge program | (18 | ) | (121 | ) |
GMIB/GMAB/GMWB reinsurance | 51 |
| 337 |
|
Coinsurance and modified coinsurance reinsurance contracts | (130 | ) | (399 | ) |
Other, net [2] | (2 | ) | 79 |
|
Net realized capital gains (losses), before-tax | $ | (106 | ) | $ | 1,443 |
|
| |
[1] | Relates to the Japanese fixed annuity product (adjustment of product liability for changes in spot currency exchange rates, related derivative hedging instruments, excluding net periodic coupon settlements, and Japan FVO securities). |
| |
[2] | Primarily consists of changes in value of non-qualifying derivatives, Japan 3Win related foreign currency swaps, and transactional foreign currency re-valuation associated with the internal reinsurance of the Japan variable annuity business, which is offset in AOCI. |
Details on the Company's net realized capital gains and losses are as follows:
Gross gains and losses on sales
| |
• | Gross gains on sales for the three months ended March 31, 2014 were primarily due to gains on the sale of corporate, RMBS, and CMBS. Gross losses on the sales three months ended March 31, 2014 were the result of losses on sales of emerging market securities, primarily within the foreign government and corporate sectors. The sales were primarily a result of duration and liquidity management, as well as tactical changes to the portfolio as a result of changing market conditions. |
| |
• | Gross gains and losses on sales for the three months ended March 31, 2013 were predominately from the sales of the Retirement Plans and Individual Life businesses resulting in a gain of $1.5 billion. |
Variable annuity hedge program
• For the three months ended March 31, 2014 the net gain related to the combined U.S. GMWB derivatives, net, which includes the U.S. GMWB product, reinsurance, and hedging derivatives, was primarily driven by gains of $14 related to outperformance of underlying actively managed funds compared to their respective indices. For the three months ended March 31, 2014 the loss on the U.S. macro hedge program was primarily due to losses of $9 related to decreased volatility, and losses of $4 driven by an improvement in domestic equity markets.
| |
• | For the three months ended March 31, 2014 the losses associated with the international program were primarily driven by losses related to decreased volatility and a decrease in interest rates. |
• For the three months ended March 31, 2013, the gain on U.S. GMWB derivatives, net, was primarily due to gains of $46 on on favorable policyholder behavior. For the three months ended March 31, 2013, the loss on the U.S. macro hedge program was primarily due to losses of $56 related to an improvement in domestic equity markets, losses of $15 related to the passage of time, and losses of $15 due to lower equity volatility.
| |
• | For the three months ended March 31, 2013, the loss associated with the international program was primarily driven by losses due to an improvement in global equity markets, and depreciation of the Japanese yen. These losses were partially offset by gains due to a decrease in Japanese interest rates. |
Other, net
| |
• | Other, net loss for the three months ended March 31, 2014 was primarily due to losses of $13 related to the Japan 3Win foreign currency swaps primarily driven by a decline in U.S. interest rates, partially offset by gains of $12 related to FVO securities driven by credit spread tightening. |
| |
• | Other, net gain for the three months ended March 31, 2013 was primarily due to gains of $71 on interest derivatives largely associated with fixed rate bonds sold as part of the Individual Life and Retirement Plans business dispositions. For further information on the business dispositions, see Note 2 of Notes to Condensed Consolidated Financial Statements. Additional gains of $30 were related to transactional foreign currency re-valuation associated with the internal reinsurance of the Japan variable annuity business, which is offset in AOCI, due to depreciation of the Japanese yen versus the U.S. dollar. |
CRITICAL ACCOUNTING ESTIMATES
The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ, and in the past have differed, from those estimates. The Company’s critical accounting estimates are discussed in Part II, Item 7 MD&A in the Company’s 2013 Form 10-K Annual Report. The following discussion updates certain of the Company’s critical accounting estimates for March 31, 2014 results.
Estimated Gross Profits Used in the Valuation and Amortization of Assets and Liabilities Associated with Variable Annuity and Other Universal Life-Type Contracts
Estimated gross profits ("EGPs") are used in the amortization of the DAC asset, which includes the present value of future profits, sales inducement assets (“SIA”); and unearned revenue reserves (“URR”). Portions of EGPs are also used in the valuation of reserves for death and other insurance benefit features on variable annuity and other universal life type contracts. URR associated with the Individual Life business is no longer included in EGP based balances due to the sale of this business in 2013.
For additional information regarding business dispositions, see Note 2 - Business Dispositions and Note 5 - Reinsurance of Notes to Condensed Consolidated Financial Statements. For additional information on DAC, see Note 6 - Deferred Policy Acquisition Costs and Present Value of Future Profits of Notes to Condensed Consolidated Financial Statements. For additional information on SIA, see Note 8 - Sales Inducements of Notes to Condensed Consolidated Financial Statements. For additional information on death and other insurance benefit reserves, see Note 7 - Separate Accounts, Death Benefits and Other Insurance Benefit Features of Notes to Condensed Consolidated Financial Statements.
Unlocks
The benefit (charge) to net income (loss) by asset and liability as a result of the Unlock is as follows:
|
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
DAC | $ | 8 |
| $ | (1 | ) |
SIA | — |
| (1 | ) |
Death and Other Insurance Benefit Reserves | 6 |
| 18 |
|
Total (pre-tax) | 14 |
| 16 |
|
Income tax effect | 5 |
| 6 |
|
Total (after-tax) | $ | 9 |
| $ | 10 |
|
The Unlock benefit for the three months ended March 31, 2014 and 2013 was primarily due to actual separate account returns being above our aggregated estimated returns.
An Unlock revises EGPs, on a quarterly basis, to reflect the Company's current best estimate assumptions and market updates of policyholder account value. Modifications to the Company’s hedging programs may impact EGPs, and correspondingly impact DAC recoverability. After each quarterly Unlock, the Company also tests the aggregate recoverability of DAC by comparing the DAC balance to the present value of future EGPs. As of March 31, 2014, the margin between the DAC balance and the present value of future EGPs for U.S. individual variable annuities was 27%. If the margin between the DAC asset and the present value of future EGPs is exhausted, then further reductions in EGPs would cause portions of DAC to be unrecoverable and the DAC asset would be written down to equal future EGPs.
CAPITAL RESOURCES AND LIQUIDITY
Capital resources and liquidity represent the overall strength of Hartford Life Insurance Company and its ability to generate strong cash flows from each of the business segments, borrow funds at competitive rates and raise new capital to meet operating and growth needs over the next twelve months.
Liquidity Requirements and Sources of Capital
The Hartford has an intercompany liquidity agreement that allows for short-term advances of funds among the HFSG Holding Company and certain affiliates of up to $2.0 billion for liquidity and other general corporate purposes. The Connecticut Insurance Department granted approval for certain affiliated insurance companies that are parties to the agreement to treat receivables from a parent, including the HFSG Holding Company, as admitted assets for statutory accounting purposes. On April 29, 2013 HLIC issued a Revolving Note (the "Note") in the principal amount of $100 to Hartford Life and Accident Insurance Company, under the intercompany liquidity agreement. The Note bore interest at 0.92% and matures on April 29, 2014. On May 29, 2013 Hartford Life and Annuity Insurance Company, issued a Note in the principal amount of $225 to Hartford Life and Accident Insurance Company, under the intercompany liquidity agreement. The Note bore interest at 1.00% and matures on May 29, 2014. On February 28, 2014, the total outstanding balances on these notes were repaid in full.
Until April 1, 2014, Hartford Life and Annuity Insurance Company ("HLAI"), a wholly-owned subsidiary of the Company, ceded certain variable annuity contracts and their associated riders as well as certain payout annuities issued by HLAI or assumed by it to White River Life Reinsurance Company ("WRR"), an affiliate captive reinsurer. The economic purpose of the WRR arrangement is to provide the Company and its subsidiaries with a more efficient vehicle to manage risks in connection with these products. The reinsurance transaction between HLAI and WRR was mainly structured as modified coinsurance ("modco"). Accordingly, the assets and reinsured reserves remained on the books of HLAI and all insurance and investment experience was passed to WRR through modco adjustments. The reinsurance arrangement between HLAI and WRR did not impact the Company's reserving methodology or the amount of required regulatory capital associated with the reinsured business. Under this transaction, the Company ceded $5 and $10 for the three months ended March 31, 2014, and 2013, respectively.
Pursuant to an intercompany note agreement between WRR and the Company's ultimate parent, The Hartford Financial Services Group, Inc. ("HFSG"), WRR was able to borrow up to $1 billion from HFSG in order to maintain certain statutory capital levels required by its plan of operations and which could have been used by WRR to settle outstanding payables with HLAI. As of December 31, 2013, WRR has borrowed $655 under the intercompany note agreement.
Effective April 1, 2014, the Company recaptured all reinsured risks from WRR to HLAI. On April 30, 2014, the Hartford dissolved WRR which resulted in WRR paying off the $655 note and returning $345 in capital to The Hartford, all of which was contributed as capital to HLAI to support the recaptured risks. This transaction received required regulatory approvals. For further information regarding the WRR reinsurance agreement, see Note 11 -Transactions with Affiliates and Note 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements .
Derivative Commitments
Certain of the Company’s derivative agreements contain provisions that are tied to the financial strength ratings of the individual legal entity that entered into the derivative agreement as set by nationally recognized statistical rating agencies. If the legal entity’s financial strength were to fall below certain ratings, the counterparties to the derivative agreements could demand immediate and ongoing full collateralization and in certain instances demand immediate settlement of all outstanding derivative positions traded under each impacted bilateral agreement. The settlement amount is determined by netting the derivative positions transacted under each agreement. If the termination rights were to be exercised by the counterparties, it could impact the legal entity’s ability to conduct hedging activities by increasing the associated costs and decreasing the willingness of counterparties to transact with the legal entity. The aggregate fair value of all derivative instruments with credit-risk-related contingent features that are in a net liability position as of March 31, 2014, is $721. Of this $721 the legal entities have posted collateral of $780 in the normal course of business. In addition, the Company has posted collateral of $44 associated with a customized GMWB derivative. Based on derivative market values as of March 31, 2014, a downgrade of one or two levels below the current financial strength ratings by either Moody’s or S&P would not require additional assets to be posted as collateral. These collateral amounts could change as derivative market values change, as a result of changes in our hedging activities or to the extent changes in contractual terms are negotiated. The nature of the collateral that we would post, if required, would be primarily in the form of U.S. Treasury bills, U.S. Treasury notes and government agencies.
As of March 31, 2014, there were no derivative relationships that could be subject to immediate termination in the event of rating agency downgrades to either BBB+ or Baa1.
On March 6, 2014, Moody’s lowered its counterparty credit and insurer financial strength ratings on Hartford Life Insurance Company to Baa2. Given this downgrade action, termination rating triggers of four derivative counterparty relationships were impacted. The counterparties have the right to terminate the relationships and would have to settle the outstanding derivatives prior to exercising termination rights. The Company is in the process of re-negotiating the rating triggers which it expects to successfully complete.
Accordingly, the Company's hedging programs have not been adversely impacted by the announcement of the downgrade of Hartford Life Insurance Company. As of March 31, 2014, the notional amount and fair value related to this counterparty is $10.3 billion and $(34), respectively.
Insurance Operations
In the event customers elect to surrender separate account assets, the Company will use the proceeds from the sale of the assets to fund the surrender and the Company’s liquidity position will not be impacted. In many instances the Company will receive a percentage of the surrender amount as compensation for early surrender (surrender charge), increasing the Company’s liquidity position. In addition, a surrender of variable annuity separate account or general account assets will decrease the Company’s obligation for payments on guaranteed living and death benefits.
The Company may from time to time retire or repurchase its funding agreement backed notes through cash repurchases, in the open market, privately negotiated transactions or otherwise. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. In the first quarter of 2014, the Company did not repurchase any funding agreements. The amounts of any future repurchases may be material.
As of March 31, 2014, the Company’s cash and short-term investments of $2.7 billion, included $225 of collateral received from, and held on behalf of, derivative counterparties and $24 of collateral pledged to derivative counterparties. The Company also held $1.7 billion of treasury securities, of which $528 had been pledged to derivative counterparties and $1.9 billion of government agency securities of which $211 had been pledged to derivative counterparties.
Total general account contractholder obligations are supported by $38 billion of cash and total general account invested assets, excluding equity securities, trading, which includes a significant short-term investment position, as depicted below, to meet liquidity needs.
The following table summarizes the Company’s fixed maturities, short-term investments, and cash, as of March 31, 2014:
|
| | | |
Fixed maturities | $ | 28,446 |
|
Short-term investments | 2,086 |
|
Cash | 599 |
|
Less: Derivative collateral | 988 |
|
Total | $ | 30,143 |
|
Capital resources available to fund liquidity, upon contract holder surrender, are a function of the legal entity in which the liquidity requirement resides. Obligations related to life insurance products will be generally funded by both Hartford Life Insurance Company and Hartford Life and Annuity Insurance Company; obligations related to retirement and institutional investment products will be generally funded by Hartford Life Insurance Company; and obligations of the Company’s international annuity subsidiary and affiliate will be generally funded by the legal entity in the country in which the obligation was generated.
The Company is a member of the Federal Home Loan Bank of Boston (“FHLBB”). Membership allows the Company access to collateralized advances, which may be used to support various spread-based business and enhance liquidity management. The Connecticut Department of Insurance (“CTDOI”) will permit the Company to pledge up to $1.25 billion in qualifying assets to secure FHLBB advances for 2014. The amount of advances that can be taken are dependent on the asset types pledged to secure the advances. The pledge limit is recalculated annually based on statutory admitted assets and capital and surplus. The Company would need to seek the prior approval of the CTDOI if there were a desire to exceed these limits. As of March 31, 2014, the Company had no advances outstanding under the FHLBB facility.
|
| | | |
Contractholder Obligations | As of March 31, 2014 |
Total Contractholder obligations | $ | 187,649 |
|
Less: Separate account assets [1] | 138,480 |
|
General account contractholder obligations | $ | 49,169 |
|
Composition of General Account Contractholder Obligations | |
Contracts without a surrender provision and/or fixed payout dates [2] | $ | 16,363 |
|
Fixed MVA annuities [3] | 7,640 |
|
International fixed MVA annuities | 1,424 |
|
Guaranteed investment contracts (“GIC”) [4] | 30 |
|
Other [5] | 23,712 |
|
General account contractholder obligations | $ | 49,169 |
|
| |
[1] | In the event customers elect to surrender separate account assets or international statutory separate accounts, the Company will use the proceeds from the sale of the assets to fund the surrender, and the Company’s liquidity position will not be impacted. In many instances the Company will receive a percentage of the surrender charge, increasing the Company’s liquidity position. In addition, a surrender of variable annuity separate account or general account assets will decrease the Company’s obligation for payments on guaranteed living and death benefits. |
| |
[2] | Relates to contracts such as payout annuities or institutional notes, other than guaranteed investment products with an MVA feature (discussed below) or surrenders of term life, group benefit contracts or death and living benefit reserves for which surrenders will have no current effect on the Company’s liquidity requirements. |
| |
[3] | Relates to annuities that are recorded in the general account (under U.S. GAAP), although these annuities are held in a statutory separate account, as the contractholders are subject to the Company's credit risk. In the statutory separate account, the Company is required to maintain invested assets with a fair value greater than or equal to the MVA surrender value of the Fixed MVA contract. In the event assets decline in value at a greater rate than the MVA surrender value of the Fixed MVA contract, the Company is required to contribute additional capital to the statutory separate account. The Company will fund these required contributions with operating cash flows or short-term investments. In the event that operating cash flows or short-term investments are not sufficient to fund required contributions, the Company may have to sell other invested assets at a loss, potentially resulting in a decrease in statutory surplus. As the fair value of invested assets in the statutory separate account are generally equal to the MVA surrender value of the Fixed MVA contract, surrender of Fixed MVA annuities will have an insignificant impact on the liquidity requirements of the Company. |
| |
[4] | GICs are subject to discontinuance provisions which allow the policyholders to terminate their contracts prior to scheduled maturity at the lesser of the book value or market value. Generally, the market value adjustment reflects changes in interest rates and credit spreads. As a result, the market value adjustment feature in the GIC serves to protect the Company from interest rate risks and limit the Company’s liquidity requirements in the event of a surrender. |
| |
[5] | Surrenders of, or policy loans taken from, as applicable, these general account liabilities, which include the general account option for Individual Annuity individual variable annuities and the variable life contracts of the former Individual Life business, the general account option for annuities of the former Retirement Plans business and universal life contracts sold by the former Individual Life business may be funded through operating cash flows of the Company, available short-term investments, or the Company may be required to sell fixed maturity investments to fund the surrender payment. Sales of fixed maturity investments could result in the recognition of significant realized losses and insufficient proceeds to fully fund the surrender amount. In this circumstance, the Company may need to take other actions, including enforcing certain contract provisions which could restrict surrenders and/or slow or defer payouts. See Note 2 - Business Dispositions of Notes to the Condensed Consolidated Financial Statements as to the sale of the Retirement Plans and Individual Life businesses and related transfer of invested assets in January 2013. |
Off-Balance Sheet Arrangements and Aggregate Contractual Obligations
There have been no material changes to the Company’s off-balance sheet arrangements and aggregate contractual obligations since the filing of the Company’s 2013 Form 10-K Annual Report.
Dividends
Dividends to the Company from its insurance subsidiaries are restricted, as is the ability of the Company to pay dividends to its parent company. Future dividend decisions will be based on, and affected by, a number of factors, including the operating results and financial requirements of the Company on a stand-alone basis and the impact of regulatory restrictions.
The payment of dividends by Connecticut-domiciled insurers is limited under the insurance holding company laws of Connecticut. These laws require notice to and approval by the state insurance commissioner for the declaration or payment of any dividend, which, together with other dividends or distributions made within the preceding twelve months, exceeds the greater of (i) 10% of the insurer’s policyholder surplus as of December 31 of the preceding year or (ii) net income (or net gain from operations, if such company is a life insurance company) for the twelve-month period ending on the thirty-first day of December last preceding, in each case determined under statutory insurance accounting principles. In addition, if any dividend of a Connecticut-domiciled insurer exceeds the insurer’s earned surplus, it requires the prior approval of the Connecticut Insurance Commissioner. The insurance holding company laws of the other jurisdictions in which the Company’s insurance subsidiaries are incorporated (or deemed commercially domiciled) generally contain similar (although in certain instances somewhat more restrictive) limitations on the payment of dividends.
The Company’s subsidiaries are permitted to pay up to a maximum of approximately $1 billion in dividends in 2014 without prior approval from the applicable insurance commissioner. With respect to dividends to its parent, the Company’s dividend limitation under the holding company laws of Connecticut is $919 in 2014. However, because the Company’s earned statutory surplus was negative as of December 31, 2013, the Company is not permitted to pay any dividends to its parent in 2014 without prior approval from the Connecticut Insurance Commissioner.
Effective March 3, 2014, The Hartford made HLA the single nationwide underwriting company for its Group Benefits business by capitalizing HLA to support the Group Benefits business and separating it from the legal entities that support the Talcott Resolution operating segment. On January 30, 2014, The Hartford received approval from the State of Connecticut Insurance Department ("CTDOI") for HLAI and HLIC to dividend approximately $800 of cash and invested assets to HLA and this dividend was paid on February 27, 2014. All of the issued and outstanding equity of the Company was then distributed from HLA to Hartford Life, Inc. As a result, HLIC has no remaining ordinary dividend capacity for the twelve months following this transaction. Any additional dividends from HLIC in 2014 would be extraordinary in nature and require prior approval from the CTDOI.
Cash Flows |
| | | | | | |
| Three Months Ended March 31, |
| 2014 | 2013 |
Net cash provided by operating activities | $ | 881 |
| $ | 309 |
|
Net cash provided by (used for) investing activities | $ | 572 |
| $ | 1,424 |
|
Net cash used for financing activities | $ | (1,307 | ) | $ | (2,154 | ) |
Cash – end of period | $ | 599 |
| $ | 920 |
|
Net cash provided by operating activities increased in 2014 mainly due to an increase in changes in payables, accruals and other activity of approximately $900.
Net cash provided by investing activities in 2014 primarily relates to net proceeds of available-for-sale securities of $725, partially offset by change in short-term investments of $159. Net cash provided by investing activities in 2013 primarily relates to net proceeds of available -for-sale securities of $1.7 billion, net proceeds from businesses sold of $460, and net proceeds from mortgage loans of $76, partially offset by net payments on derivatives of $742.
Net cash used for financing activities in 2014 relates to a net capital contribution of $795, and net outflows on investment and universal life-type contracts of $506. Net cash used for financing activities in 2013 relates to a net capital contributions of $1.2 billion, fee repayment to recapture affiliate reinsurance of $347, decrease in securities loaned or sold of $274, and net outflows on investment and universal life-type contracts of $293.
Operating cash flows in both periods have been adequate to meet liquidity requirements.
Ratings
Ratings impact the Company’s cost of borrowing and its ability to access financing and are an important factor in establishing the competitive position in the insurance and financial services marketplace. There can be no assurance that the Company’s ratings will continue for any given period of time or that they will not be changed. In the event the Company’s ratings are downgraded, the Company’s cost of borrowing and the ability to access financing as well as its level of revenues, or the persistency of its business may be adversely impacted.
On March 6, 2014, Moody’s Investors Service (“Moody’s) affirmed the debt ratings of The Hartford Financial Services Group, Inc. and the insurance financial strength ratings of its property and casualty subsidiaries and Hartford Life and Accident Insurance Company. The outlook on these entities was changed to positive from stable. Moody’s downgraded the insurance financial strength rating of Hartford Life Insurance Company to Baa2 from A3. Moody’s affirmed the insurance financial strength rating of Hartford Life and Annuity Insurance Company. The outlook for Hartford Life Insurance Company and Hartford Life and Annuity Insurance Company is stable.
On April 22, 2014, Fitch downgraded the insurer financial strength rating of Hartford Life Insurance Company and Hartford Life and Annuity Insurance Company to BBB+ from A- with a stable outlook.
The following table summarizes Hartford Life Insurance Company’s significant member companies’ financial ratings from the major independent rating organizations as of April 23, 2014:
|
| | | | |
Insurance Financial Strength Ratings: | A.M. Best | Fitch | Standard & Poor’s | Moody’s |
Hartford Life Insurance Company | A- | BBB+ | BBB+ | Baa2 |
Hartford Life and Annuity Insurance Company | A- | BBB+ | BBB+ | Baa2 |
These ratings are not a recommendation to buy or hold any of the Company’s securities and they may be revised or revoked at any time at the sole discretion of the rating organization.
The agencies consider many factors in determining the final rating of an insurance company. One consideration is the relative level of statutory surplus necessary to support the business written. Statutory surplus represents the capital of the insurance company reported in accordance with accounting practices prescribed by the applicable state insurance department.
Statutory Surplus
The Company’s aggregate statutory capital and surplus, as prepared in accordance with the National Association of Insurance Commissioners’ Accounting Practices and Procedures Manual (“US STAT”), was $4.6 billion as of March 31, 2014 and $5 billion as of December 31, 2013, respectively. The statutory surplus amount as of December 31, 2013 is based on actual statutory filings with the applicable regulatory authorities. The statutory surplus amount as of March 31, 2014, is an estimate, as the first quarter 2014 statutory filings have not yet been made.
IMPACT OF NEW ACCOUNTING STANDARDS
For a discussion of accounting standards, see Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Consolidated Financial Statements included in the Company’s 2013 Form 10-K Annual Report and Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information contained in the Financial Risk Management section of Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Company's of the Company’s 2013 Form 10-K Annual Report is incorporated herein by reference.
Item 4. CONTROLS AND PROCEDURES
Evaluation of disclosure controls and procedures
The Company’s principal executive officer and its principal financial officer, based on their evaluation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) have concluded that the Company’s disclosure controls and procedures are effective for the purposes set forth in the definition thereof in Exchange Act Rule 13a-15(e) as of March 31, 2014.
Changes in internal control over financial reporting
On January 1, 2013, The Hartford implemented a new enterprise general ledger designed to create a simplified and standardized financial reporting environment while enhancing management's decision effectiveness and improving the control environment surrounding financial data and information. Effective January 1, 2014, the Company began accounting and reporting from the enterprise general ledger.
Part II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
The Company is involved in claims litigation arising in the ordinary course of business, both as a liability insurer defending or providing indemnity for third-party claims brought against insureds and as an insurer defending coverage claims brought against it. The Company accounts for such activity through the establishment of unpaid loss and loss adjustment expense reserves. Management expects that the ultimate liability, if any, with respect to such ordinary-course claims litigation, after consideration of provisions made for potential losses and costs of defense, will not be material to the consolidated financial condition, results of operations or cash flows of the Company.
The Company is also involved in other kinds of legal actions, some of which assert claims for substantial amounts. These actions include, among others, individual actions in which punitive damages are sought, such as claims alleging bad faith in the handling of insurance claims or other allegedly unfair or improper business practices. Management expects that the ultimate liability, if any, with respect to such lawsuits, after consideration of provisions made for estimated losses, will not be material to the consolidated financial condition of the Company. Nonetheless, given the large or indeterminate amounts sought in certain of these actions, and the inherent unpredictability of litigation, the outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows in particular quarterly or annual periods.
Item 1A. RISK FACTORS
Investing in the Company involves risk. In deciding whether to invest in the securities of the Company, you should carefully consider the risk factors disclosed in Item 1A of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, any of which could have a significant or material adverse effect on the business, financial condition, operating results or liquidity of the Company. This information should be considered carefully together with the other information contained in this report and the other reports and materials filed by the Company with the SEC.
Item 6. EXHIBITS
|
| |
See Exhibits Index on page | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HARTFORD LIFE INSURANCE COMPANY
|
|
/s/ Peter F. Sannizzaro |
Peter F. Sannizzaro Senior Vice President and Principal Accounting Officer (Principal Financial Officer and duly authorized signatory) |
May 2, 2014 |
HARTFORD LIFE INSURANCE COMPANY AND SUBSIDIARIES
FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2014
EXHIBITS INDEX
|
| | |
Exhibit No. | | |
| | |
12.01 | | Computation of Ratio of Earnings to Fixed Charges ** |
| | |
15.01 | | Deloitte & Touche LLP Letter of Awareness ** |
| | |
31.01 | | Certification of Beth A. Bombara pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ** |
| | |
31.02 | | Certification of Peter F. Sannizzaro pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ** |
| | |
32.01 | | Certification of Beth A. Bombara pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ** |
| | |
32.02 | | Certification of Peter F. Sannizzaro pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ** |
| | |
101.INS | | XBRL Instance Document ** |
| | |
101.SCH | | XBRL Taxonomy Extension Schema ** |
| | |
101.CAL | | XBRL Taxonomy Extension Calculation Linkbase ** |
| | |
101.DEF | | XBRL Taxonomy Extension Definition Linkbase ** |
| | |
101.LAB | | XBRL Taxonomy Extension Label Linkbase ** |
| | |
101.PRE | | XBRL Taxonomy Extension Presentation Linkbase ** |
**Filed with the Securities and Exchange Commission as an Exhibit to this report.